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ABSTRACT 
 
The role of RAD54 N-terminal domain in branch migration of Holliday 
junctions 
Nadish Goyal 
Alexander V. Mazin, Ph.D.  
 
 Homologous recombination plays an important role in repairing the most 
harmful types of DNA damage, including DNA double-strand breaks and inter-
strand cross-links, in promoting faithful chromosome segregation during meiosis, 
and in telomere maintenance. RAD54 protein, a member of theSwi2/Snf2 family 
of ATP-dependent DNA translocases, is crucial to the homologous recombination 
pathway. The protein is conserved in all eukaryotes. RAD54 is a multifunctional 
protein that promotes branch migration of Holliday Junctions, chromatin 
remodeling, and stimulation of DNA strand exchange activity of RAD51. The 
structure of RAD54 lacking the N-terminal domain has been solved. The central 
domain of RAD54 has DNA dependent ATPase motifs that are well conserved in 
all members of helicase Superfamily 1 and 2; however, the N-terminal domain is 
unique for RAD54 orthologues and is not well understood.  
Here, using biochemical approaches and site-directed mutagenesis, we 
characterized the role of the RAD54 N-terminal domain in branch migration of 
Holliday junctions. We found that by removing N-terminal domain residues we 
were able to uncouple ATPase and branch migration activities of RAD54. Also, 
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we found that a recently identified DNA binding site in the N-terminal domain of 
RAD54 has a preference for branched DNA substrates similar to that of the full 
length RAD54. Disruption of DNA binding of the N-terminal domain inhibited the 
branch migration activity of RAD54 without affecting its ATPase activity. Our 
results demonstrate for the first time that the DNA binding by the N-terminal 
domain is necessary for the branch migration activity of RAD54. This requirement 
of second DNA binding domain for branch migration may be conserved among 
branch migration proteins.  
 We also identified specific small-molecule inhibitors for branch migration 
activity of RAD54. Interestingly, the initial analysis showed that two small-
molecule compounds, C-A23, and C-G01 had a stronger inhibition on branch 
migration without significantly affecting its ATPase activity. This suggests that 
they may inhibit branch migration by interacting with the N-terminal domain of 
RAD54. However, further work needs to done to determine their exact 
mechanism of action and the function of branch migration in cells using these 
inhibitors. 
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INTRODUCTION 
 
Homologous recombination is a highly conserved mechanism involved in 
the maintenance of genomic stability by repairing toxic DNA lesions such as 
double-strand breaks, DNA inter-strand crosslinks and stalled replication forks in 
somatic cells. Homologous recombination pathway is also required for accurate 
segregation of chromosomes during meiosis by generating crossovers between 
paternal and maternal chromosomes (Bishop, 2006; Neale and Keeney, 2006; 
Pâques and Haber, 1999; Stark and Jasin, 2003). All homologous recombination 
pathways are generally considered error-free as they require an intact homologous 
strand of DNA to serve as a donor template for repair of the broken chromosome. 
The process of homologous recombination involves recognition of a double-strand 
break site, resection of DNA ends with the help of endonucleases to generate DNA 
duplex with protruding 3’ single-stranded DNA tails (Figure 1.1). RAD51 
recombinase binds to the resected ssDNA tails to form a nucleoprotein filament 
that searches for homologous double-strand DNA. Once homology is found, the 
nucleoprotein filament invades the homologous duplex DNA which results in the 
formation of displacement loop or D-Loop. After the D-loop intermediate is formed, 
3’-end of the invading strand is extended followed by capture of the second strand 
of the broken chromosome by a process called strand annealing, finally resulting 
in the formation of double D-loops that are converted to Holliday junctions. Branch 
migration and resolution of Holliday junctions ultimately result in generating 
crossover or non-crossover products (Gravel et al., 2008; San Filippo et al., 2008; 
Venkitaraman, 2002). 
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Figure 1.1 The DNA double‐strand break repair by Homologous 
Recombination. The initial steps involve, 5’ to 3’ exonucleolytic processing of 
double-strand break ends to produce 3’‐ssDNA tails, the formation of Rad51‐
ssDNA filaments, search for homology and strand invasion into the homologous 
duplex DNA‐template leading to the formation of displacement loops (D‐loop). 
Then, homologous recombination may proceed either by (A) SDSA forming non‐
crossover products or (B) DSBR forming crossover products.  
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In addition to the Homologous Recombination pathway, DNA double-strand 
breaks can also be by Non-Homologous End-Joining. The selection of the 
mechanism of double-strand break repair depends on whether the DNA ends at 
the double-strand break site are resected or not. While the Non-homologous End 
joining pathway is effective only when the double-strand break ends are intact and 
not resected (Mimitou and Symington, 2008), the homologous recombination 
pathway requires the resected 3’ ssDNA tail to proceed as mentioned above 
(Figure 1.1). Hence, resection of double-strand break ends can be termed as the 
committed step in the homologous recombination pathway. This step is 
accomplished by specialized multifunctional enzyme complexes that contain DNA 
break recognition proteins, helicases, and nucleases that are regulated by specific 
DNA sequences in prokaryotes and cyclin-dependent kinases in eukaryotes. 
Various components of the homologous recombination pathway initiate the repair 
process upon resection of DNA ends at the double-strand break site. Depending 
on the mode of DNA repair, homologous recombination is sub-categorized into two 
major pathways namely, double strand break repair pathway, DSBR, and 
synthesis dependent strand annealing pathway, SDSA (Figure 1.1). The DSBR 
pathway is characterized by the formation of a double-Holliday junction, unlike the 
SDSA pathway which involves the formation of a single Holliday junction. In the 
SDSA pathway, the D-loop complex formed by the extension of the invading strand 
by DNA polymerase on the homologous DNA sequence dissociates by branch 
migration and anneals with the complimentary resected end as opposed to the 
DSBR pathway in which second-end capture takes place. Hence, SDSA pathway 
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produces only non-crossover products as a result of bypassing the second-end 
capture step (Nimonkar et al., 2008; Zhu et al., 2008). This pathway is especially 
important during DNA double-strand break repair in somatic cells. In contrast, the 
DSBR pathway that generates crossing over is essential for segregation of 
homologous chromosomes during meiosis (Allers and Lichten, 2001).  
 
1.1 MULTI-PROTEIN COMPLEXES INVOLVED IN EUKARYOTIC 
HOMOLOGOUS RECOMBINATION REPAIR 
 
Early studies to understand the mechanism of homologous recombination 
in eukaryotes were carried out in yeast. In particular, Saccharomyces cerevisiae 
was used as a model organism for studying homologous recombination. Several 
key proteins were identified in S. cerevisiae mutant screens which demonstrated 
increased sensitivity to ionizing radiation with little sensitivity to ultraviolet radiation 
(Game and Mortimer, 1974). These proteins which included Rad50, Rad51, 
Rad52, Rad54, Rad55, Rad57, Rad59, Mre11, and Xrs2 belongs to the RAD52 
epistasis group that constitutes the core of the homologous recombination 
enzymatic machinery (Sommer et al., 1998; Story and Steitz, 1992). Each of these 
proteins has a distinct role to play in both mitotic and meiotic recombination. 
Furthermore, a few members of the Rad52 epistasis group such as Rad50, Rad51, 
Rad52, Rad54 and Mre11 have mammalian analogues which make them critical 
proteins in the homologous recombination pathway. 
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1.1.1 Proteins involved in pre-synaptic resection of double-strand break 
ends 
In yeast, a heterotrimeric protein complex known as the MRX (Mre11-
Rad50-Xrs2) complex participates in processing of the DNA double-strand break 
ends to generate 3’-ssDNA tails (Figure 1.1). In higher eukaryotes, including 
humans, its homologue is known as MRN (MRE11-RAD50-NBS1). The end 
resection occurs in two steps in yeast and follows the same pattern in humans as 
well, which involves initial limited resection followed by a processive resection 
(Neveling et al., 2009). The MRX or MRN complex participates only in the initial 
limited resection. Of these proteins, Mre11 is a highly conserved eukaryotic 
nuclease protein that binds first to the DNA double-strand break ends (Lindsley 
and Cox, 1990). As with most other yeast proteins, Mre11 is the yeast homolog of 
human MRE11. Mre11 initially forms a complex with Rad50 and is recruited to the 
double-strand break site for nucleolytic processing. Another yeast protein Xrs2, 
which is also a functional homolog of human Nbs1, associates with Mre11 and 
Rad50 to form the heterotrimeric Mre11/Rad50/Xrs2, MRX complex in yeast. The 
function of Xrs2 in yeast or Nbs1 in humans has not been fully understood but 
several studies demonstrate Xrs2 to be involved in targeting Mre11 and Rad50 to 
the double-strand break site. Once formed, the MRX complex further associates 
with the Sae2 nuclease to eliminate a short nucleotide from double-strand break 
ends to complete the initial limited resection (Lieber et al., 2003). Protein CtIP is 
the human homolog of yeast Sae2 protein and shares a region of homology with 
Sae2 in its C-terminal domain containing 108 amino acids. CtIP protein performs 
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a similar function of stimulating Mre11 endonucleolytic activity (Neveling et al., 
2009; West et al., 1998). Several studies demonstrated that yeast strains carrying 
mutations in Mre11, Rad50 or Xrs2 genes showed defects in meiotic 
recombination and DNA repair. These mutants also show delayed processing of 
double-strand break ends in mitotic cells thereby confirming the importance of the 
MRX complex in early stages of homologous recombination (Galletto et al., 2006; 
Lindsley and Cox, 1990; McEntee et al., 1981; Sattin and Goh, 2004). 
Following the initial limited resection, two distinct pathways emerge for the 
processive resection (Neveling et al., 2009). One pathway employs a 5’ to 3’ 
exonuclease protein, Exo1, whereas the other pathway utilizes two proteins – Sgs1 
helicase and Dna2 nuclease. The human homologs for several of the yeast 
proteins involved in the end-resection pathway have been identified. The human 
homolog of yeast Sgs1 is BLM helicase, and both the proteins belong to the RecQ 
family of helicases. Also, yeast Exo1 and human Exo1 protein sequences are 27% 
identical and 55% similar suggesting comparable functional properties (Walker et 
al., 2001). In vitro studies demonstrated that BLM stimulates human Exo1 
resection activity by physically interacting with it in an ATP independent manner 
(Walker et al., 2001). This complex assembly of proteins exemplifies the 
importance of DNA double-strand break end resection in homologous 
recombination. 
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1.1.2 Role of Rad51 recombinase and Rad54 helicase-like protein during 
Homologous Recombination 
 
Once the double-strand break ends undergo resection to produce 3’-ssDNA 
overhangs, Rad51 recombinase binds to ssDNA ends, forming a contiguous 
nucleoprotein filament (Kowalczykowski, 2008). This nucleoprotein filament then 
searches for homologous DNA sequence to use as a template for double-strand 
break repair (Chen et al., 2008; Kowalczykowski, 2008; Ogawa et al., 1993; 
Stasiak and Di Capua, 1982). One model for homology search comprises cycles 
of binding and releasing potential homologous templates until homology is located. 
This is the random collision model and is ATPase-independent. (Kowalczykowski, 
1991; Sung et al., 2003). Another model, sliding model wherein the nucleoprotein 
filament can diffuse along the dsDNA track has recently gained an experimental 
support (Ragunathan et al., 2012). Once homology is found, the nucleoprotein 
filament invades the homologous DNA template, displacing one of the DNA 
strands of the duplex DNA, forming a displacement loop (D-loop or joint molecule) 
(Figure 1.2). The invading DNA strand is then extended by DNA polymerase and 
the cross structure formed at the point of strand exchange is known as a Holliday 
junction (Holliday, 2007; Liu and West, 2004). Depending upon the DNA repair 
pathway, the Holliday junction can either be dissolved or extended by movement 
along the DNA axis in a process called branch migration. Several proteins were 
identified in eukaryotes able to perform branch migration of Holliday junctions; 
RAD54 is the most potent among them (Mazin et al., 2010). The structure-specific 
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endonuclease, Mus81-Eme1, can carry out the resolution of the Holliday junctions 
to produce crossover or non-crossover products and complete the repair process 
(Heyer, 2004; Liu and West, 2004).  
 
 
Figure 1.2 Strand-Exchange activity of RAD51. The in vivo strand-exchange 
activity of RAD51 (left) is mimicked using a D-loop formation assay in vitro (right). 
The nucleoprotein filament is formed by incubation of RAD51 protein with single-
stranded DNA, following which homologous double-stranded DNA (pUC19) is 
added to form D-loops. 
 
 
Rad51, a member of the RAD52 epistasis group, is a highly conserved 
recombinase. Rad51 shares structural homology with RecA recombinase (30% 
identity) found in E. coli (Sung et al., 2003). Rad51 binds single-stranded DNA 
forming a right handed helical filament, in which DNA structure is significantly 
extended (Story et al., 1992; Sung et al., 2003). Rad51/RecA has two DNA binding 
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sites: the primary binding site is involved in filament formation and the secondary 
binding site allows for the capture of duplex DNA during the search for homology 
(Kowalczykowski, 1991; Sung et al., 2003). Rad51’s ability to differentiate between 
single-stranded and double-stranded DNA as well as the stability of the Rad51-
single-stranded DNA filament can be modulated by different ions (Liu et al., 2004; 
Shim et al., 2006; Sigurdsson et al., 2001). In presence of Ca2+ ion, hRad51 forms 
an active and stable Rad51-single-stranded-DNA filament whereas, in presence 
of Mg2+ ion, it forms an inactive filament (Bugreev and Mazin, 2004). Ca2+ slows 
down the rate of ATP hydrolysis by Rad51, preventing Rad51 dissociation from 
nucleoprotein filament, and thus stimulates strand exchange and joint molecule 
formation between single-stranded DNA and the homologous duplex DNA 
(Bugreev and Mazin, 2004). This Ca2+ dependent stimulation may be biologically 
relevant because an elevation in Ca2+ levels has been observed in human cells 
during the DNA damage response (Gafter et al., 1997; Negre-Salvayre and 
Salvayre, 1992; Sakai et al., 1994; Schieven et al., 1993; Spielberg et al., 1991) 
as well as during meiosis I when homologous recombination is thought to take 
place (Carroll et al., 1994; Tombes et al., 1992). Therefore, by modulating Rad51’s 
ATPase activity, filament stabilization and strand exchange activity of Rad51 can 
be regulated (Bugreev and Mazin, 2004). 
Rad54 has been shown to stabilize Rad51 nucleoprotein filaments (Mazin 
et al., 2003). Rad54 interacts physically and functionally with Rad51 (Clever et al., 
1997; Raschle et al., 2004), and stimulates the strand exchange activity of Rad51.  
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Rad54 belongs to the SWI2/SNF2 family of helicase-like proteins and is 
evolutionarily conserved. The members of this family of helicase-like proteins are 
known for their chromatin remodeling activity. The helicase-like proteins do not 
have DNA strand separation activity like canonical helicases, however, they use 
DNA-dependent ATP hydrolysis to translocate along the DNA generating positive 
supercoils in the DNA ahead and negative supercoils behind the protein. This 
allows the DNA strands to transiently “breathe”. Rad54 promotes chromatin 
remodeling and displacement of proteins from double-stranded DNA. Importantly, 
it binds Holliday junctions with high affinity and drives their branch migration in an 
ATPase dependent manner (Bugreev et al., 2006b). Rad54 interacts with Mus81-
Eme1 (Mms4), a structure-specific endonuclease, stimulating its DNA cleavage 
activity (Matulova et al., 2009; Mazina and Mazin, 2008). Thus, Rad54 is a 
multifunctional protein performing functions throughout homologous recombination 
and linking the whole process together (Mazin et al., 2010). 
 
1.2 FUNCTIONS OF RAD54 IN HOMOLOGOUS RECOMBINATION 
The RAD54 gene was discovered in genetic screens for Saccharomyces 
cerevisiae mutants conferring strong sensitivity to ionizing radiation (IR), but only 
moderate sensitivity to ultra violet (UV) light (Game and Mortimer, 1974; Suslova, 
1969; Zacharov, 1970). Complementation analysis identified it as a member of the 
RAD52 epistasis group constituting the core of the homologous recombination 
enzymatic machinery (Symington, 2002). Rad54, along with Rad51 and Rad52, is 
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one of the three most IR-sensitive mutants in S. cerevisiae (Friedberg et al., 1995; 
Game, 1993). 
In vivo, Rad54 is a moderately abundant nuclear protein. There are an 
estimated 7× 103 and 2.4 × 105 Rad54 molecules per cell in exponentially growing 
diploid yeast cells and in an unsynchronized population of mouse embryonic stem 
(ES) cells, respectively (Clever et al., 1999; Essers et al., 2002a). In both yeast 
and mammals, Rad54 expression shows cell cycle dependence with an increase 
in transcription during late G1 phase (Cole and Mortimer, 1989; Cole et al., 1989; 
Essers et al., 2002a; Johnston and Johnson, 1995). This increase in S and G2 
phases is also observed with other recombination proteins indicating the important 
role of homologous recombination during DNA replication and may account for the 
increased resistance of cells to DNA double-strand break-inducing agents in G2 
(Takata et al., 1998).  
Rad54 is a well conserved protein of the Rad52 group, a generally well 
conserved group in eukaryotes. For instance, hRad54 shares 66% similarity and 
48% identity with yRad54 (Kanaar et al., 1996; Petrini et al., 1997; Thoma et al., 
2005). Rad54 has homologues in other eukaryotes including S. pombe (Muris et 
al., 1996), Arabidopsis (Shaked et al., 2006), Drosophila (Kooistra et al., 1997), 
chicken (Bezzubova et al., 1997), zebrafish (Thoma et al., 2005), mouse, humans 
(Haseltine and Kowalczykowski, 2009; Kanaar et al., 1996), and, at least, in one 
archaean genus, Sulfolobus (Durr et al., 2005). Despite structural conservation 
among the Rad52 group members, their functions in recombination and DNA 
repair across different organisms are not fully conserved. In S.cerevisiae and S. 
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pombe, rad51 and rad54 mutants (rhp51 and rhp54, in S. pombe) show almost 
indistinguishable phenotypes with respect to the severity of their damage 
sensitivities (e.g., IR, UV-light), recombination, and chromosome loss in mitotic 
cells (Muris et al., 1993; Muris et al., 1996) whereas, the phenotypes of RAD51-/- 
and RAD54-/- mutants are significantly different in mice, as well as in chicken cells. 
RAD51 gene disruption causes early embryonic lethality of mice. Even in cell 
culture, the RAD51 knockouts fail to proliferate (Lim and Hasty, 1996; Sonoda et 
al., 1998; Tsuzuki et al., 1996). In contrast, disruption of the RAD54 gene results 
in viable mice. However, the sensitivity of mouse embryonic stem cells and chicken 
DT-40 cells to IR and methyl methanesulfonate (MMS) is increased (Bezzubova 
et al., 1997; Essers et al., 1997; Essers et al., 2000). 
In mammals, the RAD54 gene plays the most important role during early 
developmental stages. In mice, RAD54-/- mutants show hypersensitivity to ionizing 
radiation during early developmental stages which is rescued by Non-homologous 
end joining pathway in adult mice (Essers et al., 2000). However, regardless of the 
developmental stage, RAD54-/- mice are hypersensitive to DNA damage caused 
by interstrand cross-linking agents (ICL), e.g., mitomycin C, which cannot be 
repaired by the Non-homologous end joining (De Silva et al., 2000). Furthermore, 
mutations in the RAD54 gene have been linked to breast, colon and lymphoma 
cancer which is consistent with the role of Rad54 in maintaining genomic stability 
(Matsuda et al., 1999). 
Rad54 also plays an important, but less critical, role in other classes of 
homologous recombination events. In S. cerevisiae, rad54 mutations cause a 
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relatively mild defect in mating-type switching, while rad51 and rad52 mutations 
completely abolish this recombination event (Schmuckli-Maurer and Heyer, 1999). 
In S. cerevisiae, Rad54 plays a relatively minor role in meiotic recombination, due 
to the presence of a meiosis-specific homologue, Rdh54/Tid1 (Klein, 1997). The 
spore viability in the rad54 single mutant is reduced to 25-65% whereas the rad54 
rdh54 double mutant is fully defective in viable spore formation, demonstrating that 
these two homologous proteins collectively possess the activities important for 
meiotic recombination (Schmuckli-Maurer and Heyer, 2000; Shinohara et al., 
1992; Shinohara et al., 1997). In mice, Rad54 plays a minor role in meiotic 
recombination, since RAD54-/- mutants are fertile (Essers et al., 1997). Meiosis-
specific Rad54 homologues are yet to be identified in higher eukaryotes. 
Mammalian Rad54B, which was initially thought to be the Rad54 meiosis-specific 
homolog, does not appear to have an important function in meiosis; as both 
RAD54B-/- and RAD54-/- RAD54B-/- mice are fertile (Wesoly et al., 2006). 
 
1.3 STRUCTURAL FEATURES OF RAD54 PROTEIN 
Rad54 sequencing identified it as a member of the group of proteins 
involved in translocation along nucleic acids that are broadly defined as helicases 
(Gorbalenya and Koonin, 1993; Troelstra et al., 1992). The common feature of 
these proteins is that they couple ATP hydrolysis to directional movement along 
nucleic acids, which may or may not result in strand separation of nucleic acids. 
Members of this group have a role in almost every cellular process from DNA 
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replication and repair, transcription, translation, splicing, and nuclear transport 
(Singleton et al., 2007). 
 Rad54 is a member of Superfamily (SF) 2 of helicases (Troelstra et al., 
1992). Rad54 possesses seven classical “signature” motifs: I, Ia, II, III, IV, V, and 
VI, a characteristic of SF2 protein members (Figure 1.3) (Nimonkar et al., 2007) 
plus several more recently identified motifs, like TxGx between motif Ia and motif 
II that is thought to play a role in oligonucleotide binding. The seven conserved 
motifs line the two RecA-like motor domains, constituting the “core” or the minimal 
translocation motor responsible for the conversion of energy from ATP hydrolysis 
to the mechanical energy needed for translocation (Singleton et al., 2007).  
Within SF2 superfamily, Rad54 belongs to the Snf2 (also known as 
SWI2/SNF2) protein family of dsDNA-dependent ATPases. Unlike canonical DNA 
helicases, Snf2 family members cannot separate strands of the duplex DNA. 
Instead, the Snf2 proteins can translocate along DNA, to carry out chromatin 
remodeling, DNA topology alterations, and displacement of proteins from DNA 
(Haushalter and Kadonaga, 2003; Nimonkar et al., 2007). Several structural 
characteristics distinguish the Snf2 proteins from proteins of other SF2 families, 
e.g., DEAD-box RNA helicases, the RecQ helicase family, the DEAH helicase 
family, and others (Nimonkar et al., 2007). Each RecA-like lobe contains one of 
the Snf2-specific insertions HD1 and HD2 (helical domains 1 and 2). In the primary 
sequence, these protrusions are inserted between motifs III and IV, making the 
spacing between these two motifs much larger in Snf2 proteins as compared to 
the rest of the SF2 proteins (Flaus and Owen-Hughes, 2001).  
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X-ray crystallographic structures for two Rad54 orthologues, from zebrafish 
and Sulfolobus solfataricus, have been solved (Figure 1.3) (Durr et al., 2006; Durr 
et al., 2005; Thoma et al., 2005). The zebrafish Rad54 structure includes a part of 
the N-terminal domain, the two RecA-like α/β-domains (lobe 1 and 2) found in all 
SF1 and SF2 helicases, and the carboxyl-terminal domain (Thoma et al., 2005). 
Each RecA-like lobe contains one insertion HD1 and HD2, respectively, which 
appear as protrusions (Durr et al., 2005; Thoma et al., 2005). The carboxyl-
terminal domain appears to be the only element unique to Rad54 that is present in 
the truncated structures. The carboxyl-terminal domain contains a tentative Zn-
coordinating motif that may stabilize its entire assembly. The crystal structure of 
the catalytic domain of the S. solfataricus Rad54 homolog bound to a dsDNA 
substrate provided insight into the mechanism of Snf2 ATPases translocation 
along dsDNA, which is consistent with the inchworm translocation mechanism, 
similar to that described for other helicases (Singleton et al., 2007).  
Though the RecA-like domains are conserved amongst the members of the 
helicase family proteins, the amino and the carboxyl-terminal domains of Rad54 
are unique. Even among the Rad54 orthologues, the N-terminal domain is not well 
conserved (Figure 1.4). Proteolysis studies have shown that the N-terminal domain 
of Rad54 is relatively unstructured and was therefore removed from the structural 
studies (Raschle et al., 2004). A second DNA-binding site in the N-terminal domain 
of Rad54 has been reported recently (Wright and Heyer, 2014). The N-terminal 
domain of other DNA helicases has been shown to contain motifs that confer 
functional specificity to these proteins (Briggs et al., 2005; Soultanas et al., 2000). 
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Removal of the N-terminal domain in Saccharomyces cerevisiae Rad54 severely 
weakens its physical and functional interaction with Rad51 (Raschle et al., 2004). 
The structures of the PcrA and RecG helicases show that the N-terminal domain 
is involved in protein-DNA interactions and allows these proteins to bind 
specifically to branched DNA structures (Singleton et al., 2001; Velankar et al., 
1999). Moreover, the structures of proteins from Superfamilies 3-6, show that 
these proteins form hexamers through amino-terminal contacts (Enemark and 
Joshua-Tor, 2006; Huyton et al., 2003; Singleton et al., 2000; Skordalakes and 
Berger, 2003). Therefore, the N-terminal domain of nucleic acid translocases might 
contain motifs that provide substrate specificity, contacts for protein-protein 
interactions, and the scaffold for oligomerization. 
 
 
Figure 1.3 Structure of Rad54 protein. The X-ray crystal structure of Zebrafish 
Rad54 (PDB code: 1Z3I). The conserved Rec-A like motor domains are shown in 
blue and cyan. The N-terminal domain and C-terminal domain are unique to Rad54 
orthologues and are shown in red and yellow, respectively.   
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S.cerevisiae       1 MARRRLPDR-------PPNGIGAGE---RPRLV-PRPI---NVQDSV----NRLTK------PFRV   42  
S.pombe            1 MIQQPTTAKPRISTSSKLNTVLSKNKENVPGKL-FKKF------KCP----SLVISEKRKELPLRK   55  
Fruitfly           1 MRRSLAPSQ--R-GPLRPESR----HSFTPPLLKKNKRSCQQELEREQELDRRRLG------ALRD   53  
Zebrafish          1 MRRSLAPSQ--V-AKRKQGPDSDDEEDWEPDMEPQSKR------DCR----EKYIS------PYRK   47  
Chicken            1 L------------AKRKAGGEE-EDGEWRPPAT-QKRQKAGSEAESA----DCYRS------PFRK   42  
Mouse              1 MRRSLAPSQ--L-ARRKPEDRSSDDEDWQPGTVTPKKRKSSSETQVQ----ECFLS------PFRK   53  
Human              1 MRRSLAPSQ--L-AKRKPEGRSCDDEDWQPGLVTPRKRKSSSETQIQ----ECFLS------PFRK   53  
 
S.cerevisiae      43 PYK-NT--HIPPAAGRIATGSDNIVGGRSLRKRSATVCYSGLDINADEAEYNSQDI-SFSQLTKRR  104  
S.pombe           56 KPRVNY--SEYG----------------------------SVDGKYDSAY-VSENVSGLATIKEAN   90  
Fruitfly          54 A-SNTSELPLP-------------------------IR--FTANSEYEL-----------------   74  
Zebrafish         48 PLTPLT--NRP-------------------------V---CADGNEHEA-----------------   66  
Chicken           43 PLTQLT--NRP-------------------------L---CLDSSQHEA-----------------   61  
Mouse             54 PLTQLL--NRP-------------------------P---CLDSSQHEA-----------------   72  
Human             54 PLSQLT--NQP-------------------------P---CLDSSQHEA-----------------   72  
 
S.cerevisiae     105 KDALSAQRLAKDPTRLSHIQYTLRRSFTVPIKG--YVQ-----RHSLPLTLGMKKKITPEPRPLHD  163  
S.pombe           91 -------RLILNHER-RDPSTVIKKQFSVPKPIKGHEDISKLCAHRPPPTLGMKRKVDFIPRPLYD  148  
Fruitfly          75 -----------------AIAKVLARKFKVPMDN--YVP-----DYGGKRVLGVRRC--ISRRPLHD  114  
Zebrafish         67 -----------------FIRKILSKPFKIPIPN--YTG-----VL-GLRALGLRRA--GVRKALHD  105  
Chicken           62 -----------------FIRSILSKPFKVPIPN--YKG-----PT-GLRALGIKRA--GLRSPLHD  100  
Mouse             73 -----------------FIRSILSKPFKVPIPN--YQG-----PL-GSRALGLKRA--GVRRALHD  111  
Human             73 -----------------FIRSILSKPFKVPIPN--YQG-----PL-GSRALGLKRA--GVRRALHD  111  
 
S.cerevisiae     164 PTDEFAIVLYDPSVDGEMIVHDTSMDNKEEES-KKMIKSTQEKDN---INKEKNSQEERPTQRI--  223  
S.pombe          149 PADEFAIVLYDPTTDADEIIPDIKEVLAEKRKKDELLKNRKGKKEISDSEPESDHDSCVSTDTVAS  214  
Fruitfly         115 PMACNALVLFHPP-----------------------------------------------------  127  
Zebrafish        106 PFEDGALVLYEPP-----------------------------------------------------  118  
Chicken          101 PFEEGALVLYEPP-----------------------------------------------------  113  
Mouse            112 PLEEGALVLYEPP-----------------------------------------------------  124  
Human            112 PLEKDALVLYEPP-----------------------------------------------------  124  
 
S.cerevisiae     224 -GRHPALMTNGV-----RNKPLRELLGDSENSAENKKK--FASVPVVIDPKLAKILRPHQVEGVRF  281  
S.pombe          215 CSTEQSLITSNTSKHRRPNKSLKDLLG------IQKEKPPPPPVAVVIDPKLARILRPHQIEGVKF  274  
Fruitfly         128 ------------------AYTEHERMG------MDPTK---VLVHVVVDPLLSNILRPHQREGVRF  166  
Zebrafish        119 ------------------AISAHDLIK------ADKEK---LPVHVVVDPVLSKVLRPHQREGVKF  157  
Chicken          114 ------------------LLSAHEQLK------IDKDK---VPVHVVVDPVLSRVLRPHQREGVKF  152  
Mouse            125 ------------------PLSAHDQLK------LDKEK---LPVHVVVDPVLSKVLRPHQREGVKF  163  
Human            125 ------------------PLSAHDQLK------LDKEK---LPVHVVVDPILSKVLRPHQREGVKF  163  
 
 
Figure 1.4 Sequence alignment of the N-terminal domain of Rad54 orthologs. 
The Rad54 aa sequences from Saccharomyces cerevisiae, Saccharomyces 
pombe, fruitfly (Drosophila melanogaster), zebrafish (Danio rerio), chicken (Gallus 
gallus), mouse (Mus musculus), and humans (Homo sapiens) were analyzed using 
multiple sequence alignment program, T-coffee (Di Tommaso et al., 2011). Pink, 
yellow, green, and blue colored regions show high, low, very low, and no 
conservation among sequences, respectively. 
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1.4 BIOCHEMICAL ACTIVITIES OF RAD54 PROTEIN 
 
1.4.1 Rad54 has ds-DNA dependent ATPase activity 
The biochemical activities of yeast and human Rad54 have been 
extensively studied. Both the Rad54 orthologues were found to have robust 
dsDNA-dependent ATP hydrolysis activity (Petukhova et al., 1998; Petukhova et 
al., 1999; Swagemakers et al., 1998), with a kcat ~ 3000-6000 min-1 (Mazina et al., 
2007).   
  Rad54 binding to ss DNA does not stimulate its ATPase activity, although it 
shows similar binding affinities for both ssDNA and dsDNA (Petukhova et al., 1998; 
Swagemakers et al., 1998; Tanaka et al., 2002). Compared to linear ssDNA or 
dsDNA, Rad54 shows a significantly higher binding affinity for branched DNA 
structures. The binding preference is strongest, approximately 200-fold, for the 
partial Holliday (PX) junction when compared to ssDNA or dsDNA fragments of the 
same length (Bugreev et al., 2006b).  
 
1.4.2 Rad54 translocates on ds-DNA  
 Unlike canonical helicases that have strand separation activity, Rad54 does 
not show strand separation activity (Petukhova et al., 1998) but can translocate on 
DNA. The ability of Rad54 to translocate on DNA was inferred from the biochemical 
data; where it introduced equivalent positive and negative supercoiled domains 
into closed circular dsDNA in an ATPase-dependent manner (Figure 1.5) 
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(Petukhova et al., 1999; Ristic et al., 2001; Tan et al., 1999; Van Komen et al., 
2000). In accord with Rad54’s ability to translocate on DNA, the rate of ATP 
hydrolysis increases with increase in the length of dsDNA (Mazina and Mazin, 
2004). Also, as expected for DNA translocating protein, Rad54 is able to dissociate 
a DNA triple-helix (Jaskelioff et al., 2003) in the assay that was originally developed 
to follow the translocation of a type I restriction endonuclease along DNA (Firman 
and Szczelkun, 2000). The visual translocation of ScRad54 and ScRdh54 (Tid1), 
a Rad54 meiosis-specific homologue using single-molecule analysis 
demonstrated rapid and highly processive movement at ~300 bp/s for ScRad54 
and 80-120 bp/s for ScRdh54 (Amitani et al., 2006; Nimonkar et al., 2007; Prasad 
et al., 2007).  
 
 
 
Figure 1.5 Rad54 translocates on ds-DNA. Rad54 (orange) binds to covalently 
closed circular plasmid DNA. The translocation of Rad54 (in the direction indicated 
by arrows), generates positive supercoils (+) ahead of the protein and negative 
supercoils (−) behind.  
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The precise structure of the active Rad54 complex that translocates on DNA 
remains unknown. However, it is believed that multimerization of the protein on 
DNA helps to overcome the resistance to rotational motion of the protein around 
DNA while generating supercoils in covalently closed DNA (Liu and Wang, 1987; 
Ristic et al., 2001). Although both yeast and human Rad54 protein exist as a 
monomer in solution (Petukhova et al., 1999), Rad54 binding to DNA causes 
oligomerization of the protein (Petukhova et al., 1999); the cross-linking 
experiments indicated the formation of a dimer, as the principal oligomeric species, 
and larger oligomers (Mazina et al., 2007; Petukhova et al., 1999). Furthermore, 
the formation of oligomers by hRad54 and ScRad54 in complexes with DNA was 
also detected using atomic force microscopy (Ristic et al., 2001) and electron 
microscopy (Kiianitsa et al., 2006). 
 
 
1.4.3 Rad54 promotes Chromatin Remodeling  
Like other members of the Snf2 family, Rad54 promotes chromatin 
remodeling, i.e., nucleosome redistribution along DNA, in an ATPase dependent 
manner (Figure 1.6) (Alexeev et al., 2003; Alexiadis and Kadonaga, 2002; 
Jaskelioff et al., 2003; Kwon et al., 2007; Wolner and Peterson, 2005; Zhang et al., 
2007). This chromatin remodeling activity may involve specific interactions of 
Rad54 with histones in addition to its dsDNA translocation activity, as the N-
terminus of ScRad54 interacts specifically with the N-terminal tail of histone H3 
(Kwon et al., 2007). The chromatin remodeling activity of Rad54 may serve at least 
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two functions in homologous recombination: First, Rad54 could start clearing 
nucleosomes and other chromatin-bound proteins at the break site prior to end-
processing. This is supported by the in vivo studies showing an effect of Rad54 on 
the accessibility of the HML donor site for the HO endonuclease (Wolner and 
Peterson, 2005). Second, Rad54 might also facilitate the search for homology 
during synapsis by contending with chromatin structure of the target DNA. Indeed, 
in vitro studies show that Rad54 stimulates DNA strand exchange activity of Rad51 
on chromatin-loaded DNA substrates to a greater extent than on naked DNA 
substrates (Alexiadis and Kadonaga, 2002). However, further work is required to 
fully understand the role of Rad54 chromatin remodeling activity in vivo. 
 
 
Figure 1.6 RAD54 promotes chromatin remodeling. The chromatin remodeling 
makes DNA more accessible for RAD51 or other proteins, whereas, the protein 
displacement activity frees DNA for processing by other proteins.  
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1.4.4 Functional Interaction between Rad54 and Rad51  
Rad54 functions in association with Rad51, a protein which promotes DNA 
strand exchange, a basic step of homologous recombination. Interactions between 
these two proteins are extensive and critical to the function of homologous 
recombination in eukaryotes (Clever et al., 1997; Krogh and Symington, 2004; 
Rattray and Symington, 1995). Rad54 was found to interact functionally and 
physically with Rad51. To understand these interactions, extensive studies have 
been done over the last couple of decades. For example, in S. cerevisiae, Rad54 
over-expression suppresses certain repair phenotypes of rad51 mutants (Clever 
et al., 1997; Morgan et al., 2002); in absence of Rad54, the rate and extent of 
Rad51 recruitment to the HO-induced double-strand break is significantly reduced 
(Wolner et al., 2003), co-localization of  IR-induced Rad54 and Rad51 foci in 
mouse ES cells (Tan et al., 1999). The physical interaction between Rad51 and 
Rad54 proteins is species-specific and conserved from archea to humans (Clever 
et al., 1997; Golub et al., 1997; Haseltine and Kowalczykowski, 2009; Jiang et al., 
1996; Morgan et al., 2002). It has been previously reported that the Rad54 N-
terminal domain is primarily responsible for interactions with Rad51 (Alexiadis et 
al., 2004; Raschle et al., 2004). Rad54 can interact with free Rad51 protein and 
also with Rad51-nucleoprotein filament, which is the active species in DNA strand 
exchange (Mazin et al., 2003). 
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Figure 1.7 Rad54 stimulates strand exchange activity of Rad51. Rad54 
interacts with free RAD51 and the active species during homology search, Rad51-
ssDNA filament, and stimulates strand exchange activity of Rad51. 
 
Rad54-dependent stimulation of Rad51’s DNA strand exchange activity 
(Figure 1.7) was first observed for S. cerevisiae proteins but was later shown for 
archeal, Drosophila, and human orthologs as well (Alexiadis and Kadonaga, 2002; 
Haseltine and Kowalczykowski, 2009; Mazina and Mazin, 2004; Petukhova et al., 
1998; Sigurdsson et al., 2002). It was found that this stimulation is dependent on 
ATPase activity of Rad54 (Petukhova et al., 1998; Petukhova et al., 1999), 
suggesting that Rad54 translocation on dsDNA plays a role in stimulation of DNA 
strand exchange activity. It was proposed that the translocation activity of Rad54 
may both provide a more efficient delivery of dsDNA to the site of the homology 
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search within the filament and the transient disruption of dsDNA base pairs as a 
consequence of DNA translocation may make them more available for interaction 
with the ssDNA bound within the Rad51 nucleoprotein filament. However, it was 
recently shown that ATP hydrolysis plays a minimal role in stimulation of Rad51 
strand exchange activity (Deakyne et al., 2013). Therefore, further work is required 
to understand the exact mechanism for Rad54-depednent stimulation of Rad51’s 
DNA strand exchange activity. 
Furthermore, Rad54 was found to stabilize Rad51 nucleoprotein filament by 
increasing: i) the filament resistance against dissociation at elevated salt 
concentrations, ii) the Rad51-dependent protection of dsDNA against cleavages 
by restriction endonucleases, and iii) the Rad51 ability to compete with RPA for 
ssDNA binding (Wolner et al., 2003; Mazin et al., 2003). Nucleoprotein filament 
stabilization by Rad54 does not depend on its ATPase activity, as the Rad54 
ATPase-deficient mutant is still proficient in Rad51-filament stabilization (Mazin et 
al., 2003). Consistent with this, S. cerevisiae strain expressing the ATPase-
deficient rad54K341R, but not rad54∆ allele, was shown to be proficient in the 
recruitment of Rad51 to the site of DNA double-strand breaks (Wolner and 
Peterson, 2005). 
Paradoxically, Rad54 was also shown to disrupt the Rad51-dsDNA filament 
(Figure 1.7) (Li et al., 2007; Solinger et al., 2002; Wright and Heyer, 2014). The 
active form of Rad51 is the nucleoprotein filament formed on ssDNA. However, by 
analogy with E. coli RecA protein (Pugh and Cox, 1987), it is likely that Rad51 
remains associated with the dsDNA heteroduplex, the product of DNA strand 
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exchange. Therefore, Rad51 dissociation from duplex DNA would help (i) to 
recycle Rad51 for new rounds of recombination and prevent accumulation of 
cytotoxic nucleoprotein complexes (Shah et al., 2010), (ii) to free the nascent DNA 
joint in the D-loop from bound Rad51 permitting access of the primer end to a DNA 
polymerase to initiate repair DNA synthesis (Li and Heyer, 2009).  
The Rad51-Rad54-ssDNA complex formed has significant and synergistic 
effects on the activities of both the proteins. While Rad54 stimulates the DNA 
strand exchange activity of Rad51 (Figure 1.7), in turn, Rad51 also stimulates the 
biochemical activities of RAD54, the dsDNA-dependent ATPase activity and DNA 
topology modification activity (generation of positive and negative supercoils) 
(Mazin et al., 2000; Sigurdsson et al., 2002; Van Komen et al., 2000). Moreover, 
Rad51 increases the processivity of Rad54 DNA translocation along DNA (Mazina 
and Mazin, 2004). Finally, Rad51 stimulates chromatin remodeling (Alexeev et al., 
2003; Alexiadis and Kadonaga, 2002; Jaskelioff et al., 2003; Kwon et al., 2007; 
Zhang et al., 2007) and DNA branch migration activity of the Rad54 protein (Rossi 
and Mazin, 2008).  
 
1.4.5 Rad54 Promotes Branch Migration of Holliday Junctions 
Genetic data indicates the significance of post-synaptic (downstream of 
Rad51) functions for Rad54 (Krogh and Symington, 2004; Rattray and Symington, 
1994; Symington and Heyer, 2006). Evidence for the post-synaptic function of 
Rad54 was provided by the analysis of rad54 srs2 double mutants. While the rad51 
srs2 double mutant is viable, the rad54 srs2 double mutant is not (Palladino and 
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Klein, 1992). Furthermore, the synthetic lethality of the rad54 srs2 mutant is 
suppressed by rad51 mutation (Schild, 1995), indicating that Rad51-generated 
recombination intermediates are normally resolved by Rad54 and Srs2, but 
became lethal in the absence of these two proteins.  
 
 
Figure 1.8 Rad54 promotes branch migration. Branch migration is the process 
in which one strand of the duplex DNA is progressively exchanged for another 
strand of the homologous duplex DNA and involves step-wise breakage and 
reformation of bonds. The cross-structure formed at the point of strand exchange 
is Holliday junction. In vitro, this structure is mimicked using oligonucleotide 
substrates that is able to branch migrate in presence of Rad54 protein. 
 
 
Post-synaptic steps, after D-loop formation, include: 1) heteroduplex 
extension and formation of Holliday junctions, 2) priming of DNA synthesis from 
the invading 3’-OH end, 3) branch migration of Holliday junctions, 4) resolution of 
Holliday junction intermediates and 5) sealing of the strands to restore two intact 
and contiguous duplex DNAs. There is evidence that Rad54 may play a role in 
several post-synaptic steps. It was shown that ScRad54 stimulates heteroduplex 
extension during DNA exchange promoted by ScRad51 in vitro (Solinger and 
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Heyer, 2001). Also, both ScRad54 and its meiosis-specific homologue ScRdh54 
catalyze ScRad51 removal from dsDNA in an ATP-dependent fashion (Chi et al., 
2006; Solinger et al., 2002; Wright and Heyer, 2014), presumably to provide an 
access of DNA polymerases to the invading 3’-OH end for DNA synthesis (Li and 
Heyer, 2009). Moreover, Rad54 binds efficiently to Holliday junctions and 
promotes their branch migration with high efficiency in an ATPase-dependent 
manner (Bugreev et al., 2006b; Mazina et al., 2007; Rossi and Mazin, 2008). 
Finally, Rad54 stimulates the cleavage activity of Mus81-Eme1 (Mms4), a 
structure-specific endonuclease, which cleaves Holliday junction-like structures 
(Matulova et al., 2009; Mazina and Mazin, 2008).  
 The formation of the cross structure during the process of homologous 
recombination (Figure 1.8), where the strands are exchanged between the two 
different DNA molecules was first predicted by Robin Holliday, and this structure 
is therefore known as Holliday junction (also called X-junction) (Holliday, 1964). 
Holliday junction has the ability to branch migrate along the DNA axis by a process 
known as Branch migration, in which one DNA strand is progressively exchanged 
for another (Figure 1.8). Branch migration may extend or shorten the heteroduplex 
DNA, formed after DNA strand invasion, thereby controlling the amount of genetic 
information transferred between the two DNA molecules (Pâques and Haber, 
1999). It may cause dissociation of recombination intermediates and thereby affect 
the choice between a crossover and non-crossover pathway for recombination to 
proceed (Bugreev et al., 2007). There is genetic and biochemical data indicating 
the role of branch migration in re-starting stalled replication forks during cell 
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recovery after DNA damage (McGlynn et al., 2001; Michel et al., 2004; Postow et 
al., 2001; Rothstein et al., 2000; Seigneur et al., 1998).  
Holliday junction structure has been analyzed by different methods 
including comparative gel electrophoresis, molecular modeling, fluorescence 
resonance energy transfer (FRET) assay, NMR and by X-ray studies (Lilley, 2000). 
The Holliday junction may exist in the stacked or unstacked (extended) 
conformation. In the stacked conformation, pairs of helical arms stack coaxially to 
form nearly continuous criss-crossed duplexes, whereas, in the unstacked one, it 
forms a four-fold symmetric nearly planar structure. The presence of metal ions 
such as magnesium or calcium (at 100 µM and greater) neutralizes electrostatic 
repulsions caused by the phosphates, resulting in stacked conformation of Holliday 
junctions, whereas in the absence of metal ions, the DNA junction is fully extended. 
The switch between the extended and stacked conformations is important for 
proteins acting on Holliday junctions. For example, RuvAB protein shows a binding 
preference to the Holliday junctions in the extended conformation (Ariyoshi et al., 
2000), whereas, hMSH4–hMSH5 complex, preferentially binds the Holliday 
junction in the stacked conformation (Snowden et al., 2004). 
Branch migration occurs while the Holliday junction is in an extended state, 
whereas the stacked conformation is refractory for the branch migration process 
(Karymov et al., 2005). A single step of branch migration requires the breakage of 
two base pairs at the point of strand exchange located on diametrically opposite 
arms, rotation around, and formation of the terminal base pairs of the remaining 
two arms. Single-molecule techniques were used to observe the rotation of DNA 
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strands during branch migration promoted by RuvAB (Han et al., 2006). The rate 
of spontaneous branch migration, when the Holliday junction is in the open 
conformation, is extremely fast with a step time of 300-400 µs (Panyutin and Hsieh, 
1994), corresponding to a migration rate of 2500-3300 bp/sec, whereas, it is 
reduced to an estimated rate of about 3.3-3.7 bp/sec in the presence of 
magnesium (>100 µM) (Panyutin and Hsieh, 1994). The spontaneous branch 
migration proceeds bi-directionally making it inefficient under physiological 
conditions. Therefore, to provide directionality and processivity to the process of 
branch migration, there is a requirement for specialized enzymes.  
 In prokaryotes, RuvAB and RecG enzymes promote branch migration of 
Holliday junctions (Liu and West, 2004; Lloyd and Buckman, 1991; Lloyd and 
Sharples, 1993; Sharples et al., 1999; West, 1997). In eukaryotes, several branch 
migration proteins have been identified. Of all the known branch migration proteins, 
RuvB belongs to the ATPases associated with diverse cellular activities (AAA+) 
family (RuvB) and all the others belong to the SF2 helicase superfamily. These 
SF2 proteins include: (1) RecG, a member of the RecG family; (2) several 
members of the RecQ helicase family, for example, BLM, WRN, RECQ1, and 
RECQ5 in humans (Bugreev et al., 2008; Constantinou et al., 2000; Kanagaraj et 
al., 2006; Karow et al., 2000; Wu et al., 2006); (3) FANCM, a member of the DEAH 
helicase family; and (4) Rad54, a member of the Snf2 family of DNA translocases.  
Despite structural diversity among branch migration proteins belonging to 
different families, all of these proteins i) are capable of translocation on DNA in an 
ATPase-dependent manner, and ii) show high binding affinity to the Holliday 
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junction (or other cruciform DNA structures that are capable of branch migrating). 
These two functions can either be segregated, for example in RuvAB complex, 
where RuvA protein is structure-specific DNA binding protein and RuvB protein is 
a motor protein (West, 1997). Or these functions can be combined in a single 
polypeptide, like in RecQ helicase family members, BLM, WRN, or RecQ1, that 
have a motor domain and a separate structure-specific DNA-binding region located 
in their C-terminus (Hickson, 2003). In the Rad54 protein, the domain(s) 
responsible for binding to the Holliday junction is yet to be identified.  
Similar to other branch migration proteins, Rad54 translocates on dsDNA in 
an ATPase-dependent manner (Amitani et al., 2006)  and binds efficiently to 
synthetic Holliday junctions (Bugreev et al., 2006b; Mazina et al., 2007). Rad54 
shows higher affinity for the X-junction and the partial X-junction (PX-junction), 
approximately 30-fold and 200-fold respectively, compared to dsDNA. The PX-
junction is an appropriate substrate for DNA branch migration proteins as it 
resembles one end of a D-loop, the product of DNA strand invasion (Figure 1.8). 
The branch migration activity of Rad54 was demonstrated using a fully movable 
X-junction and was found to be ATPase-dependent (Bugreev et al., 2006a; 
Bugreev et al., 2006b). In addition to 4-stranded branch migration, Rad54 
catalyzes 3-stranded branch migration of PX-junction and of plasmid-size DNA 
substrates. It was found that Rad54 protein efficiently promotes branch migration 
Holliday junctions through DNA regions of several thousand base pairs (Figure 
1.8) (Bugreev et al., 2006b)  and that the rate of branch migration is comparable 
with that of RuvAB, a classical branch migration protein from E.coli.  
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 The “minimal” branched DNA substrate that efficiently stimulates ATP 
hydrolysis consists of three DNA arms, two short dsDNA arms, 15 bp each, and a 
ssDNA arm of 45 nt (Mazina et al., 2007), which is consistent with the 
crystallographic data showing that the S. solfataricus Rad54 catalytic core domain 
can accommodate a 15 bp dsDNA fragment (Durr et al., 2005). HRad54 titrations 
using the “minimal” DNA substrate showed that the stoichiometry for Rad54's 
ATPase activity is two protein monomers per DNA molecule (Mazina et al., 2007). 
However, the branch migration was relatively low at dimer concentrations and 
reached a maximum at a concentration of 10 ± 2 monomers per DNA molecule 
indicating the requirement for higher oligomeric structures for branch migration. 
The difference in the stoichiometry for ATPase and branch migration activities 
suggests that either the additional Rad54 monomers have an ATPase-
independent DNA binding activity or are involved in Rad54 protein-protein 
interactions essential for branch migration activity. Previously, it was shown that 
different multimeric forms of RECQ1 are associated with different enzymatic 
activities of the protein (Muzzolini et al., 2007).  
 
1.5 ROLE OF RAD54 BRANCH MIGRATION ACTIVITY IN HOMOLOGOUS 
RECOMBINATION 
 During the initial steps of homologous recombination, Rad51-promoted joint 
molecule (D-loop) formation takes place. Then, the 3’ end of the invading ssDNA 
is extended by DNA polymerase, retrieving the information lost at the site of the 
break. Following this, the homologous recombination may proceed through either 
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of the two pathways (Allers and Lichten, 2001; Hunter and Kleckner, 2001). The 
extended joint molecules could either dissociate, leading to rejoining of the broken 
chromosome through synthesis-dependent strand annealing (SDSA) (Allers and 
Lichten, 2001), or they proceed through capture of the second processed DNA 
end, producing single or double Holliday junctions (Cromie et al., 2006; Schwacha 
and Kleckner, 1995), which can later be resolved by structure-specific 
endonucleases (Pâques and Haber, 1999). The joint molecules (D-loops) 
dissociation after the completion of template-dependent DNA synthesis is an 
essential step of double-strand break repair via the SDSA mechanism (Pâques 
and Haber, 1999). It has been shown that Rad54 promotes dissociation of D-loops 
formed by Rad51 protein owing to its ATP-dependent branch-migration activity. 
More importantly, Rad54 can also dissociate D-loops containing Rad51 protein, 
which mimics in vivo recombination intermediates.  
Consistent with this, there is genetic data that Rad54’s D-loop dissociation 
activity contributes to its function during the late stages of homologous 
recombination. Specifically, the D-loops dissociation ability of Rad54 in vitro 
agrees with the reduced length of gene conversion tracts in yeast strains 
overexpressing Rad54 protein (Kim et al., 2002).  
Rad54 can also dissociate double D-loops (Bugreev et al., 2007), generated 
by Rad52 through the annealing of the second end of broken DNA to the single D-
loops (Figure 1.1) (Bugreev et al., 2007; McIlwraith and West, 2008; Nimonkar et 
al., 2009; Sugiyama et al., 2006). The double D-loops dissociation by Rad54 
occurs through a mechanism, in which D-loop dissociation is directly associated to 
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rejoining of the broken DNA ends without a reannealing step (Bugreev et al., 2007). 
Undissociated double D-loops can lead to the formation of double Holliday 
junctions and then crossovers, which might lead to detrimental loss of 
heterozygosity and lead to genome instability in somatic cells. Therefore, double 
D-loop dissociation by Rad54 may play an important role by promoting 
homologous recombination via non-crossover pathways. Thus, DNA branch 
migration activity of the Rad54 protein may play a part in the double-stranded 
break repair mechanism postulated by the SDSA model (Pâques and Haber, 
1999).   
 
1.6 RESOLUTION OF HOLLIDAY JUNCTION  
The interaction between Rad54 protein and Mus81, a structure-specific 
endonuclease, is evolutionarily conserved in eukaryotes (Hanada et al., 2006; 
Interthal and Heyer, 2000; Matulova et al., 2009; Mazina and Mazin, 2008; Mimida 
et al., 2007). Mus81 belongs to XPF/MUS81 family of nucleases that share a highly 
conserved motif (V/IERKX3D) constituting an integral part of the endonuclease 
catalytic site. Mus81 functions as a heterodimer with a non-catalytic partner protein 
known as Eme1 in fission yeast and humans or as Mms4 in budding yeast and 
Drosophila (Ciccia et al., 2008). The role of Mus81 in the resolution of Holliday 
junctions was first proposed in studies on S. pombe, where all the defects of mus81 
mutants could be rescued by expression of RusA, a bacteriophage resolvase that 
is highly specific for Holliday junctions (Blais et al., 2004; Boddy et al., 2001; Boddy 
et al., 2000). The Holliday junction is a substrate for Mus81, responsible for its 
34 
 
 
 
cleavage and formation of crossover products to complete the double-strand break 
repair process (Heyer, 2004; Liu and West, 2004). 
Rad54 interacts with Mus81-Eme1 (Mms4) and stimulates the DNA 
cleavage activity of Mus81-Eme1 (Figure 1.9) (Matulova et al., 2009; Mazina and 
Mazin, 2008). This stimulation shows a functional link between Rad54, a branch 
migration protein, and Mus81–Eme1 (Mms4), a structure-specific endonuclease. 
The observations that Mus81-Eme1 stimulation requires the addition of Rad54 to 
DNA-junctions first or, at least concurrently with Mus81-Eme1, suggest that Rad54 
targets Mus81 to DNA junctions via protein-protein interactions (Matulova et al., 
2009; Mazina and Mazin, 2008).  
 
 
 
Figure 1.9 Rad54 stimulates endonuclease activity of Mus81. The DNA 
intermediates formed during homologous recombination need to be resolved to 
complete the repair process. Rad54 interacts with Mus81 and stimulates 
endonuclease activity of Mus81-Eme1, a structure-specific endonuclease that 
recognizes branched DNA substrates. 
 
35 
 
 
 
Stimulation of Mus81-Eme1 activity by Rad54 in vitro is consistent with 
genetic data in S. cerevisiae (Interthal and Heyer, 2000; Matulova et al., 2009) and 
in mouse ES cells (Hanada et al., 2006). Taken together, these results suggest 
that Rad54 and Mus-81 may cooperate in the processing of Holliday junctions 
intermediates formed during the repair of double-strand breaks or stalled 
replication forks. 
 
1.7 REGULATION OF RAD54 ACTIVITIES  
Homologous recombination pathway helps in maintaining genome stability. 
However, if it is not controlled or regulated, it could lead to loss-of-heterozygosity, 
genomic rearrangements, and toxic recombination intermediates leading to cell 
death (Heyer et al., 2010). Therefore, regulation of homologous recombination 
needs to be carefully monitored in the cell. A good target for the regulation of 
homologous recombination pathway is Rad54, which is a versatile protein 
functioning throughout the process of homologous recombination. In S. pombe, 
Rhp54 is targeted for ubiquitin-mediated proteolysis to (1) down-regulate 
homologous recombination in the G1 phase, (2) shift the recombination bias from 
inter-sister to inter-homolog during meiosis (Trickey et al., 2008).  
On the other hand, in S. cerevisiae, ScRad54 is regulated by Mek1 (a 
meiosis-specific kinase) phosphorylation at T132, shown both in vitro and in vivo 
(Niu et al., 2007; Niu et al., 2009). The phosphorylation of ScRad54 at T132 is 
required to bias the meiotic recombination towards inter-homolog instead of inter-
sister interactions (Niu et al., 2007). The T132D phosphomimetic mutation in 
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ScRad54 showed significantly weak interaction with ScRad51, thereby reducing 
the stimulation of ScRad54’s ATPase activity by ScRad51 as well the D-loop 
formation by ScRad51 when compared to wild-type ScRad54 (Niu et al., 2009). 
The interaction between ScRad54 and ScRad51 is also regulated during meiosis 
by Hed1, a meiosis-specific Rad51 binding protein that prevents binding of 
ScRad54 to ScRad51 (Busygina et al., 2008; Tsubouchi and Roeder, 2006). Hed1 
also inhibits the interaction of ScRad51 with ScRdh54, though to a lesser extent 
compared to ScRad54 (Busygina et al., 2008). The inhibition of ScRad54 functions 
during meiosis is believed to be transient as ScRad54 is required for successful 
meiosis.   
 Recently, it was shown that cell cycle phase-specific phosphorylation of 
hRad54 by Nek1 at Ser-572 promotes removal of hRad51 in the late G2 phase 
prior to the onset of mitosis and completion of homologous recombination (Spies 
et al., 2016). Several post-translational modifications have also been identified in 
human Rad54 (Kettenbach et al., 2011; Li et al., 2009; Mertins et al., 2014; Sharma 
et al., 2014), with most of these modifications occurring in the N-terminal domain 
of Rad54. The N-terminal domain of Rad54 is not well conserved amongst 
orthologs, probably to enable species specific interactions with partner proteins. 
Therefore, post translational modifications occurring in the Rad54 N-terminal 
domain could regulate its interaction with different proteins during the process of 
homologous recombination. Clearly, further work is needed to shed light on how 
the different functions of Rad54 are tightly regulated in the cell.  
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1.8 PROTEIN REGULATION BASED ON ITS OLIGOMERIC STATE 
Protein oligomerization is common and takes place in all biological systems. 
An estimated 35% of all the proteins in a cell are oligomeric (Goodsell and Olson, 
2000). The oligomeric proteins could either be homo-oligomers or hetero-
oligomers, ranging from dimers to higher order oligomers (Gabizon and Friedler, 
2014). The different oligomeric states of the protein could be associated with 
different activities, and switching between these states may help the protein 
regulate its functions. For example, RecQ1 helicase exhibits DNA unwinding in the 
monomer or tightly bound dimer form, whereas, the higher-order oligomers of 
RecQ1 have DNA strand annealing activity (Muzzolini et al., 2007). Therefore, 
correct protein oligomerization is critical for its function and is tightly regulated by 
various factors. Protein oligomerization could be regulated by the binding of 
partner proteins, nucleotide cofactors, metal cofactors, or by binding to DNA etc. 
In the example of RecQ1 helicase, the presence of ssDNA favors formation of 
higher order oligomers whereas, the presence of ATP or ATPγS shifted the 
equilibrium towards smaller oligomeric species (Muzzolini et al., 2007). 
Rad54 protein exists as a monomer in solution but rapidly undergoes 
oligomerization in presence of DNA (Petukhova et al., 1999). The stoichiometry for 
Rad54's ATPase activity was shown to be two protein monomers per DNA 
molecule (Mazina et al., 2007), whereas, the branch migration reached a maximum 
at a concentration of 10 ± 2 monomers per DNA molecule indicating the 
requirement for higher oligomeric structures for branch migration (Mazina et al., 
2007). Thus, like other proteins, Rad54 has functions that are dependent on its 
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oligomeric state. Therefore, it would be interesting to determine 1) the Rad54 
domain that regulates its DNA-dependent oligomeric state and 2) the role 
oligomerization plays in modulating Rad54’s activities.   
 Because oligomerization is common, and crucial for the activity of many 
proteins, there is an increasing interest to develop small-molecule compounds that 
would modulate the state of protein oligomerization. The protein oligomerization 
could be modulated by binding of the small-molecules directly to the 
oligomerization interface or by stabilizing the protein in a specific oligomeric state. 
A number of compounds already in clinical use were later discovered to act by 
modulating protein oligomerization. For example, the anti-cancer drug, Taxol, 
binds to β-tubulin and allosterically inhibits assembly and disassembly dynamics 
of microtubules (Derry et al., 1995; Wani et al., 1971). Therefore, modulating 
protein oligomerization provides a promising target for therapeutic intervention.  
 
1.9 SMALL-MOLECULE INHIBITORS OF HOMOLOGOUS RECOMBINATION 
PROTEINS 
Tumorigenesis is the uncontrolled growth of cells that are able to avoid cell 
death mechanisms (Bartkova et al., 2005). This uncontrolled and often rapid 
proliferation of cells can lead to benign tumors, and some of these may develop 
into malignant tumors (cancers). In the past, cancer therapy has relied on the use 
of a combination of radiation with toxic chemotherapeutic agents for several years. 
This approach, though successful in experimental settings, has not been so 
successful from the clinical point of view (Russell et al., 2003). The rapid and 
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uncontrolled growth of cancer cells increases the stress on DNA damage and 
replication pathways, making them “addicted” to DNA-damage repair pathways for 
survival (Curtin, 2012). It is believed that the DNA repair proteins are regulated 
differently in cancer cells compared to normal cells. In many cancers, the 
expression of DNA repair proteins is upregulated or dysfunctional. In many tumor 
cell lines, the Rad51 mRNA and Rad51 protein levels were increased by 11-fold 
and 7-fold, respectively, compared to normal cell lines (Raderschall et al., 2002). 
On the other hand, some studies found a decrease in Rad51 protein levels in 
tumors (Takaku et al., 2011) suggesting deregulation of the Rad51 levels in 
tumors. Additionally, the expression of Rad54, and Rad51 associated protein 1 
(RAD51AP1) was on an average 4-fold and 2-fold higher, respectively, in BRCA1 
deficient tumors (Martin et al., 2007). Taken together, these results indicate 
upregulation of homologous recombination pathway in tumors as means of 
surviving the DNA damage caused by either rapid cell growth or by toxic 
chemotherapeutic agents used for cancer therapy. Therefore, new cancer 
therapies targeting homologous recombination proteins, in addition to the use of 
chemotherapeutic agents that cause DNA damage is the need of the hour. 
The use of small molecule compounds to modulate the activity of proteins 
has increased over the past few years because of the ease with which they could 
be applied and removed over a controlled time period. Another advantage of using 
small molecules besides being used as drugs to treat specific diseased conditions 
is to understand the activities or functions of a protein in the cell. For example, B02 
inhibits Rad51 recombinase and has been shown to potentiate the effect of 
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cisplatin used for the treatment of cancer. Also, streptonigrin, an inhibitor of Rad54 
ATPase activity, was used to study the mechanistic differences between two 
different activities of Rad54: stimulation of strand exchange and branch migration. 
In addition to these, several other small-molecule inhibitors targeting different 
homologous recombination proteins have been identified.  
Given the malleable and heterogeneous nature of cancer cells, one 
drawback of using small-molecule compounds is that prolonged use over time 
could result in the development of resistant cancer cells. Cancer cells can develop 
resistance via various mechanisms like by mutating or amplifying the drug target, 
genetic alterations to avoid cell death wherein, or by acquiring features enabling 
them to survive under selective drug pressure. In addition, cells may also become 
resistant either by altering the drug transport or metabolism.  
Hence, there is a need for new therapies and patient-specific therapies to 
successfully eradicate cancer cells. One strategy could involve inhibition of specific 
DNA repair proteins and knowing the DNA damage response status of a particular 
tumor in order to induce synthetic lethality in cancer cells. For this, continuing 
research is necessary to fully understand the homologous recombination process 
in normal cells versus tumor cells and how the multiple DNA repair pathways are 
coordinated to carry out the repair. 
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1.10 SUMMARY  
 
 Homologous recombination plays a critical role in repair of the most harmful 
types of DNA lesions, DNA double-strand breaks, and interstrand cross-links, in 
faithful segregation of homologous chromosomes during meiosis, and in telomere 
maintenance. Failure to repair double-strand breaks due to inefficient homologous 
recombination results in the accumulation of chromosomal aberrations as well as 
mutations, leading to genome instability, and predisposition to cancers, and other 
disorders like Bloom’s Syndrome, Werner’s syndrome, and Fanconi Anemia.  
 Rad54 is one of the key proteins of homologous recombination and is 
evolutionarily conserved. It is a motor protein that translocates on duplex DNA in 
an ATPase-dependent manner. Rad54 is a multifunctional protein that by 
interacting with different protein partners throughout the process of homologous 
recombination, helps in linking together early and late steps of homologous 
recombination. The transition from the early function of Rad54 in stimulating Rad51 
to branch migration of Holliday junctions during late stages of homologous 
recombination remains to be understood. In other words, how the different 
activities of Rad54 during homologous recombination are regulated, is not yet 
known. 
 Therefore, for my Ph.D. dissertation, we focused on understanding what 
regulates Rad54’s activities and the mechanism for branch migration of Holliday 
junctions. We wanted to determine the domain in Rad54 that is responsible for 
DNA-dependent oligomerization and the role of oligomerization in regulating 
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Rad54 activities. Here, we demonstrate that the N-terminal domain of Rad54 is 
essential for its DNA branch migration activity along with the conserved ATPase 
or “core” domain.  
 Using N-terminal truncated Rad54 and different mutants of Rad54, we show 
that a second DNA-binding site in the N-terminal domain is essential for DNA 
branch migration activity of Rad54. This second DNA-binding site is dispensable 
for other Rad54 activities such as ATP hydrolysis and translocation. We found that 
this second DNA-binding site has a preference for branched DNA structures and 
DNA binding by this site enables oligomerization of Rad54. We also identified a 
specific amino acid Ser-49, important for oligomerization. Also, CDK2 dependent 
phosphorylation of Rad54 at Ser-49 in vitro or the phosphomimetic mutation, 
S49E, impairs the ability of Rad54 to oligomerize and inhibits its branch migration 
activity without affecting its ATP hydrolysis or the ability to stimulate strand 
exchange activity of Rad51. Taken together, our results show for the first time that 
the N-terminal domain plays a pivotal role in the assembly of the active Rad54 
branch migration complex. Also, CDK2-dependent phosphorylation of hRad54 at 
Ser-49 may help in regulating two important functions of Rad54: stimulation of 
Rad51’s strand exchange activity and branch migration of Holliday junctions.  
 For future studies, we would be interested in determining the specific role 
of branch migration activity of Rad54 in the process of homologous recombination 
by expressing hRad54S49E and hRad54S49A mutants in cells. Furthermore, we show 
that by targeting N-terminal domain of Rad54, it is possible to specifically inhibit 
one of its functions without affecting the others. This could have a potential 
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application in drug development, as inhibitors of homologous recombination 
proteins have shown to potentiate the effects of anti-cancer drugs.  
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RAD54 N-terminal domain: a DNA sensor that couples ATP hydrolysis with 
branch migration of Holliday junctions 
 
 
2.1 ABSTRACT 
 
In eukaryotes, RAD54 protein plays an important role in homologous 
recombination. RAD54 is a Swi2/Snf2 ATP-dependent DNA translocase that 
promotes branch migration of Holliday Junctions, chromatin remodeling, and 
stimulates DNA strand exchange activity of RAD51. The branch migration activity 
of RAD54 is the strongest among eukaryotic proteins. However, despite extensive 
studies, the mechanism of this activity is not well understood. Here, we 
demonstrate that the RAD54 N-terminal domain is essential for branch migration 
along with the conserved ATPase/DNA binding domain. Our results demonstrate 
that the N-terminal domain is responsible for initiation of branch migration through 
two connected, but distinct steps; the N-terminal domain binds to Holliday 
Junctions with high affinity, and the binding event triggers RAD54 multimerization 
that is essential for branch migration. We identified the RAD54 N-terminal domain 
mutations that separately affect DNA binding and multimerization by N-terminal 
domain. We also show that the RAD54 N-terminal domain may play a regulatory 
role serving as a target for CDK2; S49 phosphorylation by CDK2 down regulates 
branch migration activity by attenuating  DNA-dependent multimerization of 
RAD54.  
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2.2 INTRODUCTION 
The homologous recombination pathway is responsible for the repair of 
DNA double-strand breaks, the most harmful types of DNA lesions, faithful 
chromosome segregation during meiosis, and telomerase-independent telomere 
maintenance (Jasin and Rothstein, 2013; Krejci et al., 2012; San Filippo et al., 
2008). Homologous recombination uses homologous DNA molecules as a 
template to repair double-strand breaks and therefore is, generally, an error-free 
process. During double-strand break repair by homologous recombination, the 
dsDNA ends undergo exonucleolytic resection to generate protruding ssDNA tails 
(Symington, 2014). RAD51 recombinase binds to these ssDNA tails forming a 
nucleoprotein filament that performs a search for homologous dsDNA 
(Kowalczykowski, 2008). The RAD51-ssDNA filament then invades the 
homologous dsDNA generating joint molecules also known as D-loops. D-loops 
further extend into the DNA four-way cross-structure that is known as a Holliday 
Junction (Holliday, 1964; Mazin et al., 2010; Wyatt and West, 2014). The Holliday 
junction has a remarkable ability to translocate along the DNA axis through a 
process known as branch migration, in which one strand of the DNA duplex is 
progressively exchanged for the homologous strand of another DNA duplex by the 
stepwise breakage and reformation of base pairs. Branch migration may cause 
either dissociation or extension of joint molecules, depending on the specific 
homologous recombination mechanism. It may also promote a restart of DNA 
replication stalled at a DNA damage site by switching DNA template strands 
through a reversible regression of replication forks into Holliday junctions.  
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Previously, we showed that RAD54, a member of the Rad52 epistasis group 
(Game, 2000; Krogh and Symington, 2004), promotes branch migration of Holliday 
junctions.  RAD54 is a multifunctional protein that, in addition to branch migration, 
can physically interact with RAD51 (Golub et al., 1998; Raschle et al., 2004) to 
stimulate its DNA strand exchange activity (Mazina and Mazin, 2004; Petukhova 
et al., 1998; Sigurdsson et al., 2002). RAD54 was also shown to remodel 
nucleosomes (Alexeev et al., 2003) and displace RAD51-dsDNA complexes 
(Solinger et al., 2002).  
RAD54 promotes branch migration with significantly greater efficiency than 
other known eukaryotic branch migration proteins, like BLM or RECQ1 (Bugreev 
et al., 2006b; Mazina et al., 2012). Moreover, similar to RuvAB, a canonical branch 
migration protein from E.coli, RAD54 is capable of driving branch migration of 
Holliday junctions, through large regions of DNA sequence heterology (Mazin et 
al., 2010; Mazina et al., 2012). Previous studies showed that the branch migration 
activity of RAD54 requires ATP hydrolysis and involves the formation of higher 
order RAD54 oligomers on Holliday junction-like structures (Bugreev et al., 2006b; 
Mazina et al., 2007). However, the mechanism of RAD54 branch migration is 
currently not well understood.  
RAD54 belongs to the SWI/SNF2 family of helicase-like proteins of 
Superfamily (SF) 2 helicases (Gorbalenya and Koonin, 1993; Laurent et al., 1993). 
Similar to other SWI/SNF proteins, but unlike canonical helicases, RAD54 does 
not have DNA strand separation activity. Structurally, RAD54 is composed of the 
N-terminal domain, the ATPase/DNA binding core domain, and the C-terminal 
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domain. The ATPase/DNA binding core domain contains seven motifs conserved 
in all SF2 and SF1 proteins, I, Ia, II, III, IV, V and VI that constitute the two RecA-
like domains responsible for protein binding to DNA and translocation in an 
ATPase-dependent manner (Caruthers and McKay, 2002; Singleton et al., 2007; 
Thoma et al., 2005). The RAD54 N-terminal domain and C-terminal domain are 
unique for RAD54 orthologues and their functional role remains to be elucidated. 
In this study, using the N-terminal truncated RAD5496-747, we found that the N-
terminal domain of RAD54 is essential for its branch migration activity. At the same 
time, the RAD5496-747 retains the ability to translocate on dsDNA in an ATPase-
dependent manner, indicating a specific role of the RAD54 N-terminal domain in 
branch migration. We found that a distinct DNA binding site located in the N-
terminal domain (Wright and Heyer, 2014) is critical for RAD54 branch migration. 
First, this site shows a strong preference for Holliday junction and Holliday junction-
like structures. Second, DNA binding by this site enables protein multimerization 
that is required for branch migration.  We identified a specific amino acid residue, 
S49, which is important for protein multimerization. Furthermore, we show that 
CDK2 phosphorylation at S49 in vitro or the S49E phosphomimetic mutation 
impairs DNA-dependent RAD54 oligomerization and inhibits RAD54 branch 
migration activity. Taken together, these data indicate that the N-terminal domain 
may play a pivotal role in assembly of an active RAD54 branch migration complex 
and in the regulation of RAD54 branch migration activity.  
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2.3 Materials and Methods 
Proteins and DNA 
All oligonucleotides used in this study (Table 2.1) were purchased from IDT 
Inc and purified using denaturing 6-10% PAGE. To prepare oligonucleotide dsDNA 
substrates, complementary ssDNA oligonucleotides were annealed as described 
(Rossi et al., 2010) and stored at -20 °C. Oligonucleotides were labeled using [γ-
32P] ATP and T4 polynucleotide kinase. T4 polynucleotide kinase and restriction 
endonucleases were purchased from New England Biolabs. PreScission™ 
Protease was purchased from GE Healthcare Life Sciences. CDK2/Cyclin E 
complex was a generous gift of Bruce Clurman (Fred Hutchinson Cancer Research 
Center). The CDK2/CyclinA2 complex was purchased from ProQinase GmbH 
(Germany).  
 
Table 2.1 Sequences of the oligonucleotides used in this study * 
 
Number Length in nucleotides Sequence, 5’3’ 
#64 48 
GTC GAC GAC GTC TGA GTA CTC ATC TAG TGT GAC ATC 
ATC GCA TCG AGA 
 
#65 48 
TCT CGA TGC GAT GAT GTC ACA CTA GAT GAG TAC TCA 
GAC GTC GTC GAC 
 
#71 94 
CTT TAG CTG CAT ATT TAC AAC ATG TTG ACC TAC AGC 
ACC AGA TTC AGC AAT TAA GCT CTA AGC CAT CCG CAA 
AAA TGA CCT CTT ATC AAA AGG A 
#169 93 
TCC TTT TGA TAA GAG GTC ATT TTT GCG GAT GGC TTA 
GAG CTT AAT TGC TGA ATC TGG TGC TGT TTT TTT TTT TTT 
TTT TTT TTT TTT TTT TTT 
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#170 94 
T CCT TTT GAT AAG AGG TCA TTT TTG CGG ATG GCT TAG 
AGC TTA ATT GCT AAA TCT GGT GCT GTA GGT CAA CAT 
GTT GTA AAT ATG CAG CTA AAG 
#171 63 ACA GCA CCA GAT TTA GCA ATT AAG CTC TAA GCC ATC CGC AAA AAT GAC CTC TTA TCA AAA GGA 
#174 61 GAC GCT GCC GAA TTC TAC CAG TGC CTT GCT AGG ACA TCT TTG CCC ACC TG CAG GTT CAC CC 
#175 62 TGG GTG AAC CTG CAG GTG GGC AAA GAT GTC CTA GCA ATG TAA TCG TCA AGC TTT ATG CCG TT 
#176 63 CAA CGG CAT AAA GCT TGA CGA TTA CAT TGC TAG GAC ATG CTG TCT AGA GGA TCC GAC TAT CGA 
#177 62 ATC GAT AGT CGG ATC CTC TAG ACA GCA TGT CCT AGC AAG GCA CTG GTA GAA TTC GGC AGC GT 
#180 25 CTT TGC CCA CCT GCA GGT TCA CCC A 
#181 25 TCG ATA GTC GGA TCC TCT AGA CAG C 
#244 60 
A CAT TGC TAG GAC ATG CTG TCT AGA GGA TCC GAC TAT 
CGA TAA AAC CCT GCA AGT TCG TA 
 
#249 30 TG CAG GTG GGC AAA GAT GTC CTA GCA ATG T 
#250 15 CTT TGC CCA CCT GCA  
TFO 22 TTC TTT TCT TTC TTC TTT CTT T 
 
*Bold red letters indicate the nucleotides that form mismatched pairs in the 
branch migration products. 
 
 
Purification of RAD54 and N-terminal truncated mutants from insect cells 
Human RAD54 and RAD5496-747 were purified from Sf21 cells as described 
previously (Mazina and Mazin, 2004) with alterations indicated below. We used 
RAD54 constructs with an N-terminal GST tag and a PreScission Protease™ 
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recognition site (LEVLFQGP). Following fractionation on a Glutathione Sepharose 
and a Superdex 200 column, the RAD54 pool was incubated with PreScission 
Protease (GE Healthcare) (10 U/100 mg of RAD54) for 4 h at 4 °C. The sample 
was diluted to 100 mM KCl and loaded on a 1 ml Resource S column. The fractions 
containing RAD54 or RAD54 mutants were analyzed for nuclease contamination, 
pooled, and stored in small aliquots at -80 °C. The protein appeared nearly 
homogeneous in a Coomassie-stained SDS-polyacrylamide gel. 
 
Expression and purification of RAD54, and RAD54 mutant proteins from 
E.coli 
Human RAD54, RAD54T31E, RAD54S49E, RAD541-142, RAD541-142T31E, 
RAD54 1-142 S49E, RAD541-142RKRK33-36AAAA, RAD541-142RK52-53AA, RAD54RKRK33-36AAAA, 
and RAD54RKRK33-36AAAA, S49E with a Sumo-His affinity tag, were cloned in the 
pETHSUL vector (Weeks et al., 2007) and expressed in E. coli Rosetta 2 cells. 
The cDNA sequence used for cloning was amplified using DNA primers listed in 
Table 2.2 and pFastBac-HTc vector containing RAD54 cDNA as template. The 
cloning was performed using Ligation independent cloning protocol as described 
previously (Weeks et al., 2007). All RAD54 mutants were generated using 
QuickChange site directed mutagenesis kit (Agilent Technologies) and DNA 
primers listed in Supplemental Table 2. Rosetta 2 cells were transformed with the 
recombinant plasmids and cultured at 37 °C to an O.D.600 of 0.4. The cultures were 
transferred to 16 °C and allowed to grow until an O.D.600 of 0.6-0.8, followed by 
induction of protein expression with 0.1 mM isopropyl-1-thio-β-D-
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galactopyranoside for 20 h. Cells were harvested by centrifugation (7000 x g) and 
stored at -80oC. All purification steps were carried out at 4 °C. Cells (10 g) were 
thawed and resuspended in ten volumes of lysis buffer (20 mM KH2PO4 pH 7.5, 
200 mM KCl, 10% Sucrose, 10 mM 2-mercaptoethanol) supplemented with EDTA-
free protease inhibitor cocktail (Roche Applied Science). The cells were lysed by 
passing their suspension twice through an Emulsiflex C-5 (Avestin) at 15, 000 – 
20, 000 psi. The crude extract was clarified by centrifugation (148, 000 X g for 60 
min) and passed through 0.45 µm filter. The filtrate was loaded onto a 5 ml HiTrap 
Ni2+ column (GE Healthcare). The column was washed extensively with buffer A 
(20 mM KH2PO4 pH 7.5, 500 mM KCl, 10% glycerol, 10 mM 2-mercaptoethanol) 
supplemented with 50 mM Imidazole. RAD54 protein was eluted using buffer A 
supplemented with 500 mM Imidazole and the eluate was supplemented with 2 
mM EDTA. Sumo-His tags were cleaved off by Sumo hydrolase (dtUD1) (200 µg) 
for 4 h at 4 °C. The cleaved RAD54 was fractionated on a Superdex 200 column 
(58 ml) equilibrated with buffer A. The fractions containing RAD54 were pooled, 
diluted 5 times using buffer B (20 mM KH2PO4 pH 7.5, 10% glycerol, 10 mM 2-
mercaptoethanol) and loaded on to 1 ml Resource S column (GE Healthcare), 
equilibrated with buffer B supplemented with 100 mM KCl. The proteins were 
eluted with a 20 ml gradient of KCl (100-450 mM) in buffer B. The fractions 
containing RAD54 or RAD54 mutants were analyzed for nuclease contamination, 
pooled, and stored in small aliquots at -80 °C. The protein appeared nearly 
homogeneous in a Coomassie-stained SDS-polyacrylamide gel. 
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The RAD541-142 was purified as above except that a 58-ml Sephacryl S-200 
HR column (GE Healthcare) was used in place of Superdex 200. For the RAD541-
142 mutants, 1 ml Heparin column was used instead of Resource S column.  
 
 
 
Table 2.2 Primers used in this study * 
 Forward/Reverse Sequence, 5’3’ 
RAD54 WT 
 
Forward 
AG ATT GGT GGC GGC ATG AGG AGG AGC TTG GCT CCC 
Reverse 
GAG GAG AGT TTA GAC ATT AGC GGA GGC CCC GCT GTT 
CCT CAT G  
RAD541-142 
Forward AG ATT GGT GGC GGC ATG AGG AGG AGC TTG GCT CCC
Reverse GAG GAG AGT TTA GAC A TTA A TGG ACA GGG AGT TTC TCC TTG 
RAD54 S49E  
Forward G GAG TGT TTC CTG GAA CCT TTT CGG AAA CCT TTG AG
Reverse CT CAA AGG TTT CCG AAA AGG TTC CAG GAA ACA CTC C 
RAD54KRK12-
14AAA 
Forward CCC AGC CAG CTG GCC GCG GCA GCA CCT GAA GGC AGG TCC 
Reverse GGA CCT GCC TTC AGG TGC TGC CGC GGC CAG CTG GCT GGG 
RAD54RKRK33-
36AAAA 
Forward CCT GGC CTA GTG ACT CCT GCG GCA GCG GCA TCC AGC AGT GAG ACC C 
Reverse GGG TCT CAC TGC TGG ATG CCG CTG CCG CAG GAG TCA CTA GGC CAG G 
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RAD54RK52-53AA 
Forward GAG TGT TTC CTG TCT CCT TTT GCG GCA CCT TTG AGT CAG CTA ACC  
Reverse GGT TAG CTG ACT CAA AGG TGC CGC AAA AGG AGA CAG GAA ACA CTC  
 
*Bold red letters indicate the nucleotides that were mutated. 
 
 
Spectrophotometric ATPase assay 
The hydrolysis of ATP by Rad54 protein was monitored 
spectrophotometrically as described (Kowalczykowski and Krupp, 1987). The 
oxidation of NADH, coupled to ADP phosphorylation, resulted in a decrease in 
absorbance at 340 nm, which was continuously monitored by a Hewlett-Packard 
8453 diode array spectrophotometer using UVvisible ChemStation software. The 
rate of ATP hydrolysis was calculated from the rate of change in absorbance using 
the following formula: the rate of A340 decrease (s-1) X 9880 = rate of ATP 
hydrolysis (µM/min). The reactions were carried out in standard buffer containing 
25 mM Tris-acetate, pH 7.5, 10 mM MgCl2, 1 mM DTT, 2 mM ATP, 3 mM 
phosphoenolpyruvate, pyruvate kinase (20 U/ml), lactate dehydrogenase (20 
U/ml), and NADH (200 μg/ml) unless otherwise indicated, and the indicated 
concentrations of RAD54 and DNA. Reactions were carried out at 30 °C unless 
otherwise indicated. 
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Branch migration assay 
PX junctions were prepared by annealing 32P-labeled forked DNA 
intermediates (#71/169*) with 3’-tailed DNAs (#170/171) (50% molar excess of 
cold tailed DNA) (Rossi et al., 2010). The RAD54 protein (60 nM, unless indicated 
otherwise) was incubated with 32P-labeled synthetic PX-junction (32 nM, 
molecules unless indicated otherwise), in a 100-µl branch migration buffer 
containing 25 mM Tris acetate, pH 7.5, 3 mM magnesium acetate, 2 mM ATP, 1 
mM dithiothreitol, 100 µg/ml BSA, the ATP-regenerating system (30 units/ml 
creatine phosphokinase and 10 mM phosphocreatine). The reactions were carried 
out at 30 °C. Aliquots (10 µl) were withdrawn at indicated time points, and DNA 
substrates were deproteinized by treatment with stop solution (1.36% SDS, 1.4 
mg/ml proteinase K, 6% glycerol, 0.015% bromophenol blue) for 15 min at 37 °C. 
Samples were analyzed by electrophoresis in 8% polyacrylamide gels (29:1) in 1x 
TBE buffer (90 mM Tris borate, pH 8.3, and 1 mM EDTA) at room temperature. 
The gels were dried on DE81 chromatography paper (Whatman) and quantified 
using a Storm 840 PhosphorImager (GE Healthcare). 
 
Triple-helix displacement assay 
The assay was a modification of a procedure described previously (Firman 
and Szczelkun, 2000; Jaskelioff et al., 2003).  SspI-linearized pMJ5 (100 nM, 
molecules) and 32P-labeled triplex-forming oligonucleotide (TFO) (oligo TFO, 22-
mer) (100 nM, molecules) were mixed in buffer containing 25 mM MES (pH 5.5), 
and 10 mM MgCl2 and incubated for 15 min at 57 °C, followed by overnight 
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incubation at room temperature. The RAD54 (5 nM) was incubated for 5 min at 20 
°C in 100-µl reaction buffer containing 35 mM Tris HCl, pH 7.2, 3 mM MgCl2, 100 
µg/ml BSA, 1 mM DTT, 2 mM ATP, and the ATP-regenerating system (30 units/ml 
creatine phosphokinase and 15 mM phosphocreatine). The reaction was initiated 
by addition of the triple-helix substrate (pMJ5+TFO) (0.5 nM, molecules). 10 µl 
aliquots were withdrawn at indicated time points and the reaction was quenched 
by adding 5 µl of stop solution containing 1.36% SDS, 1.4 mg/ml proteinase K, 6% 
glycerol, 0.015% bromophenol blue followed by 15 min incubation at 37 °C. The 
DNA products were analyzed by electrophoresis in 1.2% agarose gels in a buffer 
containing 40 mM Tris acetate, pH 5.5, 5 mM sodium acetate, and 1 mM MgCl2 at 
3.5 V/cm for 2 h at 4 °C. The gels were dried on DE81 chromatography paper 
(Whatman) and quantified using a Storm 840 PhosphorImager (GE Healthcare). 
 
Gel retardation assay 
The non-mobile 32P-labeled PX junction (oligos 174/175/176/181) (30 nM, 
molecules) was incubated in binding buffer containing 25 mM Tris acetate (pH 7.5), 
5mM magnesium acetate, 100 µg/ml BSA, 2 mM DTT, 2 mM ATP, and 10% 
glycerol for 45 min at 4 °C. Then RAD54 or RAD54 mutants (at indicated 
concentrations) were added to the reaction mixture followed by additional 
incubation for 45 min. RAD54-DNA complexes were analyzed by electrophoresis 
in 6% non-denaturing polyacrylamide gels (29:1) in 0.25x TBE buffer (22.5 mM 
Tris borate pH 8.3 and 0.5 mM EDTA). The gels were dried on DE81 
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chromatography paper (Whatman) and the results were quantified using a Storm 
840 PhosphorImager (GE Healthcare). 
 
In vitro CDK2 phosphorylation assay  
RAD54 or RAD541-142 (500 ng) was incubated in a 10 µl reaction mixture 
containing 50 mM HEPES-KOH, pH 7.5, 10 mM MgCl2, 1 mM DTT, 30 µM ATP 
and 83.5 nM [γ-32P] ATP (6000 mCi/mmole) with 500 ng of purified CDK2/CyclinA2 
complexes for 30 min at 30 °C. The reactions were stopped by addition of EDTA 
to 25 mM and an equal volume of 2 x Laemmli buffer (20% glycerol, 0.3 M β-
mercaptoethanol, 4% SDS, 0.01% bromophenol blue, and 112 mM Tris HCl, pH 
6.8) and incubation for 5 min at 75 °C. Proteins were analyzed by SDS-PAGE, and 
gels were stained with Blue protein stain (Denville) as described by the 
manufacturer. The gels were then dried on DE81 chromatography paper and 
radioactive protein bands were quantified using a Storm 840 PhosphorImager (GE 
Healthcare). To estimate the extent of RAD54 phosphorylation, we used 
radioactive standards that were prepared by diluting [γ-32P] ATP stock 1,000, 5,000 
and 10,000 times, and applying 1 µl of each dilution onto DE81 chromatography 
paper that was exposed together with the gel containing phosphorylated RAD54. 
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D-loop formation 
The nucleoprotein filaments were formed by incubating RAD51 protein with 
32P-labeled ssDNA (#90, 90-mer) in buffer containing 35 mM Tris-HCl, pH 7.5, 2 
mM ATP, 100 µg/ml BSA, 1 mM DTT, 20 mM KCl (from the protein stock), 1.5 mM 
MgCl2, 0.5 mM CaCl2, and the ATP regenerating system (30 units/ml creatine 
phosphokinase and 20 mM phosphocreatine for 30 min at 37 °C. The reaction was 
transferred to 30 °C followed by addition of RAD54 and supercoiled pUC19 dsDNA 
(50 µM nucleotide or 9.3 nM molecules) to initiate D-loop formation. Aliquots (10 
µl) were withdrawn at indicated time points, and D-loops were deproteinized by 
treatment with 5 µl of stop solution (1.36% SDS, 1.4 mg/ml proteinase K, 6% 
glycerol, 0.015% bromophenol blue) for 15 min at 37 °C ; and analyzed by 
electrophoresis in 1% agarose-TAE (40 mM Tris acetate, pH 8.0, and 1 mM EDTA) 
gels. The gels were dried on DE81 chromatography paper and quantified using a 
Storm 840 PhosphorImager (GE Healthcare). 
 
ATPase Assay using Thin Layer Chromatography (TLC) 
The phosphorylated or non-phosphorylated RAD54 protein (60 nM) was 
incubated with PX-junction (10 nM, molecules) and 8 mM ATP, 20 nCi of [γ-
32P]ATP in 10 µl of reaction buffer containing 25 mM Tris acetate, pH 7.5, 2 mM 
DTT, 100 μg/ml BSA, 11 mM magnesium acetate  at 30 °C. The level of ATP 
hydrolysis was determined using TLC on PEI-cellulose plates in running buffer 
containing 1 M formic acid and 0.3 M LiCl. The products of ATP hydrolysis were 
quantified using a Storm 840 PhosphorImager (GE Healthcare). 
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RAD54 protein cross-linking 
RAD54 or RAD54 mutants (1200 nM) were incubated in 10 µl reaction 
mixtures containing 20 mM HEPES-KOH, pH 7.5, 5 mM MgCl2, 5 mM EDTA, and 
40 mM KCl with PX-junction (oligos 174/175/176/181) (0.4 µM, molecules) for 5 
min at 25 °C. Followed by, the addition of bis-maleimidohexane (BMH) (Pierce) to 
a final concentration of 25 µM. After a 10-min incubation at 25 °C, the reactions 
were quenched by the addition of β-mercaptoethanol to a final concentration of 1.1 
M. The samples were analyzed by electrophoresis in 7.5% or 15% SDS-PAGE 
gels for RAD54 or RAD541-142 proteins, respectively. The proteins were visualized 
by silver staining (Invitrogen). 
 
2.4 RESULTS 
 
2.4.1 The RAD54 N-terminal domain is essential for branch migration of 
Holliday Junctions 
We wished to explore the role of the N-terminal domain in the branch 
migration activity of RAD54. We constructed a truncated RAD5496-747 mutant 
devoid of the N-terminal 95 amino acid (aa) residues and tested its branch 
migration activity using 32P-labeled partial Holliday junctions (PX) substrate (no. 
71/169/170/171) that contains three dsDNA arms and one ssDNA arm (Figure 
2.1A). Previously, we showed that the PX junction is a preferable substrate for 
RAD54 branch migration (Bugreev et al., 2006b; Mazina et al., 2007). To reduce 
spontaneous branch migration, a single bp of heterology was introduced in one of 
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the four DNA arms, which during branch migration would create a single 
mismatched bp in each of the two branch migration products (Figure 2.1A). We 
found that the RAD5496-747 mutant has no detectable branch migration activity in a 
wide range of tested protein concentrations (Figure 2.1B-E).  
Since branch migration activity of RAD54 depends on ATP hydrolysis 
(Bugreev et al., 2006b), we tested whether the loss of branch migration activity by 
RAD5496-747 is due to disruption of its ATPase activity. Surprisingly, we found that 
the RAD5496-747 has an approximately 2-2.5-fold greater ATPase activity than 
RAD54 WT (Figure 2.1F). Thus, the N-terminal domain truncation specifically 
disrupts the branch migration, but not the ATPase activity of RAD54.  
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Figure 2.1 The RAD54 N-terminal domain is essential for branch migration, 
but not for ATP hydrolysis. A) The experimental scheme of the branch migration 
reaction. Shown is one bp heterology that was introduced into the PX junction (no. 
71/169/170/171) to reduce the spontaneous branch migration. The shaded region 
denotes the heterologous DNA branch. The direction of branch migration is 
denoted by arrows. The asterisk indicates the 32P-label. The numbers correspond 
to oligonucleotides in Table 2.1. B) The kinetics of branch migration of PX-junction 
(10 nM, molecules) promoted by RAD54 (30 nM) or RAD5496-747 (30 nM). The 
branch migration products were analyzed by electrophoresis in 8% polyacrylamide 
gels. C) Data from B is plotted as a graph. D) The DNA products of branch 
migration reactions promoted by RAD54 or RAD5496-747 on PX-junction (no. 
71/169/170/171) (10 nM, molecules) were analyzed by electrophoresis in 8% 
polyacrylamide gels. E) Data from D plotted as a graph. F) ATP hydrolysis by 
RAD54 (20 nM) and RAD5496-747 (20 nM) using supercoiled pUC19 as DNA 
substrate. Each experiment was repeated three times. Error bars represent the 
standard error of the mean (S.E.) 
 
 
 
 
2.4.2 RAD5496-747 retains DNA translocation activity  
We wanted to determine the specific role of the N-terminal domain in 
RAD54-promoted branch migration. At minimum, a branch migration protein must 
translocate along the DNA axis in an ATPase-dependent manner. We tested 
whether RAD5496-747 retains DNA translocation activity using a triple-helix 
displacement assay (Figure 2.2A) (Deakyne et al., 2013; Firman and Szczelkun, 
2000; Jaskelioff et al., 2003). The triple-helix was formed under slightly acidic 
conditions, pH 5.5, by annealing a pyrimidine-rich triplex forming oligonucleotide 
(TFO, 22 mer) to a purine-rich sequence in pMJ5 plasmid DNA through Hoogsteen 
base pairing. The triple-helix is stable at neutral pH, however, once disrupted by a 
DNA translocating protein, it will not re-form. We found that the RAD5496-747 not 
only retained DNA translocation activity but it was increased approximately 2-2.5-
fold relative to that of RAD54 WT (Figure 2.2B-C). Thus, the DNA translocation 
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activity of RAD5496-747 was increased in parallel with an increase in the ATPase 
activity, but in a sharp contrast with the loss of the branch migration activity (Figure 
2.1).  
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Figure 2.2 The 95 aa N-terminal truncation enhances DNA translocation 
activity of RAD54. A) The experimental scheme of the triple-helix displacement 
assay. The zig-zag line indicates triple-helix forming oligonucleotide (TFO) that is 
paired to the linearized pMJ5 plasmid. The asterisk indicates the 32P-label. B) The 
kinetics of triple-helix (0.5 nM, molecules) displacement by RAD54 (5 nM) or 
RAD5496-747 (5 nM) was analyzed by electrophoresis in 1.2 % agarose gels. C) 
Data from B plotted as a graph.  D) The ATPase activity of RAD54 (60 nM) and 
RAD5496-747 (60 nM) was measured in presence of various DNA substrates; 
ssDNA (no. 2), dsDNA (no. 1/2), PX-junction (no.174/175/176/181), and Holliday 
junction (no.174/175/176/177) (20 nM, molecules) at 30 °C. E) DNA binding 
preferences for RAD5496-747. RAD5496-747 (150 nM) was incubated with 32P-labeled 
non-mobile PX-junction (30 nM, no. 174/175/176/181) in the presence of the 
indicated concentrations of unlabeled DNA competitors (ssDNA, dsDNA, PX-
junction, X-junction). The complexes were analyzed by EMSA. F) Data from E 
plotted as a graph. Each experiment was repeated three times. Error bars 
represent the S.E. 
 
 
2.4.3 The N-terminal 95 aa truncation changes DNA binding preferences of 
RAD54  
 Previously, we showed that RAD54 has a strong binding preference for 
branched DNA substrates, including PX-junction and HJ-junctions (Bugreev et al., 
2006b; Mazina et al., 2007). Here, we tested DNA binding preferences of RAD5496-
747 using the DNA-dependent ATPase as a read-out and electrophoretic mobility 
shift assays (EMSA). We found that the ATPase activity of RAD5496-747, similar to 
RAD54 WT, was stimulated greater by branched DNA substrates than by linear 
dsDNA (Figure 2.2D). However, RAD5496-747 had a similar preference for PX and 
Holliday junction substrate, unlike RAD54 WT, which had a higher preference for 
PX over Holliday junction substrate.   
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We also tested DNA binding specificity of RAD5496-747 using EMSA 
(Bugreev et al., 2006b). RAD5496-747 complexes with 32P-labeled PX-junction (no. 
174/175/176/181) were formed in the presence of the increasing concentrations of 
unlabeled DNA competitors of different structures and analyzed by gel-
electrophoresis. The concentration of DNA competitors required to reduce the 
complex formation between RAD5496-747 and the 32P-labeled PX junction by 50% 
were approximately 60 nM for PX-junction (no. 174/175/176/181), 130 nM for 
Holliday junction (no. 174/175/176/177), 1400 nM for dsDNA (no. 1/2), and 3000 
nM for ssDNA (no. 2) (Figure 2.2E-F). These results demonstrate that while the N-
terminal 95 aa truncation does not disrupt the ability of RAD54 to interact 
specifically with Holliday junction-like DNA substrates, it lowers the relative 
preference for PX vs Holliday junction substrates (~2-fold) in comparison to RAD54 
WT (~5-fold) (Bugreev et al., 2006b). These data together with the results of the 
ATPase assay (Figure 2.2D) indicate a change in DNA binding specificity of the N-
terminal truncated RAD5496-747 compared with RAD54 WT.  
 
2.4.4 The RAD54 N-terminal domain binds preferentially to branched DNA 
substrates  
In addition to the DNA binding site in the core ATPase/DNA binding domain, 
RAD54 has a secondary DNA binding site in the N-terminal domain (Wright and 
Heyer, 2014). To assess a possible role of this site in RAD54 branch migration of 
Holliday junctions, we expressed the RAD541-142 N-terminal domain in E. coli 
(Golub et al., 1997), purified it, and studied its DNA binding properties. First, using 
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EMSA we found that RAD541-142 binds DNA and has even stronger binding 
preference for branched DNA than RAD5496-747, as no significant disruption of the 
RAD541-142 complex with 32P-labelled PX-junctions (no. 174/175/176/181) was 
observed in the presence of a 150-200 fold excess of cold ss- or ds-DNA (no. 2 or 
no. 1/2) competitor (Figure 2.3A-B). RAD541-142 also has a strong, approximately 
6-fold, preference for PX-junction over HJ-junction substrates, which is stronger 
than that of RAD5496-747 (Figure 2.2F), but similar to RAD54 WT (Bugreev et al., 
2006b). These data suggest that the N-terminal domain DNA binding site may play 
an important role in determining the preferential binding of RAD54 to Holliday 
junction-like structures. The N-terminal 95 aa deletion may partially disrupt this site 
changing the DNA binding specificity of RAD54.  
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Figure 2.3 The DNA binding preference of RAD541-142. A) DNA binding 
preferences for RAD541-142. RAD541-142 (300 nM) was incubated with 32P-labeled 
non-mobile PX-junction (30 nM, no. 174/175/176/181) in the presence of the 
indicated concentrations of unlabeled DNA competitors (ssDNA, dsDNA, PX-
junction, X-junction). The complexes were analyzed by EMSA. B) Data from A 
plotted as a graph. Each experiment was repeated three times. Error bars 
represent the S.E. 
 
 
 
2.4.5 Mutations that separately inhibit N-terminal domain oligomerization or 
DNA binding  
In order to identify the specific aa residues essential for DNA binding of 
RAD541-142, we generated 3 mutants by substituting stretches of basic aa residues 
with alanine residues; RAD541-142KRK12-14AAA (aa residues 12-14), RAD541-142RKRK33-
36AAAA (aa residues 33-36), and RAD541-142RK52-53AA (aa residues 52-53), (Table 
2.2). We also constructed RAD541-142T31E and RAD541-142S49E phosphomimetic 
B 
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mutants, since RAD54 was found to be phosphorylated at S49 HeLa cells 
(Kettenbach et al., 2011). This site is consensus sequence for CDK2 
phosphorylation. Further analysis showed that there are two CDK2 
phosphorylation consensus sites located in the RAD54 N-terminal domain, at 
positions 30-34 (VTPRK) and 48-52 (LSPFR). We wanted to test the effect of 
CDK2 phosphorylation at these sites on DNA binding by the RAD54 N-terminal 
domain. All RAD54 N-terminal domain mutant proteins, except RAD541-142KRK12-
14AAA, which failed to express under various tested growth conditions, were purified 
from E.coli, and examined for binding to PX-junction (no. 174/175/176/181) using 
EMSA.  
RAD541-142RK52-53AA mutant bound DNA similar to the non-mutated RAD541-
142 that formed a series of distinct complexes starting at 0.1 µM protein 
concentration (Figure 2.4A, lanes 8-12) (data not shown). In contrast, RAD541-
142RKRK33-36AAAA showed only a weak binding to PX-junction. No distinct complexes 
were observed on the gel, however, smearing observed at the highest protein 
concentration tested (0.5 µM) likely indicated the formation of unstable DNA-
protein complexes prone to dissociation during gel electrophoresis (Figure 2.4A, 
lanes 1-6). 
The S49E mutation reduced DNA binding of RAD541-142, specifically, the 
formation of large nucleoprotein complexes; whereas formation of small fast 
migrating complexes was not significantly affected (Figure 2.4A, lanes 13-17). In 
contrast, the T31E mutation had no significant effect on DNA binding by RAD541-
142 (Figure 2.4B, lanes 2-6). Thus, both the RKRK33-36AAAA and S49E mutations 
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reduced DNA binding of RAD541-142, but while the former mutation has an overall 
destabilizing effect on RAD541-142 DNA binding, the latter one specifically disrupted 
the formation of large nucleoprotein complexes.  
In solution, RAD54 is present in a monomeric form but multimerizes in the 
presence of DNA (Petukhova et al., 1999). Previously, we suggested that DNA-
dependent RAD54 oligomerization is necessary for branch migration (Mazina et 
al., 2007). To test if either of the two N-terminal domain mutations, RKRK33-
36AAAA or S49E, affect the RAD54 oligomerization, we performed crosslinking 
experiments using BMH agent that links two cysteine thiol groups separated by a 
distance no more than 13 Å.  RAD541-142, RAD541-142S49E or RAD541-142RKRK33-36AAAA 
proteins were incubated with minimal DNA flap substrate (no. 244/249/250) 
containing two 15-bp dsDNA arms and one 45-nt ssDNA arm, the smallest DNA 
substrate that is still capable to efficiently stimulate the ATPase activity of RAD54 
(Mazina et al., 2007)  followed by BMH crosslinking. The products of the protein 
crosslinking were analyzed on an SDS-polyacrylamide gel. Untreated RAD541-142, 
RAD541-142S49E, and RAD541-142RKRK33-36AAAA migrated in accord with the predicted 
size (~16 kDa) (Figure 2.5, lanes 2, 5, and 9). In the absence of DNA, BMH 
treatment gave rise to a small additional band of ~36 kDa, consistent with predicted 
dimer size (32 kDa) (Figure 2.5, lanes 3, 6, and 8). In the presence of DNA, BMH 
crosslinking resulted in a larger fraction of dimers (Figure 2.5, lanes 4, 7, and 10). 
In the case of RAD541-142 and RAD541-142RKRK33-36AAAA, large oligomers were also 
observed, some of them were unable to enter the gel (Figure 2.5, lanes 4 and 10). 
Apparently, BMH crosslinking helped to visualize intrinsically unstable 
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nucleoprotein complexes formed by RAD541-142RKRK33-36AAAA (Figure 2.4A; lanes 1-
6). In contrast, higher order oligomers were nearly completely absent in RAD541-
142S49E (Figure 2.5, lane 7).    
 Thus, RAD54S49E and RAD54RKRK33-36AAAA mutations differently affect the 
interaction of the RAD54 N-terminal domain with PX-junctions. RAD54S49E did not 
significantly disrupt the formation of fast migrating complexes in EMSA and 
formation of protein dimers in crosslinking experiments. However, this mutation 
decreased dramatically formation of large protein oligomers. To the contrary, 
RAD54RKRK33-36AAAA did not affect DNA-dependent protein oligomerization but 
significantly reduced the formation of stable protein-DNA complexes visualized by 
EMSA.  
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Figure 2.4 Mutations in RAD541-142 disrupt its DNA binding. A) The effect of 
the S49E and RKRK33-36AAAA mutations on RAD541-142 binding to PX-junction 
(30 nM, no. 174/175/176/181) was analyzed by EMSA in a 6% polyacrylamide gel. 
B) The effect of the S49E and T31E mutations on RAD541-142 binding to PX-
junction (30 nM, no. 174/175/176/181) was analyzed by EMSA in a 6% 
polyacrylamide gel. C) Data from A & B plotted as a graph. Each experiment was 
repeated three times. Error bars represent the S.E. 
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Figure 2.5 The S49E, but not the RKRK33-36AAAA, mutation inhibits DNA-
dependent oligomerization of RAD541-142. The proteins (1200 nM) were 
incubated with or without the minimal flap DNA (no. 244/249/250) (400 nM) in the 
presence or absence of BMH (25 µM) and analyzed in a 15% SDS-PAGE. Arrows 
indicate migration of the monomeric, dimeric, and oligomeric protein products. The 
molecular weight standards (Precision Plus; Bio-Rad) are shown. Each experiment 
was repeated three times. Error bars represent the S.E. 
 
 
 
2.4.6 The N-terminal domain mutations inhibit RAD54 branch migration  
Next, we wished to test the effect of the RKRK33-36AAAA and S49E 
mutations on the branch migration activity of RAD54. We constructed full length 
RAD54 carrying these N-terminal domain mutations with a sumo-His tag, 
expressed them in E.coli and purified. In control experiments, we demonstrated 
that the ATPase and branch migration activities of RAD54 WT with this tag purified 
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from E.coli were similar to that of RAD54 purified from insect cells (Figure 2.6A, 
B). Using PX-junctions (no. 71/169/170/171) as a substrate, we found that the 
branch migration activities of RAD54RKRK33-36AAAA and RAD54S49E were reduced 
(Figure 2.7A). This inhibition could not be due to a decrease in the ATPase activity 
which was even slightly elevated in both mutants relative to RAD54 WT (Figure 
2.7B). Thus, the mutations that either disrupted DNA binding of the N-terminal 
domain or inhibited its oligomerization cause inhibition of RAD54 branch migration 
activity.  
 
 
 
Figure 2.6 Comparison of activities of RAD54 purified from E.coli or insect 
cells.  A) The kinetics of branch migration of PX-junction (10 nM, molecules) 
promoted by RAD54 WT (30 nM) purified from insect cells or from E.coli. The 
branch migration products were analyzed by electrophoresis in 8% polyacrylamide 
gels. B) ATP hydrolysis by RAD54 WT (20 nM) purified form insect cells or from 
E.coli using supercoiled pUC19 as DNA substrate. Each experiment was repeated 
three times. Error bars represent the S.E. 
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Figure 2.7 The S49E and RKRK33-36AAAA mutations inhibit branch 
migration, but not ATP hydrolysis. A) The effect of the S49E and RKRK33-
36AAAA single and double mutations on the kinetics of branch migration of PX-
junction (32 nM, no. 71/169/170/171) by RAD54 (60 nM). B) The effect of the S49E 
and RKRK33-36AAAA mutations on ATP hydrolysis by RAD54 (20 nM) using 
supercoiled pUC19 as DNA substrate. Each experiment was repeated three times. 
Error bars represent the S.E. 
 
 
If two mutations inhibit branch migration by different mechanisms, one could 
expect that their combination would inhibit branch migration stronger than any of 
the mutations individually. Indeed, we found that in the RAD54RKRK33-36AAAA, S49E 
double mutant, the inhibition of branch migration activity was stronger than in either 
of the single mutants (Figure 2.7A, B) consistent with the different mechanisms of 
inhibition caused by these mutations: DNA binding vs protein oligomerization. 
 
2.4.7 N-terminal domain phosphorylation by CDK2 inhibits RAD54 branch 
migration but not its stimulation of RAD51 strand exchange  
Because RAD54 oligomerization, which is required for branch migration, is 
disrupted by S49E phosphomimetic mutation, we wanted to examine directly the 
effect of the N-terminal domain phosphorylation by CDK2 on the RAD54 branch 
migration activity. We first tested whether CDK2/cyclinA2 can phosphorylate 
RAD54 and the RAD541-142 in vitro. We observed that both proteins were 
phosphorylated with similar efficiency, consistent with the position of two CDK2 
consensuses in the RAD54 N-terminal domain (Figure 2.8A). When we used the 
RAD54S49E and RAD54T31E, S49E mutants as substrates for CDK2/cyclinA2, the level 
of phosphorylation was reduced to 65% and 15% for the single and double mutant, 
78 
 
 
 
respectively, indicating that  T31 and S49 are the major phosphorylation sites in 
RAD54 (Figure 2.8B). Next, we tested the effect of CDK2 phosphorylation on the 
branch migration activity of RAD54. We found that phosphorylation reduced 
RAD54 branch migration activity (Figure 2.9A). In contrast, we did not observe any 
effect of CDK2 phosphorylation on the ATPase activity of RAD54 (Figure 2.9B). 
We also found that CDK2 phosphorylation did not inhibit RAD54 ability to stimulate 
DNA strand exchange activity of RAD51 (Figure 2.10A and 2.10B).  These data 
suggest that CDK2 may specifically regulate RAD54 branch migration activity 
through phosphorylation of the N-terminal domain site.  
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Figure 2.8 CDK2 phosphorylates the N-terminal region of RAD54 in vitro. A) 
Left panel, Autoradiograph showing in vitro phosphorylation of RAD54 (500 ng) 
and RAD541-142 (500 ng) in the presence of [γ-32P] ATP with purified CDK2/cyclin 
complex. Right panel, Denville blue protein staining of the gel in the left panel. B) 
Left panel, Autoradiograph showing in vitro phosphorylation of RAD54 WT (500 
ng), RAD54S49E (500 ng), and RAD54T31E, S49E (500 ng) with CDK2/cyclin complex 
using [γ-32P] ATP. Right panel, Denville blue protein staining of the gel shown in 
the left panel.   
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Figure 2.9 Effect of CDK2 phosphorylation on the RAD54 branch migration 
and ATPase activity. A) The kinetics of branch migration of PX-junction (no. 
71/169/170/171) (32 nM) promoted by RAD54 (60 nM) or phosphorylated RAD54 
(60 nM). B) The kinetics of ATP hydrolyzed by RAD54 (60 nM) or phosphorylated 
RAD54 (60 nM) in presence of PX-junction (no. 174/175/176/181) (60 nM, 
molecule). The ATP hydrolysis was measured using Thin-Layer chromatography.  
B 
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Figure 2.10 Effect of phosphorylated RAD54 on strand exchange activity of 
RAD51. A) The experimental scheme of the D-loop reaction. The nucleoprotein 
filaments were formed between RAD51 and ssDNA at 37°C for 30 min. The 
reactions were then moved to 30°C. Then RAD54 was added followed by addition 
of pUC19 dsDNA substrate to initiate the reaction. B) The effect of RAD54 (50 nM) 
or phosphomimetic RAD54S49E (50 nM) on D-loop formation by RAD51 (1.25 µM) 
between 32P-labeled ssDNA (oligo 90, 2.4 µM nts) and pUC19 (50 µM, nts). The 
D-loops were analyzed by electrophoresis in 1% agarose gel. C) Data from B 
plotted as a graph. Each experiment was repeated three times. Error bars 
represent the S.E. 
 
 
2.5 DISCUSSION 
RAD54 is important homologous recombination protein evolutionarily 
conserved from low to higher eukaryotes (Mazin et al., 2010). In vitro, it possesses 
several activities including stimulation of the RAD51 DNA strand exchange activity 
and remodeling different dsDNA-protein complexes (Alexeev et al., 2003; Mazina 
and Mazin, 2004; Petukhova et al., 1998). However, RAD54 stands out as the most 
proficient branch migration protein in eukaryotes known so far (Bugreev et al., 
2006b; Mazin et al., 2010; Mazina et al., 2012). Moreover, RAD54 is the only 
known eukaryotic protein on par with E.coli RuvAB that can bypass large regions 
of DNA heterology (~100 bp) during branch migration of Holliday junctions (Mazin 
et al., 2010; Mazina et al., 2012). This property is remarkable because, in contrast 
to most other branch migration proteins, including RuvAB or BLM, RAD54 lacks 
canonical DNA helicase activity. However, the mechanism of RAD54 branch 
migration remains to be elucidated.  
 In spite of significant structural diversity, all branch migration proteins show 
high affinity to Holliday junction or Holliday junction-like structures and an ability to 
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translocate on DNA in an ATPase dependent manner. In the prototypic RuvAB 
complex, these two functions are segregated between RuvA and RuvB proteins, 
which act as the structure-specific DNA-binding protein and the ATPase motor 
protein, respectively (West, 1997). However, RAD54 and other known branch 
migration proteins including bacterial RecG and eukaryotic RecQ family helicases, 
BLM, RECQ1, and WRN, combine these two important activities in a single 
polypeptide.   
Our current data demonstrates that the N-terminal domain is essential for 
RAD54 branch migration activity. The RAD5496-747 mutant that lacks a significant 
portion of the N-terminal domain is devoid of branch migration activity nearly 
completely, while still proficient in DNA translocation and in ATP hydrolysis. We 
found that the RAD54 N-terminal domain promotes specific binding of RAD54 to 
Holliday junction substrates. The RAD541-142 has the preference for Holliday 
junction-like DNA substrates as strong as the full length RAD54. Replacement of 
basic a.a. residues 33-36 by alanines (RKRK33-36AAAA) diminished DNA binding 
by the RAD54 N-terminal domain indicating the tentative position of the N-terminal 
domain DNA binding site. Interestingly, RAD5496-747 retains the ability to recognize 
Holliday junction-like structures, albeit with an altered specificity relative to different 
types of branched DNA molecules. This result indicates that the N-terminal domain 
area between 96 and 142 aa residues may also contribute to the recognition of 
Holliday junction-like structures. Although the RAD54 N-terminal shows no 
structural homology outside of the RAD54 protein family it may represent a 
functional analog of the N-terminal domain of RecG or of the RecQ helicases CTD 
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(RQC) that are responsible for specific binding to branched DNA structures (Kim 
et al., 2013; Kitano et al., 2010; Pike et al., 2009 ; Singleton et al., 2001). 
Furthermore, deletion the RAD54 N-terminal domain, similar to deletion of the BLM 
HRDC domain adjacent to RQC (Swan et al., 2014), increased the ATPase activity 
of the enzyme. It is thought that HRDC may suppress the BLM ATPase activity 
through direct interaction with the ATPase core. 
The proteolytic cleavage analysis shows that in S. cerevisiae, the N-terminal 
domain of Rad54 is unstructured in solution (Raschle et al., 2004). These data are 
consistent with the structural flexibility of the RAD54 N-terminal domain, which 
enables its interaction with various partners, like RAD51, CDK2, or DNA (Golub et 
al., 1997; Kettenbach et al., 2011; Raschle et al., 2004; Wright and Heyer, 2014). 
Our current data further emphasize the structural flexibility of the RAD54 N-
terminal domain by demonstrating a coupling between its binding to DNA and 
oligomerization. Previously, we showed that RAD54 forms oligomeric structures 
on Holliday junction substrates during branch migration (Mazina et al., 2007), the 
property shared with other branch migration proteins including BLM and RuvAB 
(Mazina et al., 2012; West, 1997). However, the structural determinant of RAD54 
oligomerization remained unknown. Our current data show that RAD54 N-terminal 
domain is responsible for DNA-dependent RAD54 oligomerization. We found that 
the N-terminal domain alone is both necessary and sufficient for protein 
oligomerization and that the N-terminal truncation, significantly reduced the 
formation of RAD5496-747 oligomers in the presence of DNA. Moreover, we 
identified N-terminal domain mutations that separately affect DNA binding and 
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protein oligomerization. Thus, RKRK33-36AAAA mutation decreases DNA binding 
of the RAD541-142 to DNA significantly. However, even this residual DNA binding 
appeared to be sufficient to induce protein oligomerization identified in BMH cross-
linking experiments. In contrast, S49E mutation only weakly inhibits initial binding 
of RAD541-142 to DNA but disrupts the formation of large oligomeric protein 
complexes visualized by BMH cross-linking. In full-size RAD54, each of these 
mutations inhibited branch migration and their combination increased the 
inhibition. 
Taken together, these data led us to suggest a two-step process of 
formation of the active RAD54 branch migration complex. First, the RAD54 N-
terminal domain specifically targets RAD54 to Holliday junction. In the presence of 
Mg2+ (>100 µM), Holliday junction exists in stacked conformation that is refractory 
to branch migration (Mazina et al., 2007). Based on structural data, it was recently 
proposed that binding of the BLM RQC domain induces structural transition of 
Holliday junction into open conformation that is proficient in branch migration (Kim 
et al., 2013). We suggest that binding of the RAD54 N-terminal domain may have 
a similar effect on the Holliday junction conformation. Second, binding of the 
RAD54 N-terminal domain to DNA enables RAD54 oligomerization that is required 
for branch migration (Mazina et al., 2007).  
A phosphoproteomics study identified RAD54 phosphorylation at S49 
(Kettenbach et al., 2011). Two CDK2 consensus sites are located in the RAD54 
N-terminal domain, with putative phosphorylation sites at T31 and S49. Our in vitro 
CDK2 phosphorylation data are consistent, T31 and S49 as major phosphorylation 
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sites in RAD54, as T31E, S49E double mutations significantly reduced CDK2 
phosphorylation of RAD54. We found that S49E, but not T31E phosphomimetic 
mutation, inhibits RAD54 N-terminal domain oligomerization. Being incorporated 
in the full-size RAD54, this mutation inhibited the RAD54 branch migration activity 
consistent with the important role of RAD54 oligomerization for branch migration. 
The effect of the S49E mutation is specific for branch migration, as it has no 
significant effect on stimulation of RAD51-promoted DNA strand exchange by 
RAD54 indicating that RAD54 oligomerization is not required for stimulation of 
DNA strand exchange promoted by RAD51. In vitro CDK2 phosphorylation of 
RAD54 also inhibited RAD54 branch migration showing even stronger effect than 
the phosphomimetic S49E mutation.  
Previously, we showed that RAD54 branch migration activity causes 
dissociation of D-loops, the product of ssDNA invasion into homologous DNA-
template during double-strand break repair (Bugreev et al., 2007). This step of 
double-strand break repair, however, needs to be precisely controlled, as 
premature disruption of D-loops prior to their extension by DNA polymerase may 
abort double-strand break repair. CDK2-dependent inhibition of RAD54 branch 
migration may help to delay D-loop disruption until the polymerization step is 
completed (Figure 2.11). Recently, it was shown that Nek1 phosphorylates RAD54 
at S572 in late G2 phase to modulate its interaction with RAD51 (Spies et al., 
2016). Thus, multiple mechanisms are in place to control different RAD54 activities 
in the cell. 
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Figure 2.11 CDK2-dependent RAD54 regulation. The initial steps of 
homologous recombination involve, 5’ to 3’ exonucleolytic processing of double-
strand break ends producing 3’‐ssDNA overhangs, the formation of RAD51‐ssDNA 
nucleoprotein filaments, search for homology and strand invasion into the 
homologous duplex DNA‐template leading to the formation of displacement loops 
(D‐loop). RAD54 or pRAD54 both can stimulate the strand exchange activity of 
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RAD51. RAD54, through its branch migration activity, can also dissociate D-loops 
prior to the extension of the invading DNA strand disrupting the double-strand 
break repair process. pRAD54 is unable to oligomerize, thus inhibiting branch 
migration activity of RAD54 which provides sufficient time for the extension of 
invading strand. During later stages of homologous recombination, RAD54 needs 
to be in dephosphorylated form so that branch migration could occur to complete 
the repair process. Thus, phosphorylation by CDK2 modulates activities of RAD54 
during homologous recombination. 
 
 
  
In summary, we show that RAD54 N-terminal domain plays a pivotal role in 
the branch migration activity by specific binding to Holliday junctions and promoting 
DNA-dependent oligomerization. Furthermore, the RAD54 N-terminal domain, 
being a target for CDK2 phosphorylation, may play a role of the hub that controls 
RAD54 activities in the cell.  
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Characterization of RAD54 promoted annealing activity 
 
 
 
3.1 INTRODUCTION 
 
RAD54 belongs to the SWI2/SNF2 family of helicase-like proteins and is 
conserved in all eukaryotes. The members of this family of helicase-like proteins 
are known for their chromatin remodeling activity. The helicase-like proteins do not 
have DNA strand separation activity like canonical helicases, however, they use 
DNA-dependent ATP hydrolysis to translocate along the DNA generating positive 
supercoils in the DNA ahead and negative supercoils behind the protein. This 
allows the DNA strands to transiently “breathe”. RAD54 promotes chromatin 
remodeling and displacement of proteins from double-stranded DNA. It binds 
Holliday junctions and drives their branch migration (Bugreev et al., 2006b). 
RAD54 interacts with Mus81-Eme1 (Mms4), a structure-specific endonuclease, 
stimulating its DNA cleavage activity (Matulova et al., 2009; Mazina and Mazin, 
2008). Thus, RAD54 is a multifunctional protein performing functions throughout 
homologous recombination pathway and linking the whole process together 
(Heyer et al., 2006; San Filippo et al., 2008; Symington and Heyer, 2006; Tan et 
al., 2003). 
RAD54 is a member of Superfamily (SF) 2 of helicases (Troelstra et al., 
1992) and possesses seven classical “signature” motifs: I, Ia, II, III, IV, V, and VI, 
a characteristic of SF2 protein members (Nimonkar et al., 2007) plus several more 
recently identified motifs, like TxGx between motif Ia and motif II that is thought to 
play a role in oligonucleotide binding. The seven conserved motifs line the two 
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RecA-like motor domains, constituting the “core” or the minimal translocation motor 
responsible for the conversion of energy from ATP hydrolysis to the mechanical 
energy needed for translocation (Singleton et al., 2007). 
RAD54 sequencing identified it as a member of the group of proteins 
involved in translocation along nucleic acids that are broadly defined as helicases 
(Gorbalenya and Koonin, 1993; Troelstra et al., 1992). The common feature of 
these proteins is that they couple ATP hydrolysis to directional movement along 
nucleic acids, which may or may not result in strand separation of nucleic acids. 
Members of this group have a role in almost every cellular process from DNA 
replication and repair, transcription, translation, splicing, and nuclear transport 
(Singleton et al., 2007). 
  Helicases are molecular motors coupling the energy of nucleoside 
triphosphate hydrolysis to the unwinding and remodeling of structured DNA or RNA 
(Lohman and Bjornson, 1996; Patel and Donmez, 2006; Singleton et al., 2007). In 
higher organisms, approximately 1% of the genes of eukaryotic genomes 
apparently encode RNA or DNA helicases. Helicases can be classified as DNA or 
RNA helicases, depending upon their substrates. Although some helicases can 
function on both DNA and RNA molecules (Pyle, 2008). DNA helicases function in 
a variety of DNA metabolic processes, including unwinding duplex or alternative 
DNA structures (triplex, G-quadruplex), displacing protein bound to DNA, and 
chromatin remodeling (Bernstein et al., 2010; Dillingham, 2011; Wu et al., 2009). 
Traditionally, helicases have the ability to unwind double-stranded DNA or RNA in 
an ATP-dependent manner. There is, however, increasing evidence that some 
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helicases can anneal complementary strands of DNA or RNA molecules in the 
presence or absence of nucleoside triphosphate. The mechanism of this strand 
annealing activity of helicases and its biological relevance is not yet completely 
understood.   
Several members of the RecQ family of helicases have been found to 
possess annealing activity. There are five RecQ homologs in humans, and 
mutations in three of these genes (BLM, WRN, and RECQ4) are associated with 
Bloom’s, Werner, and Rothmund-Thomson syndromes, respectively. The 
mutations in RECQ5 have not been linked to any diseases, however, recq5−/− 
mice display genomic instability and are prone to cancer (Hu et al., 2005; Hu et al., 
2007). A single nucleotide polymorphism in RECQ1 is shown to correlate with 
decreased survival of pancreatic cancer patients (Li et al., 2006a; Li et al., 2006b).  
Several DNA branch migration proteins, BLM, WRN, and RECQ1, have 
been shown to possess annealing activity. Bloom’s syndrome helicase, BLM, has 
been to carry out annealing of two complementary DNA molecules (Cheok et al., 
2005; Machwe et al., 2005). Furthermore, it was shown that N-terminus of 
BLM/Sgs-1 was responsible for the annealing activity observed in vitro (Chen and 
Brill, 2010). The WRN helicase is also able to carry out annealing of 
complementary DNA molecules (Machwe et al., 2005) and this activity was 
mapped to the amino-acids 1072-1150 in the C-terminal region (Muftuoglu et al., 
2008). Annealing activity has also reported for the RECQ1 protein (Sharma et al., 
2005). RECQ1 efficiently promotes strand annealing as a higher order oligomer 
(pentamer or hexamer), while smaller oligomeric states (dimer or monomer) act to 
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unwind duplex DNA (Muzzolini et al., 2007). Therefore, different oligomeric states 
of RECQ1, modulated by binding of ssDNA and ATP, are associated with its strand 
annealing or unwinding activity. 
Unlike other branch migration proteins, annealing activity has not been 
reported for RAD54 protein. Recently, a second DNA-binding site was reported in 
the N-terminal domain of RAD54 (Wright and Heyer, 2014). Two DNA binding sites 
have also been reported for RAD51 and RAD52 proteins that carry out annealing 
and strand exchange between two DNA molecules (Khade and Sugiyama, 2016). 
Therefore, the presence of two DNA binding sites in RAD54 may suggest the ability 
to anneal two complementary DNA molecules like other branch migration proteins.  
Here, we show that RAD54 protein possesses efficient annealing activity. 
The N-terminal truncated protein, RAD5496-747, had significantly reduced annealing 
activity, and RAD541-142 did not promote ssDNA annealing. Therefore, the second 
DNA binding site in the N-terminal region of RAD54 is essential but not sufficient 
to carry out annealing indicating the requirement for both DNA binding sites for 
annealing activity. Disrupting the DNA-dependent oligomerization of the N-terminal 
domain using S49E mutant, had no effect on the ability of RAD54 to promote 
annealing. However, RAD54RKRK33-36AAAA mutant showed significantly lower 
annealing activity consistent with the requirement of two DNA binding sites for 
annealing activity.  
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3.2 MATERIALS AND METHODS 
 
Proteins and DNA 
All oligonucleotides used in this study (Table 3.1) were purchased from IDT 
Inc and purified using denaturing 6-10% PAGE. To prepare oligonucleotide dsDNA 
substrates, complementary ssDNA oligonucleotides were annealed as described 
(Rossi et al., 2010) and stored at -20 °C. Oligonucleotides were labeled using [γ-
32P] ATP and T4 polynucleotide kinase. T4 polynucleotide kinase and restriction 
endonucleases were purchased from New England Biolabs. PreScission™ 
Protease was purchased from GE Healthcare Life Sciences.  
 
 
Table 3.1. Sequences of the oligonucleotides used in this study * 
 
Number Length in nucleotides Sequence, 5’3’ 
#64 48 
GTC GAC GAC GTC TGA GTA CTC ATC TAG TGT GAC ATC 
ATC GCA TCG AGA 
 
#65 48 
TCT CGA TGC GAT GAT GTC ACA CTA GAT GAG TAC TCA 
GAC GTC GTC GAC 
 
 
 
Purification of RAD54 and N-terminal truncated mutants from insect cells 
Human RAD54 and RAD5496-747 were purified from Sf21 cells using 
baculovirus expression vector as described previously (Mazina and Mazin, 2004) 
with alterations indicated below. The purification scheme included a Glutathione 
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S-transferase (GST) affinity column, followed by a Superdex 200 column, and then 
a Resource S column. In this work, we used RAD54 constructs containing an 
amino-terminal GST affinity tag separated from the RAD54 gene by a PreScission 
Protease™ recognition sequence (L-E-V-L-F-Q-G-P). Following fractionation on 
the Superdex 200 column, the pool containing RAD54 was incubated with 
PreScission Protease (GE Healthcare) (10 U of PreScission Protease per 100 mg 
of RAD54) for 4 h at 4 °C. The sample was diluted to 100 mM KCl and loaded on 
a 1 ml Resource S column. The fractions containing RAD54 or RAD54 mutants 
were analyzed for nuclease contamination, pooled, and stored in small aliquots at 
-80 °C. The protein appeared nearly homogeneous in a Coomassie-stained SDS-
polyacrylamide gel. 
 
Expression and purification of RAD54, and RAD54 mutant proteins from 
E.coli 
Human RAD54, RAD54T31E, RAD54S49E, RAD541-142 (N-terminal 142 aa 
RAD54 fragment), RAD541-142 T31E, RAD54 1-142 S49E, and RAD54RKRK4A, with 
Sumo-His affinity tag, were cloned in the pETHSUL vector (Weeks et al., 2007) 
and expressed in E. coli Rosetta 2 cells. The cDNA sequence used for cloning was 
amplified using a pFastBac-HTc vector containing RAD54 cDNA sequence as 
template and DNA primers listed in Supplemental Table 2. The cloning was 
performed using Ligation independent cloning protocol as described previously 
(Weeks et al., 2007). All RAD54 mutants were generated using QuickChange site 
directed mutagenesis kit (Agilent Technologies) using primers listed in 
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Supplemental Table 2. Rosetta 2 cells were transformed with the recombinant 
plasmids and cultured at 37 °C to an O.D.600 of approximately 0.4. The cultures 
were transferred to 16 °C and allowed to grow until they reach an O.D.600 of 0.6-
0.8, following which the protein expression was induced with 0.1 mM isopropyl-1-
thio-β-D-galactopyranoside for 20 h. Cells were harvested by centrifugation (7000 
x g) and stored at -80oC. All purification steps were carried out at 4 °C. Cells (10 
g) were thawed and resuspended in ten volumes of lysis buffer (20 mM KH2PO4 
pH 7.5, 200 mM KCl, 10% Sucrose, 10 mM 2-mercaptoethanol) supplemented with 
EDTA-free protease inhibitor cocktail tablets (Roche Applied Science). The cells 
were lysed by passing their suspension twice through an Emulsiflex C-5 (Avestin) 
at 15, 000 – 20, 000 psi. The crude extract was clarified by centrifugation (185, 
000 X g for 60 min) and passed through 0.45 µm filter. The filtrate was loaded onto 
a 5 ml HiTrap Ni2+ column (GE Healthcare). The column was washed extensively 
with buffer A (20 mM KH2PO4 pH 7.5, 500 mM KCl, 10% glycerol, 10 mM 2-
mercaptoethanol) supplemented with 50 mM Imidazole. RAD54 protein was eluted 
using buffer A supplemented with 500 mM Imidazole and the eluate was 
supplemented with 2 mM EDTA. Sumo-His tags were cleaved off RAD54 
constructs by adding Sumo hydrolase (dtUD1) (200 µg) to the eluate followed by 
incubation for 4 h at 4 °C. The cleaved RAD54 was further fractionated on a 
Superdex-200 column (58 ml) equilibrated with buffer A. The fractions containing 
RAD54 were pooled, diluted 5 times using buffer B (20 mM KH2PO4 pH 7.5, 10% 
glycerol, 10 mM 2-mercaptoethanol) and loaded on to 1 ml Resource S column 
(GE Healthcare), equilibrated with buffer B supplemented with 100 mM KCl. The 
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protein was eluted with a 20 ml gradient of KCl (100-450 mM) in buffer B. The 
fractions containing RAD54 were analyzed for nuclease contamination, pooled, 
and stored in small aliquots at -80 °C. The protein appeared nearly homogeneous 
in a Coomassie-stained SDS-polyacrylamide gel. 
The RAD541-142 was purified as above except that a 58-ml Sephacryl S-200 
column (GE Healthcare) was used in place of Superdex-200.  
 
DNA strand annealing assay 
The annealing reactions were carried out using two complementary ssDNA 
oligonucleotides (# 64 and #65, 48-mer each), in which one was 32P-labeled at the 
5’-end. The non-labeled oligonucleotide (5 nM, molecules) was incubated in a 100-
µl reaction mixture containing 25 mM Tris acetate, pH 7.5, 3 mM magnesium 
acetate, 2 mM ATP, 1 mM dithiothreitol and 100 µg/ml BSA, for 5 min at 30 °C. 
RAD54 (20 nM) was added to the reaction mixture followed by a 1 min incubation. 
The annealing was started with the addition of the 32P- labeled DNA strand (5 nM, 
molecules). Aliquots (10 µl) were withdrawn at indicated time points and the 
reaction was quenched by the addition of 5 µl stop solution (1.36% SDS, 1.4 mg/ml 
proteinase K, 6% glycerol, 0.015% bromophenol blue) for 15 min at room 
temperature. DNA products were analyzed by electrophoresis in 10% 
polyacrylamide gels (17:1) in 1 x TBE buffer (90 mM Tris borate pH 8.3, and 1 mM 
EDTA) at 23 °C. The gels were dried on DE81 chromatography paper (Whatman) 
and quantified using a Storm 840 PhosphorImager (GE Healthcare). 
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3.3 RESULTS 
 
3.3.1 RAD54 promotes annealing of complementary ssDNA strands 
 
We tested the annealing activity of RAD54 using two complementary 
oligonucleotides (#64 and #65, 48-mers), in which one of the oligonucleotide was 
32P-labeled at the 5’-end (Figure 3.1 A). The non-labeled oligonucleotide was 
incubated in the reaction mixture for 5 min at 30 °C. Then, RAD54 was added to 
the reaction mixture and allowed to incubate for 1 min at 30°C. The annealing was 
initiated with the addition of the labeled oligonucleotide. Aliquots were withdrawn 
at indicated time points and the DNA products were analyzed by electrophoresis 
in polyacrylamide gels. We found that RAD54 promoted annealing of 
complementary ssDNA strands efficiently (Figure 3.1 B).  
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Figure 3.1 RAD54 promotes ssDNA annealing. A) the scheme for ssDNA 
annealing experiments. The ssDNA annealing was carried out between two 48-
mer oligonucleotides (no. 64/65). The asterisk indicates the 32P-label. B) The 
kinetics of annealing of ssDNA (5 nM, each oligo) promoted by RAD54 (20 nM). 
The DNA products were analyzed by electrophoresis in 10% polyacrylamide gels. 
 
 
3.3.2 Effect of nucleotide cofactors on RAD54 promoted annealing 
RAD54 is a motor protein that translocates on DNA in an ATP-dependent 
manner. Most of the activities of RAD54 are dependent on its ability to hydrolyze 
ATP, such as translocation, chromatin remodeling, and branch migration (Mazin 
et al., 2010). We wanted to determine if ATP hydrolysis was necessary for RAD54 
promoted annealing activity.  
B 
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We tested annealing activity of RAD54 in presence of ATP and ATPγS. We 
found that the annealing activity was atleast 2-fold lower in presence of ATPγS 
compared to ATP (Figure 3.2). This could suggest either that ATP hydrolysis is 
required for annealing activity or that nucleotide cofactor binding induces different 
conformational changes in the RAD54 protein affecting its annealing activity.  
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Figure 3.2 Effect of nucleotide cofactor on RAD54 annealing activity. The 
kinetics of annealing of ssDNA (5 nM, each oligo) promoted by RAD54 (20 nM) in 
presence of ATP or ATPγS. The DNA products were analyzed by electrophoresis 
in 10% polyacrylamide gels. 
 
 We wanted to test the annealing activity in presence of ADP nucleotide as 
well. However, in presence of ADP, an increase in the spontaneous annealing of 
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ssDNA strands was observed. Therefore, we could not assess the effect of ADP 
nucleotide on annealing activity of RAD54. 
 
3.3.3 N-terminal domain is necessary but not sufficient for annealing activity 
of RAD54 
Recently, a second DNA binding site was reported in the N-terminal domain 
of RAD54 (Wright and Heyer, 2014) which led us to the hypothesis that RAD54 
could promote annealing of ssDNA strands. We wanted to test if this second DNA 
binding site was required for annealing activity. We carried out annealing assays 
using two RAD54 mutants, RAD5496-747 and RAD541-142. We found that RAD5496-
747 had significantly reduced annealing activity, whereas Rad541-142 did not 
promote ssDNA annealing at all (Figure 3.3). Taken together, these results 
suggest that both the DNA binding sites are required for annealing activity of 
RAD54.   
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Figure 3.3 N-terminal domain is necessary but not sufficient for annealing 
activity of RAD54. The kinetics of annealing of ssDNA (5 nM, each oligo) 
promoted by RAD54, RAD5496-747, or RAD541-142 (20 nM). The DNA products were 
analyzed by electrophoresis in 10% polyacrylamide gels. 
 
 
3.3.4 DNA-binding by N-terminal domian, not oligomerization, is required for 
ssDNA annealing promoted by RAD54  
In Chapter 2, we demonstrated that the RAD54 N-terminal domain is 
essential for branch migration along with the conserved ATPase/DNA binding 
domain. Our results indicated that the N-terminal domain is important for coupling 
the RAD54 ATPase with branch migration through two connected, but distinct 
steps: binding to HJs and DNA-dependent RAD54 oligomerization.  
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We wanted to test if both or one of the activity of the RAD54 N-terminal 
domain was involved in annealing activity promoted by RAD54. For this, we carried 
out annealing reactions in the presence of RAD54RKRK33-36AAAA and RAD54S49E 
mutant proteins; these two mutations affect DNA-binding by N-terminal domain 
and DNA-dependent oligomerization, respectively. We found that RKRK4A 
mutation strongly reduced ssDNA annealing of RAD54, whereas, S49E had no 
significant effect on this activity (Figure 3.4). These data support our earlier 
conclusion that RKRK4A and S49E represent the separation of function mutations, 
in which RKRK4A disrupts the N-terminal domain DNA binding, whereas S49E 
mutation specifically inhibits RAD54 oligomerization without a significant direct 
effect on DNA binding.    
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Figure 3.4 DNA binding by RAD54 N-terminal domain is necessary for 
annealing activity. The kinetics of annealing of ssDNA (5 nM, each oligo) 
promoted by RAD54, RAD54S49E, or RAD54RKRK33-36AAAA (20 nM). The DNA 
products were analyzed by electrophoresis in 10% polyacrylamide gels. 
 
 
3.3.5 RAD54 promotes annealing of complementary ssDNA and ssRNA 
strands 
Recently, a novel mechanism has been proposed where RNA transcript can 
be used for homologous recombination and double-strand break repair (Keskin et 
al., 2014). The abundance of RNA transcripts in a cell makes this mechanism all 
the more interesting.  
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We wanted to further characterize the newly-found annealing activity of 
RAD54, by testing its ability to anneal ssDNA and ssRNA in vitro. We carried out 
annealing reactions using complementary ssDNA and ssRNA, under conditions 
optimized for annealing of two ssDNA strands. We found that RAD54 can anneal 
ssDNA and ssRNA to form DNA-RNA hybrid (Figure 3.5).    
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Figure 3.5 RAD54 promotes annealing of ssRNA and ssDNA. The kinetics of 
annealing of ssDNA (5 nM) and ssRNA (5 nM) promoted by RAD54 (20 nM). The 
DNA products were analyzed by electrophoresis in 10% polyacrylamide gels. 
 
 
 
3.4 DISCUSSION 
 
105 
 
 
 
RAD54 is a motor protein that belongs to the SWI2/SNF2 family of helicase-
like proteins and is conserved in all eukaryotes. The helicase-like proteins use 
DNA-dependent ATP hydrolysis to translocate along the DNA generating positive 
supercoils in the DNA ahead and negative supercoils behind the protein, allowing 
DNA strands to transiently “breathe”. RAD54 is a versatile protein that links the 
homologous recombination process together by performing functions throughout. 
(Heyer et al., 2006; San Filippo et al., 2008; Symington and Heyer, 2006; Tan et 
al., 2003). 
In this study, we found another activity for the RAD54 protein. RAD54 can 
carry out annealing between two ssDNA strands or between ssDNA and ssRNA 
efficiently. The second DNA binding site in the N-terminal region of RAD54 (Wright 
and Heyer, 2014) is essential but not sufficient to carry out annealing, indicating 
the requirement for both DNA binding sites for annealing activity. In chapter 2, we 
found that the N-terminal domain binds preferentially to branched DNA structures, 
however, it can still bind to linear ssDNA or dsDNA. The binding of the N-terminal 
domain to ssDNA is associated with the annealing activity of RAD54. The activity 
depends on the presence of two DNA binding sites in RAD54, the N-terminal 
domain site, and the ATPase core site. The RKRK4A mutation and 95 aa N-
terminal truncation that disrupt the N-terminal domain DNA binding strongly inhibit 
ssDNA annealing; similarly, RAD541-142 lacking the core DNA binding site is unable 
to support the annealing activity. In contrast, the S49E mutation that specifically 
inhibits protein oligomerization shows no significant effect on ssDNA annealing. 
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These data provide additional support to two distinct functions of the N-terminal 
domain during branch migration: DNA binding and protein oligomerization. 
Previously, it was shown that several branch migration proteins, including 
BLM and WRN, have ssDNA annealing activity (Cheok et al., 2005; Machwe et al., 
2005; Muftuoglu et al., 2008). Since this activity in most of the studied proteins, 
including RAD54 (Goyal et al, 2017, in preparation) is inhibited by RPA it unlikely 
plays a role in the cell, where RPA is abundant. Instead, it may manifest the 
presence of a secondary DNA binding site needed for branch migration in some 
cases because this site is also associated with protein oligomerization domain. 
Thus, the presence of the secondary ATPase independent DNA binding site 
coupled with protein oligomerization seems to be a general requirement for the 
branch migration proteins (Cheok et al., 2005; Wu et al., 2005).  
We also found that RAD54 can promote annealing of ssRNA and ssDNA to 
form an RNA-DNA hybrid. There is increasing evidence that suggests the 
possibility of using RNA transcripts as a template for homologous recombination 
and DNA repair (Keskin et al., 2014). RAD52 has been shown to be important for 
RNA-transcript mediated homologous recombination, as it can also anneal ssRNA 
and ssDNA to form RNA-DNA hybrid (Keskin et al., 2014). In light of these recent 
developments, the annealing activity of RAD54 cannot be overlooked. Therefore, 
further work is required to establish the exact role of annealing activity of the 
RAD54 protein in homologous recombination.  
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Identification of small-molecule inhibitors of RAD54 
 
4.1 INTRODUCTION 
The Homologous recombination pathway is responsible for the repair of 
DNA double-strand breaks, the most harmful types of DNA lesions, faithful 
chromosome segregation during meiosis, and telomerase-independent telomere 
maintenance (Jasin and Rothstein, 2013; Krejci et al., 2012; San Filippo et al., 
2008). Homologous recombination uses homologous DNA molecules as a 
template to repair double-strand breaks and therefore is, generally, an error-free 
process.  
RAD54, a key homologous recombination protein, is conserved among all 
eukaryotes. It is a multifunctional motor protein that is part of the SWI2/SNF2 
ATPase family that not only stimulates strand exchange activity of RAD51 but also 
has its own independent functions along the homologous recombination pathway. 
The SWI2/SNF2 family contains ATP-dependent chromatin remodeling proteins 
that can form multi-protein machines and their ATPase cores contain the seven 
conserved helicase domains that are associated with the Superfamily 2 helicases 
(Alexeev et al., 2003; Hauk and Bowman, 2011; Singleton et al., 2007). RAD54 is 
believed to function throughout the process of homologous recombination. During 
pre-synapsis, RAD54 stabilizes the RAD51-ssDNA filament (Mazin et al., 2003; 
Wolner and Peterson, 2005). In synapsis, RAD54 stimulates RAD51-mediated 
strand exchange and as an SWI2/SNF2 protein it can facilitate nucleosome sliding 
and induce changes in the DNA topology during the search for homologous 
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chromosomes (Alexeev et al., 2003; Alexiadis and Kadonaga, 2002; Jaskelioff et 
al., 2003). In post-synapsis, RAD54 can promote branch migration that serves to 
control the length of DNA exchanged between homologous DNA or dissociate 
Holliday junctions (Bugreev et al., 2007; Bugreev et al., 2006b). RAD54 interacts 
with Mus81-Eme1 (Mms4), a structure-specific endonuclease, stimulating its DNA 
cleavage activity (Interthal and Heyer, 2000; Matulova et al., 2009; Mazina and 
Mazin, 2008). RAD54 can also disrupt RAD51-dsDNA filaments which could be a 
final stage of the homologous recombination pathway to clear the DNA of proteins 
after the repair is completed.  
While the biochemical activities of RAD54 are well characterized, its specific 
cellular functions remain to be elucidated. In this study, we wanted to identify 
specific small-molecule inhibitors of human RAD54 protein using high throughput 
screening of chemical libraries. The specific inhibitors could be used to study the 
functions of RAD54 in human cells. Since double-strand break- and inter-strand 
crosslink- inducing agents are commonly used in anticancer therapy, the specific 
RAD54 inhibitors may also help to increase the therapy efficacy.  
With the aim of better understanding the activities of RAD54 in vitro and to 
test their function in vivo, we used a FRET-based assay for high-throughput 
screening of a 400, 000 compound library in collaboration with The Broad Institute, 
Cambridge, MA. The in vitro FRET-based primary assay was designed in a way 
that would result in increase in fluorescence as a result of DNA branch migration 
catalyzed by RAD54. In collaboration with the Broad Institute Probe Development 
Center (BIPDeC), the assay was validated (Z’ >0.8) and used for identification of 
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candidate inhibitors of RAD54. We confirmed 55 small-molecule compounds that 
inhibited RAD54 branch migration activity using the optimized assay in our lab. Out 
of these 55 compounds, we identified two compounds, C-G01 and C-A23, which 
strongly inhibited branch migration activity without significantly affecting its 
ATPase activity, similar to our N-terminal truncated RAD54 protein. Another 
compound C-E13 showed higher specificity for DT-40 chicken cells that were 
RAD18 deficient. Previously, it has been shown that RAD18 and RAD54 knockouts 
are synthetically lethal in DT-40 chicken cells (Yamashita et al., 2002). Therefore, 
C-E13 was used to generate the second-generation inhibitors to increase its 
potency.  
 
 
4.2 MATERIALS AND METHODS 
 
Chemicals, Proteins, and DNA 
All oligonucleotides used in this study (Table 4.1) were purchased from IDT 
Inc. and purified using denaturing 6-10% PAGE. To prepare oligonucleotide 
dsDNA substrates, complementary ssDNA oligonucleotides were annealed as 
described (Rossi et al., 2010) and stored at -20 °C. Oligonucleotides were labeled 
using [γ-32P] ATP and T4 polynucleotide kinase. T4 polynucleotide kinase and 
restriction endonucleases were purchased from New England Biolabs. 
PreScission™ Protease was purchased from GE Healthcare Life Sciences. The 
small-molecule compounds were a gift from the Broad Institute Probe 
Development Center.  
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Table 4.1. Sequences of the oligonucleotides used in this study * 
 
Number 
Length in 
nucleotide
s 
Sequence, 5’3’ 
#71 94 
CTT TAG CTG CAT ATT TAC AAC ATG TTG ACC TAC AGC 
ACC AGA TTC AGC AAT TAA GCT CTA AGC CAT CCG CAA 
AAA TGA CCT CTT ATC AAA AGG A 
#169 93 
TCC TTT TGA TAA GAG GTC ATT TTT GCG GAT GGC TTA 
GAG CTT AAT TGC TGA ATC TGG TGC TGT TTT TTT TTT 
TTT TTT TTT TTT TTT TTT TTT 
#170 94 
T CCT TTT GAT AAG AGG TCA TTT TTG CGG ATG GCT TAG 
AGC TTA ATT GCT AAA TCT GGT GCT GTA GGT CAA CAT 
GTT GTA AAT ATG CAG CTA AAG 
#171 63 ACA GCA CCA GAT TTA GCA ATT AAG CTC TAA GCC ATC CGC AAA AAT GAC CTC TTA TCA AAA GGA 
 
*Bold red letters indicate the nucleotides that form mismatched pairs in the 
branch migration products. 
 
 
Purification of RAD54 from insect cells 
Human RAD54 was purified from Sf21 cells using baculovirus expression 
vector as described previously (Mazina and Mazin, 2004) with alterations indicated 
below. The purification scheme included a Glutathione S-transferase (GST) affinity 
column, followed by a Superdex 200 column, and then a Resource S column. In 
this work, we used RAD54 constructs containing an amino-terminal GST affinity 
tag separated from the RAD54 gene by a PreScission Protease™ recognition 
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sequence (L-E-V-L-F-Q-G-P). Following fractionation on the Superdex 200 
column, the pool containing RAD54 was incubated with PreScission Protease (GE 
Healthcare) (10 U of PreScission Protease per 100 mg of RAD54) for 4 h at 4 °C. 
The sample was diluted to 100 mM KCl and loaded on a 1 ml Resource S column. 
The fractions containing RAD54 or RAD54 mutants were analyzed for nuclease 
contamination, pooled, and stored in small aliquots at -80 °C. The protein appeared 
nearly homogeneous in a Coomassie-stained SDS-polyacrylamide gel. 
 
ATPase Assay using Thin Layer Chromatography (TLC) 
The phosphorylated or non-phosphorylated RAD54 protein (60 nM) was 
incubated with PX-junction (10 nM, molecules) and 8 mM ATP, 20 nCi of [γ-
32P]ATP in 10 µl of reaction buffer containing 25 mM Tris acetate, pH 7.5, 2 mM 
DTT, 100 μg/ml BSA, 11 mM magnesium acetate at 30 °C. The level of ATP 
hydrolysis was determined using TLC on PEI-cellulose plates in running buffer 
containing 1 M formic acid and 0.3 M LiCl. The products of ATP hydrolysis were 
quantified using a Storm 840 PhosphorImager (GE Healthcare). 
 
 
 
 
 
 
 
112 
 
 
 
Branch migration assay 
PX junctions were prepared by annealing 32P-labeled forked DNA 
intermediates (#71/169*) with 3’-tailed DNAs (#170/171) (50% molar excess of 
cold tailed DNA) (Rossi et al., 2010). The PX sequence was designed so that one 
mismatched bp would be generated during branch migration reducing the 
spontaneous reaction. The RAD54 protein (60 nM, unless indicated otherwise) 
was incubated with 32P-labeled synthetic PX-junction (32 nM, molecules unless 
indicated otherwise), in a 100-µl branch migration buffer containing 25 mM Tris 
acetate, pH 7.5, 3 mM magnesium acetate, 2 mM ATP, 1 mM dithiothreitol, 100 
µg/ml BSA, the ATP-regenerating system (30 units/ml creatine phosphokinase and 
10 mM creatine phosphate). The reactions were carried out at 30 °C. Aliquots (10 
µl) were withdrawn at indicated time points, and DNA substrates were 
deproteinized by treatment with stop solution (1.36% SDS, 1.4 mg/ml proteinase 
K, 6% glycerol, 0.015% bromophenol blue) for 15 min at 37 °C. Samples were 
analyzed by electrophoresis in 8% polyacrylamide gels (29:1) in 1x TBE buffer (90 
mM Tris borate, pH 8.3, and 1 mM EDTA) at room temperature. The gels were 
dried on DE81 chromatography paper (Whatman) and quantified using a Storm 
840 PhosphorImager (GE Healthcare). 
 
CellTiter-Glo luminescent viability assay.  
Wild type or RAD18-deficient DT40 cells were grown in log phase, following 
which 3000 cells were seeded in 100 μl complete DMEM/F12 media containing 
10% FBS, 1.5% chicken serum, 100U/ml penicillin, 100 μg/ml streptomycin and 10 
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μM β-mercaptoethanol in a white 96-well plate (Greiner Bio-One, cat# 655083). 
Cells were allowed to grow overnight in a 37 ˚ C, 5% CO2 incubator and then treated 
with compounds in indicated concentrations. After 48h the cells were added with 
30 μl/well of CellTiter–Glo reagent (Promega, cat# G7572) and incubated for 10 
min at room temperature. The luminescent signal was read by GloMax®-Multi 
Microplate Multimode Reader. 
 
 
4.3 RESULTS 
 
4.3.1 High-throughput screening for RAD54 inhibitors 
We conducted a high-throughput screening of a 500, 000 compound library 
in collaboration with The Broad Institute, MA to identify molecules that branch 
migration activity of RAD54, using a fluorescence-based assay (Figure 4.1). The 
assay utilizes a fluorescein molecule and a black hole quencher on the two strands 
of a duplex DNA. If RAD54 is able to branch migrate the DNA substrate, the black 
home quencher would be separated from the fluorescein molecule, and we would 
observe fluorescence signal. However, if the small molecule is an inhibitor of 
RAD54 branch migration activity, we would not observe any signal. This initial 
screening identified 55 potential inhibitors of RAD54 branch migration activity. 
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Figure 4.1 Fluorescence-based assay for identification of RAD54 small-
molecule inhibitors. Fluorescence-quenching assay for RAD54 branch 
migration.  Experimental scheme. FLU-fluorescein; BHQ –black hole quencher.  
 
 
 
 
4.3.2 Validation of hits identified by high-throughput screening 
The hits identified by the high-throughput screening were then validated 
using the branch migration assay optimized in our lab. The hits were then grouped 
in terms of potency to inhibit the branch migration reaction. We found five 
compounds that showed >75% branch migration inhibition (shown in red), nine 
compounds that showed >50% branch migration inhibition (shown in blue), and 
nine compounds that showed >30% branch migration inhibition (shown in green) 
(Figure 4.2). These compounds were also tested for their ability to inhibit ATP 
hydrolysis by RAD54 using the TLC-based method and for specificity using 
RAD51-promoted strand exchange reaction as read-out (Table 4.2).  
We found two compounds, C-G01 and A-23, which selectively inhibited 
branch migration activity of RAD54 and did not affect RAD54’s ATPase or RAD51’s 
strand exchange activity. The deletion of the N-terminal 95 aa of RAD54 did not 
115 
 
 
 
affect its ability to hydrolyze ATP, however, branch migration activity was almost 
reduced to zero. Because we observe similar effect with compounds, C-G01 and 
C-A23, we hypothesize that these compounds function by interacting with the N-
terminal domain of RAD54.  
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Figure 4.2 Validation of 55 RAD54 inhibitors using branch migration assay. 
The effect of compounds (30 μM) on RAD54 (50 nM) branch migration of PX 
junctions (10 nM, molecules) over a 30 min reaction period. Red shows the five 
compounds that show >75 % branch migration inhibition. Blue shows the nine 
compounds that show >50 % branch migration inhibition. Green shows the 9 
compounds in comparison with SN (shown in solid green) that show >30 % branch 
migration inhibition. 
 
116 
 
 
 
Table 4.2 IC50 values for compounds in specificity assays.  
Inhibitors, Broad ID BM, IC50, μMATPase, IC50, μM
IC50 ratio 
(ATPase/BM) 
IC50 ratio (SE/BM)
C-G01 BRD-K70804394-001-10-8 0.37 6.8 18.4 81.1 
C--A23 BRD-K62090360-001-10-4 0.83 >12 >14.5 >602 
C-E13 BRD-K84577567-001-09-7 2.7 3.6 1.3 21.1 
C-A17 BRD-K27541991-001-02-4 4.7 34.7 7.4 >42.6 
C-A13 BRD-K56525905-001-13-3 5.2 31.1 6.0 >38.5 
C-E23 BRD-K94926671-001-02-2 6.6   6.6 
C-C11 BRD-K08408435-001-10-6 7.2 8.1 1.1 16.1 
C-E07 BRD-A04445933-001-11-9 8.4 >100 >11.9 >29.8 
C-A15 BRD-K00370289-003-02-6 9.3 22.5 2.4 >21.5 
C-A05 BRD-K74453742-001-11-7 9.8 34.1 3.5 48.9 
C-I05 BRD-K72075906-003-02-7 10.1 53.4 5.3 10.6 
C-G09 BRD-K87744949-001-03-2 12   6.9 
C-G23 BRD-K33212518-001-07-7 13.7 >200 >14.6 14.6 
C-A21 BRD-K36595427-001-11-4 16 68 4.3 >12.6 
C-A19 BRD-K88534205-300-02-3 16.3 >200 >12.3 >12.3 
C-C03 BRD-K64037573-001-09-8 20.1 >200 >10.0 >10 
C-I01 BRD-K38997908-001-09-2 20.5 >200 >10 >9.8 
C-E11 BRD-K01531637-001-12-4 22.9 220 9.6 11.6 
C-C05 BRD-K02487325-001-10-9 23.7 >200 >8.4 >8.4 
C-C07 BRD-K99032625-300-02-7 25.2 186 7.4 9.6 
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4.3.3 Analysis of compounds in DT-40 chicken cells 
Homologous recombination and Translesion DNA synthesis are two major 
pathways accounting for survival post-replication DNA damage. Translesion DNA 
synthesis fills the gap in the daughter strand after replication, whereas, 
homologous recombination utilizes intact sister chromatid as a template to repair 
gaps and breaks on the daughter strand. It was shown in DT-40 chicken cells, that 
RAD18 and RAD54 genes are synthetically lethal (Yamashita et al., 2002). RAD18 
is an essential protein for repair by Translesion DNA synthesis and RAD54 is 
involved in homologous recombination pathway. Therefore, we used RAD18 
knockout chicken DT-40 cell line, to test the effect of the RAD54 inhibitors in cells.  
We found four compounds, C-G01, C-A23, C-E13, and C-E07 that showed 
an atleast 2-fold reduction in the viability of RAD18 knockout cells compared to the 
wildtype DT-40 cells. One of these compounds, C-E13, showed more than 10-fold 
difference between viability of RAD18 knockout and wildtype cells. Therefore, we 
used compound C-E13 to generate the second generation of inhibitors for RAD54.  
 
 
 
 
 
 
 
 
118 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 Effect of RAD54 inhibitors on the survival of RAD18-deficient and 
wildtype DT-40 cells. Wildtype and Rad18-deficient DT-40 cells were subjected 
to increasing concentrations of RAD54 inhibitors. The cell survivability was tested 
using CellTiter-Glo luminescent assay. The IC50 values for each inhibitor molecule 
are mentioned in the inset.  
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Figure 4.4 Structures of first generation RAD54 inhibitors  
 
 
4.3.4 Screening of the second generation of inhibitors of RAD54 
Using the compound, C-E13, as the base molecule (Figure 4.4), chemical 
modifications were introduced in its structure with an effort to increase its potency, 
oral bioavailability, solubility, chemical and metabolic stability, and minimal toxic 
effects.  
We tested the 32 second generation inhibitors in the optimized branch 
migration assay. We found eleven compounds that showed >70% branch 
C‐E13 C‐G01 
C‐E07 C‐A23 
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migration inhibition (shown in red) (Figure 4.6), nine compounds that showed 
>50% branch migration inhibition (shown in blue), and four compounds that 
showed >30% branch migration inhibition (shown in green). Moreover, we also 
found two compounds, A3 and B1, which stimulated the branch migration activity 
of RAD54 (Figure 4.5).  
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Figure 4.5 Screening for 32 second generation inhibitors of RAD54. The effect 
of compounds (30 μM) on RAD54 (50 nM) branch migration of PX junctions (10 
nM, molecules) over a 30 min reaction period. Red shows the eleven compounds 
that show >70 % branch migration inhibition. Blue shows the nine compounds that 
show >50 % branch migration inhibition. Green shows the four compounds that 
show >30 % branch migration inhibition. 
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Figure 4.6 Structures of second generation RAD54 inhibitors  
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4.4 DISCUSSION 
 
RAD54, a key homologous recombination motor protein, is conserved 
among all eukaryotes. Mutations in RAD54 have been linked to breast cancer, 
colon cancer, and lymphoma (Matsuda et al., 1999). RAD54 is a multifunctional 
protein that is believed to function throughout the process of homologous 
recombination. This versatile role of RAD54 makes it a good target to regulate the 
process of homologous recombination using small-molecule modulators. Over the 
past few years, the use of small-molecule compounds has increased dramatically 
because; (i) of the ease with which they could be applied and removed over 
controlled period of time, (ii) they could target one specific function of the protein 
rather than inhibiting the protein altogether, (ii) they help understand protein 
functions in cell, and (iv) they could be used as drugs to treat specific diseased 
conditions.  
RAD54 functions throughout the process of homologous recombination, 
however, what regulates it functions or interaction with other partner proteins is not 
yet completely understood. Therefore, to better understand the regulation of 
RAD54 activities, we used the “chemical genetics” approach, wherein, a small-
molecule modulator is used to regulate protein functions.  
A high-throughput screening of a 400, 000 compound library was conducted 
in collaboration with The Broad Institute, MA. The high-throughput screening assay 
was designed to identify compounds specifically inhibiting branch migration activity 
of RAD54. Branch migration is the process in which the Holliday junction 
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translocates along the DNA axis, progressively exchanging one strand of duplex 
DNA for the homologous strand of another DNA duplex. It may either cause 
dissociation or extension of joint molecules, depending on the specific homologous 
recombination mechanism. It may also promote a restart of DNA replication, stalled 
at a DNA damage site by switching DNA template strands through a reversible 
regression of replication forks into Holliday junctions.  
Branch migration is a complex process that, at minimum requires ATP-
dependent DNA translocation and binding to Holliday junction. It is believed that 
most of the activities of RAD54 are dependent on its ability to hydrolyze ATP. We 
wanted to determine the mechanism of action of the 55 small-molecule inhibitors 
of RAD54 branch migration identified in the high-throughput screening. For this, 
we first wanted to confirm the small-molecule inhibitors using the optimized branch 
migration reaction in our lab, followed by testing their ability to inhibit ATP 
hydrolysis by RAD54.  
We found that most of the compounds inhibited ATP hydrolysis of RAD54; 
however, we identified two compounds, C-G01 and C-A23, which inhibited branch 
migration without affecting ATPase activity. Furthermore, when tested for their 
ability to inhibit RAD54 in chicken DT-40 cells, C-G01 and C-A23, showed more 
than 2-fold difference in the survival assays for the RAD18-deficient cell line 
compared to wildtype cells. RAD18 and RAD54 knockouts have been shown to be 
synthetically lethal in DT-40 chicken cells (Yamashita et al., 2002). Another 
compound, C-E13, had IC50 10-fold lower for RAD18-deficient cells compared to 
wildtype cells.    
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Therefore, compound C-E13 was used to develop second-generation of 
RAD54 inhibitors by modifying its structure to improve its drug-like properties. A 
number of second-generation of inhibitors, when tested in the branch migration 
reaction, showed an increase in the potency for inhibiting RAD54 in vitro. These 
compounds need to be tested in DT-40 cells to establish their specificity.  
Compounds, C-G01 and C-A23, did not affect RAD54’s ATPase activity but 
were selective in inhibiting its branch migration activity. We observed similar 
results with N-terminal truncated RAD54 protein (Chapter 2). We have previously 
shown that the N-terminal domain of RAD54 is essential for the branch migration 
activity of RAD54. RAD5496-747 was deficient in branch migration activity but had 
2-3 fold higher ATPase activity. Moreover, we identified residues in the N-terminal 
region that affected the DNA binding by N-terminal domain or the DNA-dependent 
oligomerization by the N-terminal domain. Therefore, we hypothesize that these 
two compounds, C-G01 and C-A23, interact with the N-terminal domain to inhibit 
branch migration activity of RAD54. Further work is needed to test this hypothesis. 
More importantly, we show that it is possible to inhibit one activity of RAD54 without 
affecting other activities that are dependent on ATPase activity of RAD54. This 
would enable to selectively inhibit one function of RAD54 and test its biological 
function in cells.  
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CONCLUSIONS & FUTURE DIRECTIONS 
 
Homologous recombination pathway is responsible for the repair of DNA 
double-strand breaks, the most harmful types of DNA lesions, faithful chromosome 
segregation during meiosis, and telomerase-independent telomere maintenance 
(Krejci et al., 2012; San Filippo et al., 2008); (Jasin and Rothstein, 2013). It is 
critical for maintaining genome stability in all living organisms. Together with 
nucleotide excision repair, base excision repair, and non-homologous end joining, 
homologous recombination forms the house-keeping networks ensuring the 
stability of DNA.  
Dysfunction of homologous recombination pathway causes genome 
instability that could lead to cancer and various chromosomal abnormalities such 
as Down’s and other syndromes causing premature aging diseases. Most of these 
disorders occur due to mutations in proteins such as the RecQ family helicases 
BLM, WRN, and RECQ4 (Mohaghegh and Hickson, 2001); and the Fanconi’s 
anemia-related helicases FANCJ (Hiom, 2010) and FANCM (Whitby, 2010). The 
mutations in BRCA1 and BRCA2 proteins, involved in homologous recombination, 
result in genomic instability and predisposition to breast and ovarian cancer (Lok 
and Powell, 2012; Moynahan and Jasin, 2010). Therefore, making the studies on 
these proteins essential.  
 On one hand, we have gained quite a bit of knowledge on the initial steps 
of homologous recombination (Krogh and Symington, 2004; Li and Heyer, 2008) 
that includes: recognition of double-strand break site, resection of DNA with the 
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help of enzymes at the double-strand break site to generate DNA duplex with 
protruding 3’ single-stranded DNA tails. Followed by the formation of nucleoprotein 
filament between RAD51 and ssDNA, which searches for homologous DNA 
template, and strand invasion into the homologous duplex DNA forming the 
displacement loop or D-loop (Kowalczykowski, 2000; Sung et al., 2003). However, 
following joint molecule formation, the pathways that regulate the processing and 
resolution of these DNA intermediates are not well understood.   
 The choice of pathways during homologous recombination may revolve 
around the proteins that promote branch migration. Branch migration is the 
process in which one DNA strand is progressively exchanged for another strand 
of the homologous DNA. It may extend or shorten the heteroduplex DNA formed 
after DNA strand invasion, affecting the length of conversion tracks and thereby 
the amount of genetic information transferred between the two homologous DNA 
molecules (Pâques and Haber, 1999). Branch migration may cause dissociation 
of recombination intermediates, thereby, affecting the choice between a crossover 
and non-crossover pathway for homologous recombination to proceed (Bugreev 
et al., 2007). Branch migration may also a play role in restarting stalled replication 
forks during cell recovery after DNA damage (McGlynn et al., 2001; Michel et al., 
2004; Postow et al., 2001; Rothstein et al., 2000; Seigneur et al., 1998). RAD54, 
an important protein of the core homologous recombination machinery, can 
promote branch migration of Holliday junctions. Despite extensive studies, the 
mechanism of RAD54 branch migration activity is not well understood.  
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Therefore, the focus of my research was to understand the mechanism of 
RAD54 promoted branch migration activity and how this activity is regulated in 
cells. Specifically, we wanted to determine the RAD54 domain that is responsible 
for its DNA-dependent oligomerization and the role of oligomerization in regulating 
RAD54 activities. 
 Here, we demonstrate that the N-terminal domain of RAD54 is essential for 
its branch migration activity along with its “core” ATPase domain. In chapter 2, we 
showed that RAD54 mutant lacking a significant portion of the N-terminal domain, 
RAD5496-747, is almost completely devoid of the branch migration activity. 
However, this mutant still retains its ability to hydrolyze ATP and the ability to 
translocate on DNA. We also found that the second DNA binding site in the N-
terminal domain promotes specific binding to Holliday junction substrates. RAD541-
142 shows a preference for Holliday junction-like DNA substrates similar to full 
length RAD54. On replacing basic amino acid residues 33-36 by alanines 
(RKRK33-36AAAA), we observed diminished DNA binding by the RAD54 N-
terminal domain suggesting the tentative position of the N-terminal domain DNA 
binding site. Interestingly, RAD5496-747 still retains the ability to recognize Holliday 
junction-like structures, although the specificity for different branch DNA molecules 
was changed. Together these results suggest the N-terminal domain area between 
96 and 142 amino acid residues may also contribute to the recognition of Holliday 
junction-like structures. The N-terminal domain of RAD54 may represent a 
functional analog of the N-terminal domain of RecG or of the RecQ helicases 
carboxyl terminal domain (RQC) that are responsible for specific binding to 
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branched DNA structures (Kim et al., 2013; Kitano et al., 2010; Pike et al., 2009 ; 
Singleton et al., 2001). Furthermore, deletion the RAD54 N-terminal domain, 
similar to deletion of the BLM HRDC domain adjacent to RQC (Swan et al., 2014), 
increased the ATPase activity of the enzyme. It is thought that HRDC may 
suppress the BLM ATPase activity through direct interaction with the ATPase core. 
For future studies, we would be interested in identifying the residues involved in 
recognition and binding to the Holliday junction-like substrates.  
The proteolytic cleavage analysis of S. cerevisiae Rad54 shows that the N-
terminal domain is unstructured in solution (Raschle et al., 2004). These data are 
consistent with the structural flexibility of the RAD54 N-terminal domain, which 
enables its interaction with various partners, like RAD51, CDK2, or DNA (Golub et 
al., 1997; Kettenbach et al., 2011; Raschle et al., 2004; Wright and Heyer, 2014). 
In chapter 2, we further emphasized on the structural flexibility of the N-terminal 
domain of RAD54 by demonstrating a coupling between its binding to DNA and 
oligomerization. Previously, it was demonstrated that during branch migration 
RAD54 forms oligomeric structures on Holliday junction substrates (Mazina et al., 
2007), a property shared with other branch migration proteins including BLM and 
RuvAB (Mazina et al., 2012; West, 1997). However, the RAD54 domain 
responsible for oligomerization was unknown. We showed that the N-terminal 
domain of RAD54 is responsible for DNA-dependent oligomerization of RAD54. 
The N-terminal domain alone is both necessary and sufficient for protein 
oligomerization and that the N-terminal truncation, significantly reduced the 
formation of RAD5496-747 oligomers in the presence of DNA. Moreover, we 
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identified mutations in the N-terminal domain that separately affect DNA binding 
and protein oligomerization. The RKRK33-36AAAA mutation decreased binding of 
the RAD541-142 to DNA significantly. However, even this residual DNA binding 
appeared to be sufficient to induce protein oligomerization observed in cross-
linking experiments with BMH. In contrast, S49E mutation only weakly inhibits 
initial binding of RAD541-142 to DNA but disrupts the formation of large oligomeric 
protein complexes visualized by BMH cross-linking. In full-size RAD54, each of 
these mutations inhibited branch migration without affecting the ATPase activity of 
the protein. The combination of these two mutations led to a stronger inhibition of 
branch migration activity. 
Taken together, these data led us to suggest a two-step process of 
formation of the active RAD54 branch migration complex. First, RAD54 is targeted 
to the Holliday junction by its N-terminal domain. The binding of RAD54 N-terminal 
domain may induce a structural transition of Holliday junction to open conformation 
that is proficient in branch migration. Second, binding of the RAD54 N-terminal 
domain to DNA enables RAD54 oligomerization necessary for branch migration 
(Mazina et al., 2007).  
A phosphoproteomics study identified that RAD54 was phosphorylated at 
Ser-49 (Kettenbach et al., 2011). Two CDK2 consensus sites are located in the 
RAD54 N-terminal domain, with putative phosphorylation sites at Thr-31 and Ser-
49. Consistent with this, in vitro CDK2 phosphorylation data identified, T31 and 
S49 as major phosphorylation sites in RAD54, as T31E, S49E double mutations 
significantly reduced CDK2 phosphorylation of RAD54. We found that S49E, but 
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not T31E phosphomimetic mutation, inhibited oligomerization of RAD54 N-terminal 
domain. When incorporated in the full-size RAD54, this mutation inhibited the 
RAD54 branch migration activity consistent with the important role of RAD54 
oligomerization in its branch migration activity. The effect of the S49E mutation is 
specific for branch migration, as it had no significant effect on stimulation of 
RAD51-promoted DNA strand exchange by RAD54 indicating that RAD54 
oligomerization is not required for this stimulation. Phosphorylated RAD54 (in vitro 
by CDK2) also inhibited its branch migration activity, consistent with the results 
observed for the phosphomimetic S49E mutation.  
RAD54 branch migration activity can lead to dissociation of D-loops, the 
product of ssDNA invasion into homologous DNA-template during double-strand 
break repair (Bugreev et al., 2007). This step of double-strand break repair, 
however, needs to be precisely controlled, as premature disruption of D-loops prior 
to their extension by DNA polymerase may abort double-strand break repair. 
CDK2-dependent inhibition of RAD54 branch migration may help to delay D-loop 
disruption until the polymerization step is completed. Recently, it was also shown 
that Nek1 phosphorylates RAD54 at S572 in late G2 phase to modulate its 
interaction with RAD51 (Spies et al., 2016). Thus, multiple mechanisms are in 
place to control different RAD54 activities in the cell.  
For future studies, we would be interested in determining the exact role of 
branch migration activity of RAD54 in homologous recombination pathway. We 
have identified mutations in the N-terminal domain of RAD54 that specifically affect 
its branch migration activity without affecting its ATPase activity. These mutations 
131 
 
 
 
could be introduced in the cells and their effect determined using DR-GFP assay, 
which measures the homologous recombination events taking place after the 
deliberate introduction of a double-strand break.  
In chapter 3 we reported annealing activity for the multifunctional RAD54 
protein. RAD54 can carry out annealing of two complementary single-stranded 
DNA molecules or between single-strand DNA and single-strand RNA efficiently. 
We found that the second DNA binding site in the RAD54 N-terminal domain was 
necessary but not sufficient for its annealing activity, indicating the requirement for 
two binding sites for annealing activity. RAD541-142 shows preference for branched 
DNA structures, however, it can still bind to linear single-stranded or double-
stranded DNA. This binding to single-stranded DNA by N-terminal domain is 
associated with annealing activity of RAD54. 
Previously we show that the RKRK33-36AAAA mutation and 95 amino 
acids N-terminal truncation disrupt the DNA binding ability of N-terminal domain of 
RAD54 and its ability to branch migrate Holliday junctions. These two mutations 
also disrupted the annealing activity of RAD54; similarly, RAD541-142 lacking the 
core DNA binding site is unable to support the annealing activity. In contrast, the 
S49E mutation that specifically inhibits protein oligomerization shows no significant 
effect on ssDNA annealing (chapter 3). These data provide additional support that 
RKRK33-36AAAA and S49E mutations separately affect DNA binding and protein 
oligomerization, respectively by the N-terminal domain of RAD54.  
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The annealing activity has been reported for other several other branch 
migration proteins, including, BLM and WRN proteins. However, the annealing 
activity for most of these proteins is inhibited by RPA. Therefore, it is unlikely that 
it plays an important role in the cell where RPA is in abundance. Instead, it may 
manifest the presence of a secondary DNA binding site necessary for branch 
migration as in some cases this site is also associated with protein oligomerization 
domain. Thus, the presence of the secondary ATPase independent DNA binding 
site coupled with protein oligomerization may be a general requirement for the 
branch migration proteins.  
 We also report that RAD54 can anneal single-stranded DNA and RNA to 
generate DNA-RNA hybrid. The possibility of using RNA transcripts as a template 
for recombination and double-strand break repair (Keskin et al., 2014; Storici et 
al., 2007) makes this finding intriguing. Our lab in collaboration with Storici lab was 
successful in establishing the role of RAD52 in RNA-transcript dependent 
recombination (Keskin et al., 2014). Next, to gain more insight into this newly 
discovered RNA-transcript dependent recombination, we would be interested in 
assessing the possible role of RAD54’s annealing activity in the same.  
 Previously, streptonigrin was identified as an inhibitor of ATPase activity of 
RAD54 (Deakyne et al., 2013). Strepatonigrin inhibited RAD54’s branch migration 
activity but had minimal effect on stimulation of strand exchange activity of RAD51. 
This indicated that ATPase activity of RAD54 was dispensable for the stimulation 
of RAD51’s activity. Thus, streptonigrin helped to shed light on the involvement of 
ATPase activity of RAD54 in stimulation of RAD51’s strand exchange activity 
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(Deakyne et al., 2013). However, streptonigrin was found to be cytotoxic and could 
not be used in further studies. In Chapter 4, we conducted a high-throughput 
screening to identify inhibitors of RAD54 branch migration activity. The small-
molecule inhibitors could be used to better understand the functions of RAD54 in 
vitro as well test its function in vivo. For this, we developed a fluorescence-based 
assay in our lab to screen a ~400, 000 small-molecule compounds library in 
collaboration with The Broad Institute, MA. We identified 55 compounds from the 
initial screen that were further characterized using assays optimized in our lab. We 
identified two compounds, C-G01 and C-A23, which strongly inhibited the branch 
migration activity of RAD54 but had no significant effect on its ATPase activity. We 
believe that these compounds exert their action by interacting with the N-terminal 
domain of RAD54 because we observed similar results with N-terminal truncated 
RAD54 protein. Therefore, we would like to determine the mechanism of action for 
these two compounds and study their interaction with the N-terminal domain of 
RAD54 using various truncated and mutants of RAD54 protein. Moreover, these 
compounds could be used to study the exact function of branch migration in cells 
as they have no effect on the ATPase activity. Compared to streptonigrin’s 
structure that contained an active aminoquinone moiety, C-G01 contained a 
quinoxaline group that is isomeric with the quinazoline group in C-A23. These 
groups may be the active component of the inhibitors but unlike streptonigrin, they 
do not contain ketone groups within conjugated cyclic ring systems that play a role 
in generating reactive oxygen species. Therefore, these inhibitors may prove to be 
more successful in understanding RAD54’s cellular activities. 
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 Previously, it was shown that RAD54 and RAD18 knockouts are 
synthetically lethal in chicken DT-40 cells (Yamashita et al., 2002). We identified 
another compound, C-E13, that was 10-fold more potent in killing RAD18-deficient 
DT-40 cells compared to wildtype DT-40 cells. Thus, compound C-E13 was used 
to develop C-E13 analogs by substituting various chemical groups at the ortho-, 
para-, and meta-positions to increase its potency and minimize potential off-target 
effects. A number of second-generation of inhibitors, when tested in the branch 
migration reaction, showed an increase in the potency for inhibiting RAD54 in vitro. 
These compounds need to be further tested in DT-40 cells to establish their 
specificity in vivo.  
 Another protein that we studied in the lab was RAD52 protein, which is 
responsible for DNA single-strand annealing sub-pathway of homologous 
recombination that is RAD51-independent. RAD52 can also promote D-loop 
formation, similar to RAD51, suggesting that it may potentially substitute RAD51 
in some homologous recombination events. More importantly, mutations in RAD52 
are synthetically lethal with mutations in BRCA1, BRCA2, PALB2, or in five RAD51 
paralogs. The concept of synthetic lethality provides a framework for discovering 
drugs that selectively kill cancer cells. In chapter 5 we exploited synthetic lethality 
between the RAD52 and BRCA1&2 genes. We proposed that targeting RAD52 
with small molecule inhibitors would disrupt the RAD52-dependent sub-pathway 
of homologous recombination in BRCA1- and BRCA2-deficient cells leading to cell 
death. Therefore, RAD52 represented an attractive potential therapeutic target as 
no RAD52 mutations or inactivation has been documented in human tumors. Using 
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fluorescence-quenching based assay for high-throughput screening, we identified 
14 small-molecule compounds that specifically inhibited RAD52 ssDNA annealing 
and DNA pairing activities with IC50 better than 10 µM. We found that one of the 
compounds, D-I03, which had the strongest inhibitory effect in human cells was 
also selective in inhibiting the growth of CML patient cells where the expression of 
BRCA1 is constitutively reduced. Also, D-I03 specifically disrupted the formation 
of RAD52 foci induced by cisplatin without affecting RAD51 foci in cells. In accord 
with specific targeting of RAD52 in human cells, D-I03 inhibited the single-strand 
annealing in USO2 cells, without significantly affecting canonical homology-
dependent recombination.  
Previously, it was demonstrated that the N-terminal domain is responsible 
for single-strand DNA annealing and DNA pairing activities of RAD52. Therefore, 
we suggest that D-I03 may specifically target this domain. However, further work 
is required to determine its mechanism of action. Our data suggests that RAD52 
inhibitors can potentially be used as prototypes for development of novel therapies 
against hereditary breast cancer and ovarian cancers with defective BRCA1 or 
BRCA2 proteins. In addition to this, RAD52 inhibitors can also be used to study its 
biochemical activities and cellular functions.  
 Taken together, our results demonstrate that the N-terminal domain of 
RAD54 is essential for its branch migration activity. The N-terminal domain 
promotes: (i) specific binding of RAD54 to Holliday junction-like substrates, and (ii) 
DNA-dependent oligomerization, necessary for the formation of active RAD54 
branch migration complex. In addition, RAD54 N-terminal domain contains two 
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putative sites that could be phosphorylated by CDK2 in the cell. Phosphorylation 
at Ser-49 by CDK2 inhibits DNA-dependent oligomerization of the N-terminal 
domain and therefore, can regulate branch migration activity of RAD54 during the 
process of homologous recombination. Moreover, we show that inhibitors of 
homologous recombination proteins, RAD54 and RAD52, could be used to study 
cellular functions of these proteins as well for developing novel cancer therapies 
in combination with current therapies.  
I believe that my contributions to this field have deepened our 
understanding of the RAD54 branch migration activity and the mechanisms that 
regulate branch migration. This would further help in defining its role in 
homologous recombination.  
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Appendix A: Targeting BRCA1- and BRCA2- deficient cells with small-
molecule inhibitors of RAD52 
 
 
 
 
A.1 ABSTRACT 
RAD52, an evolutionarily conserved protein from yeast to humans, is a 
member of Homologous recombination pathway and plays a role in genome 
maintenance. In contrast to yeast Rad52 which is crucial for most of the 
homologous recombination events, RAD52 knockout shows no significant 
phenotypic effect in mammals. However, recent work demonstrated that 
combination of RAD52 mutation with mutations in genes that cause hereditary 
breast cancer and ovarian cancer like BRCA1, BRCA2, PALB2, and RAD51C 
results in lethality. In this study, to use RAD52 as a potential therapeutic target for 
cancer therapy we screened a 372,903-compound library to identify small 
molecule inhibitors using a fluorescence-quenching assay for ssDNA annealing 
activity of RAD52. Further characterization using biochemical and cell-based 
assays of the obtained 70 alleged inhibitors led to the identification of compounds 
that specifically inhibit the biochemical activities of RAD52, selectively inhibit the 
growth of BRCA1- and BRCA2-deficient cells and inhibit RAD52-dependent single-
strand annealing in human cells. In future, these identified compounds can be used 
for development of novel cancer therapy and as a probe to study mechanisms of 
DNA repair.  
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A.2 INTRODUCTION 
 DNA repair is crucial for maintaining genomic integrity in all organisms. 
Multiple DNA repair systems evolved to eliminate a broad variety of DNA lesions 
caused by different exogenous agents or genotoxic products of metabolism. 
Homologous recombination is one such highly conserved DNA repair mechanism 
pathway that is involved in repair of double-stranded breaks, the most harmful form 
of DNA damage, which are induced by ionizing radiation and other agents or 
endogenously due to stalled replication forks, DNA interstrand crosslinks, and 
incomplete telomere synthesis. Even though there are other alternate pathways 
like non-homologous end joining to repair double-strand breaks, they are not error-
free and precise like homologous recombination as it utilizes an intact homologous 
DNA strand as a donor template for the repair. (Pâques and Haber, 1999; San 
Filippo et al., 2008) 
The process of homologous recombination involves recognition of a double-
strand break, enzymatic processing of the break site to produce 3’-ssDNA tails, 
the formation of RAD51-ssDNA filament that searches for homology and promotes 
strand invasion into the homologous duplex DNA leading to the formation of 
displacement loop (D-loop) intermediate. After this step, homologous 
recombination may either proceed via synthesis-dependent strand annealing or 
double-stranded break repair mechanism. In synthesis-dependent strand 
annealing, D-loops dissociate and the extended invading strand re-anneals with 
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the resected second end of double-strand break forming non-crossover 
recombinants, whereas in double-strand break repair, the displaced strand of the 
D-loop may anneal with the second resected end of the double-strand break 
leading to formation of Holliday junctions, their branch migration, and resolution to 
form crossover recombinants. (Allers and Lichten, 2001; Pâques and Haber, 
1999). 
Due to its essential role in DNA repair mechanism, mutations in proteins 
involved in homologous recombination, most commonly BRCA1 and BRCA2, 
result in genomic instability and predispose to breast and ovarian cancer (Lok and 
Powell, 2012; Moynahan and Jasin, 2010). In this case, when homologous 
recombination is defective the BRCA1- and BRCA2- deficient cancer cell viability 
depends on the remaining alternative DNA repair mechanisms (Helleday, 2011; 
Lok and Powell, 2012; Lord and Ashworth, 2012). Thus, it was demonstrated that 
PARP1, a protein involved in DNA damage signaling and repair of DNA single-
stranded breaks, is essential for viability of cancer cells that are deficient in the 
homologous recombination pathway (Bryant et al., 2007; Farmer et al., 2005). 
Furthermore, hereditary breast cancer and ovarian cancer cells, deficient in 
BRCA1 or BRCA2 can be eliminated using PARP1 inhibitors with a minimal harm 
to normal cells with at least one copy of functional BRCA1/2 genes (Helleday, 
2011; Lok and Powell, 2012; Lord and Ashworth, 2012).   
New findings demonstrated that cells deficient in either BRCA1/2, PALB2 
(partner and localizer of BRCA2) or five RAD51 paralogs, including RAD51C, when 
combined with a deficiency in recombination factor RAD52, are synthetic lethal 
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(Chun et al., 2013; Feng et al., 2011; Lok et al., 2013). Mutations in PALB2 and 
RAD51C also contribute to hereditary breast and ovarian cancer (Antoniou et al., 
2014; Meindl et al., 2010). Both PARP1 and RAD52 play different roles in 
maintaining cell viability in BRCA1/2-deficient and PALB2-deficient cells. PARP1 
is involved in repair of DNA SSBs.  During DNA replication, unrepaired SSBs may 
cause the formation of DNA double-stranded breaks or stalled replication forks 
which are repaired by the homologous recombination pathway. BRCA1/2/PALB2, 
constitute the major sub-pathway of homologous recombination; mutations in 
these proteins disrupt homologous recombination making hereditary breast and 
ovarian cancer cells vulnerable to PARP1 inhibitors. However, recent data indicate 
that in addition to the BRCA1/2/PALB2 sub-pathway, the secondary homologous 
recombination sub-pathway operates in a mammalian cell that depends on RAD52 
protein (Feng et al., 2011; Lok et al., 2013). In normal mammalian cells, this 
pathway plays a minor role, as RAD52-/- mice are viable and fertile and do not 
display DNA damage sensitivity, abnormalities, or significant cancer predisposition 
(Rijkers et al., 1998). However, this sub-pathway becomes essential for viability in 
cells that lack the BRCA1/2/PALB2 sub-pathway. Thus, these findings identify 
RAD52 as a potential therapeutic target for familial breast cancer, familial ovarian 
cancer, and other types of cancer with defective BRCA1/2/PALB2 genes.  Keeping 
this concept in mind, one of the co-authors (T.S.) demonstrated that inhibition of 
RAD52 DNA binding activity by small peptide aptamer exerted synthetic lethality 
in BRCA1- and BRCA2-mutated cancer cells without any detectable side effects 
in normal cells and in mice (Sullivan et al., 2016).   
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Here, in order to develop small molecule inhibitors of the RAD52 ssDNA 
annealing activity, we performed a high throughput screening of a 372,903-
compound library using a fluorescence-quenching assay. We then characterized 
the obtained 70 alleged RAD52 inhibitors using biochemical and cell-based 
assays. We found several compounds that specifically inhibit the biochemical 
activities of RAD52 and growth of BRCA1- and BRCA2- deficient cells. One of 
these compounds, D-I03, also specifically inhibited RAD52-dependent single-
strand annealing in human cells. We will use these compounds for the 
development of novel cancer therapy and also as a probe to study the mechanisms 
of DNA repair in human cells.  
 
 
A.3 MATERIAL AND METHODS: 
Chemicals, proteins, and DNA.  
Cisplatin was purchased from Sigma-Aldrich. Human RAD52 and RAD51 
(Figure A.1) were purified as described (Bugreev et al., 2005). The 
oligonucleotides (Table A.1) were purchased from IDT, Inc and further purified by 
electrophoresis (Rossi et al., 2010). Supercoiled pUC19 pCBASce and pMX-GFP 
plasmid DNAs were purified using Qiagen kits. All DNA concentrations are 
expressed as moles of nucleotide.  
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Figure A.1 Analysis of RAD51 and RAD52 proteins in an SDS-polyacrylamide 
gel. Proteins were stained with Coomassie blue. Lane M, Migration markers; Lane 
1, Rad52; Lane 2, RAD51. 1μg of each protein was loaded on a 12% SDS-
polyacrylamide gel. 
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Table A.1 Sequences of the oligonucleotides used in Appendix A. 
 
  
N 
 
Length, 
nt 
  
Sequence (5’→3’) 
 
337- 
 
FLU 
 
 
60 
FLU-CACTGTGATGCACGATGATCGACGACAGTAGTCAGT 
GCTGGGTCAACATCTGTATGCAGG 
 
1337- 
 
BHQ1 
 
 
39 
AGCACTGACTACTGTCGTCGATCATCGTGCATCACAGTG– 
BHQ1 
 
 
265-55 
 
 
55 
ATACAGATGTTGACCCAGCACTGACTACTGTCGTCAATCAT 
CGTGCATCACAGTG 
 
 
90 
 
 
90 
CGGGTGTCGGGGCTGGCTTAACTATGCGGCATCAGAGCA 
GATTGTACT GAG AGT GCA CCA TAT GCG GTG TGA AAT 
ACC GCA CAG ATG CGT 
 
Note: “FLU” and “BHQ1” denote Fluorescein and Black Hole Quencher 1, 
respectively 
 
 
Compound libraries, compounds. 
We used a 93672-compound Broad’s diversity-oriented synthesis (DOS) 
library and a 279,231-compound Molecular Libraries Probe Center Network 
(MPLCN) library. All the compounds were dissolved in DMSO (Sigma, Cat # 
D8418). In the working solutions, the DMSO concentration added with the stock of 
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compounds was 2% (v/v) unless indicated otherwise. The compounds for 
confirmation analysis were purchased from Asinex Ltd., ChemBridge Co., 
ChemDiv Inc, Enamine, FCH Group, Frontier Scientific Services Inc., 
InterBioScreen Ltd., Life Chemicals Inc., Scientific Exchange Inc., Sigma-Aldrich 
Co., and Vitas-M Laboratory Ltd. 
 
The fluorescence-quenching assay for RAD52 DNA annealing.  
Tailed dsDNA substrate was prepared by thermal annealing of ssDNA 
oligonucleotides 337-F and 1337-BHQ1 containing Fluorescein and Black Hole 
Quencher 1 residues at the 5’ and 3’ end, respectively.  DNA annealing was 
initiated by adding RAD52 (20 nM) to the mixture of ssDNA oligonucleotide 265-
55 (5 nM, molecules) and tailed dsDNA 337-F/1337-BHQ1 (5 nM, molecules) in 
buffer containing 25 mM Tris-acetate pH 7.5, 100 µg.ml-1 BSA and 1 mM DTT. The 
fluorescence intensity was measured in a 3-mm quartz cuvette (Starna Cells) using 
a FluoroMax-3 (HORIBA) fluorimeter with 492 nm excitation wavelength and 520 
nm emission wavelength at 30 °C for at least 2000 s.  
 
High-Throughput Screening for RAD52 inhibitors. 
The fluorescence-quenching assay for RAD52-promoted DNA annealing 
was optimized to a 4 μl 1536 well protocol using 25 nM RAD52 and 8 nM 
(molecules) DNA in buffer containing 25 mM Tris-acetate pH 7.5, 100 µg.ml-1 BSA, 
1 mM DTT, and 0.01% Pluronic F-68.  Wells containing no RAD52 were used as 
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a positive control to estimate the activity of fully inhibited protein; wells in which the 
compounds were replaced with only the vehicle (DMSO) were used as a neutral 
control.  The HTS was performed using the 8 channel BioRAPTR 1536 (Beckman) 
for reagent dispensing.  The reactions were carried out for 30 minutes followed by 
measurement of an endpoint fluorescence (485 nm excitation, 535 nm emission) 
using an EnVision multimode plate reader (Perkin Elmer). Wells containing no 
RAD52 enzyme were used to as positive control, and data were analyzed using 
Genedata. The compounds with an inhibitory effect of 30% or greater were tested 
further by measuring the concentration dependence (in a range from 1 nM to 100 
μM) of their inhibition of RAD51. The most potent inhibitory compounds were 
analyzed further using non-fluorescent assays. Detailed methods for RAD52 
screening are in PubMed:  
https://pubchem.ncbi.nlm.nih.gov/bioassay/651660#section=Top 
 
The D-loop formation by RAD52 or RAD51.  
To form RAD52 nucleoprotein complexes, RAD52 (0.45 μM) was incubated 
with a 32P-labeled ssDNA (oligo 90) (3 μM, nt) in buffer containing 25 mM Tris-
Acetate, pH 7.5, 100 μg.ml-1 BSA, 0.3 mM magnesium acetate, and 2 mM DTT at 
37 °C for 15 min. To form RAD51 nucleoprotein filament, RAD51 (1 0.45 μM) was 
incubated with 32P-labeled ssDNA (1.35 μM, nt) in buffer containing 25 mM Tris-
Acetate, pH 7.5, 100 μg.ml-1 BSA, 1 2 mM calcium chloride, 1 mM ATP and 2 mM 
DTT for 15 min at 37 °C. Then inhibitors were added to both reactions and 
incubation continued for 15 min at 37 °C. D-Loop formation was initiated by 
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addition of supercoiled pUC19 DNA (50 μM or 22.5 μM, nucleotides, for RAD52 
and RAD51-promoted reactions, respectively) and was carried out 15 min at 37 
°C. The reactions were stopped and deproteinized by the addition of 1.5% SDS 
and proteinase K (0.8 mg/ml) for 15 min at 37 °C, mixed with a 0.10 volume of 
loading buffer (70% glycerol, 0.1% bromophenol blue), and analyzed by 
electrophoresis in 1% agarose gels in TAE buffer (40 mM Tris acetate, pH 8.3, and 
1 mM EDTA) at 5 V/cm for 3 h. The gels were dried on DEAE-81 paper (Whatman) 
and the yield of D-loops quantified using a Storm 840 PhosphorImager and 
ImageQuant 5.2 (GE Healthcare). The D-loop yield was expressed as a 
percentage of plasmid DNA carrying D-loops relative to the total plasmid DNA. 
To form RAD51 nucleoprotein filament, RAD51 (0.45 μM) was incubated 
with 32P-labeled ssDNA (1.35 μM, nt) in buffer containing 25 mM Tris-Acetate, pH 
7.5, 100 μg/ml BSA, 1.5 mM calcium chloride, 1mM ATP and 2 mM DTT for 15 min 
at 37 °C. Then inhibitors were added to both reactions and incubation continued 
for 15 min at 37 °C. D-Loop formation was initiated by addition of supercoiled 
pUCFBR DNA (22.5 μM, nt) and was carried out 15 min at 37 °C.  
 
Calculation of the IC50 value for RAD52 inhibitors.  
IC50 values were calculated using GraphPad Prism V5.0 software. The 
data were obtained from three independent repeats of experiments. 
 
 
 
171 
 
 
 
Acridine orange displacement assay for DNA binding.  
To rule out DNA binding as an undesired mechanism of action, we tested 
the ability of the selected compounds to bind DNA. The compounds in varied 
concentrations were added into 30 μl reaction mixtures containing 50 nM acridine 
orange and 6 μg/ml salmon sperm DNA, 10 mM HEPES, pH 7.5; 1 mM EDTA pH 
7.5; 100 mM NaCl in 384-well plates, and the reactions were incubated at room 
temperature for 20 min followed by fluorescence polarization measurement using 
an EnVision (Perkin Elmer) equipped with a 480 nm excitation filter and 535 nm S 
and P emission filters with a D505 FP/D535 dichroic mirror. Mitoxantrone (10 μM) 
was used as a positive control.  The S and P values are processed with the 
standard fluorescence polarization calculation formula (mP=1000*(S-
G*P)/(S+G*P) where G is the G-factor and is approximately 1. 
 
Luminescent cell viability assay.  
BxPC3 cells were kept in RPMI 1640 (ATCC) media supplemented with 
10% FBS (Gibco); Capan-1 cells were kept in IMDM (ATCC) media containing 
20% FBS (GIBCO); UWB1.298 and UWB1.298 (BRCA1+) cells were kept in 
48.5% RPMI1640 (ATCC), 48.5% MEGM (Clonetics/Lonza, MEGM kit, CC-3150) 
and 3% FBS (GIBCO) respectively. Cells in log-phase were harvested and 100 µl 
cell suspensions were re-plated in a 96-well plate with a final density of 4000 
cells/well. After overnight growth, cells were treated with indicated concentrations 
of compounds. Media containing the invariant concentration of compounds were 
refreshed every 3 days until cells were finally lysed by 30 μl/well of Promega 
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CellTiter-Glo reagents and read on a Promega GloMax 96 reader on day 10 (9 
days exposure). Promega CellTiter-Glo protocol is available on the web:   
http://www.promega.com/resources/protocols/technical-bulletins/0/celltiter-glo-
luminescent-cell-viability-assay-protocol/  
 
The clonogenic survival assay.  
MDA-MB-436 cells were cultured in RPMI + 10% FBS. BRCA-proficient and 
BRCA-deficient cells were plated on day 0 in triplicate at 5,000 cells/well. On days 
1 and 3, the cells were treated with 0, 2.5 μM, 5 μM, or 10 μM D-I03, D-G23 or D-
G09. Cells were counted on day 4 on a hemocytometer, using Trypan Blue 
exclusion, and immediately were plated in a clonogenic assay at a density of 500 
cells/well in a 6 well plate, in RPMI + 10% FBS. After two weeks, the colonies were 
fixed/stained with 0.05% of 10 mg/ml ethidium bromide in 50% ethanol and 
visualized with Alphaimager gel imager (Alpha Innotech).  
 
CML viability assay.  
Lin-CD34+ primary CML and normal cells were obtained by magnetic 
sorting using the EasySep negative selection human progenitor cell enrichment 
cocktail followed by treatment with human CD34 positive selection cocktail 
(StemCell Technologies), and were subsequently cultured in StemSpan H3000 
media (StemCell Technologies) supplemented with a cocktail of growth factors 
(100 ng/mL stem cell factor, 20 ng/mL interleukin3 [IL-3], 100 ng/mL fms-related 
tyrosine kinase 3 ligand, 20 ng/mL granulocyte colony-stimulating factor, 20 ng/mL 
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IL-6). For the viability assay, CD34+ CML (n=3) and normal (n=5) cells were plated 
at 1x104 cells/well in 96 well plates on day 0, and treated with 0 μM, 2 μM, 5 μM, 
or 10 μM D-I03 on days 0 and 2. Viable cells were counted on day 4 using Trypan 
Blue staining. 
 
Measurement of compound binding to RAD52 by SPR.  
Experiments were performed using the ProteOn XPR36 SPR array system 
(Bio-Rad). ProteOn GLH sensor chips were preconditioned with two short pulses 
each (10 s) of 50 mM NaOH, 100 mM HCl, and 0.5% SDS. Then the system was 
equilibrated with PBS-T buffer (20 mM Na-phosphate, 150 mM NaCl, and 0.1% 
polysorbate 20, pH 7.4). Individual ligand flow channels were activated for 5 min 
at 25 °C with a mixture of 1-ethyl-3-[3-dimethylaminopropyl carbodiimide 
hydrochloride) (0.2 M) and sulfo-N-hydroxysuccinimide (0.05 M). Immediately after 
chip activation, either RAD52 (100 µg.ml-1 in 25 mM Tris-Acetate, 20 mM KCl, 0.3 
mM magnesium acetate, pH 7.5) or the anti-HIV mAb 2F5 (100 µg.ml-1 in 10 mM 
sodium acetate, pH 5.0) was injected across ligand flow channels for 5 min at a 
flow rate of 30 µl.min-1.  
Excess active ester groups on the sensor surface were capped by a 5-min 
injection of 1 M ethanolamine HCl (pH 8.5). This resulted in the coupling of RAD52 
and 2F5 at a density of 9,000 RUs (response unit, which is an arbitrary unit that 
corresponds to 1 pg/mm2). The standard deviation in the immobilization level from 
the six spots within each channel was less than 4%. Compounds in indicated 
concentrations in 25 mM Tris-Acetate, 20 mM KCl, 0.3 mM magnesium acetate, 
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pH 7.5, supplemented with 0.005% polysorbate 20 and 2% DMSO were injected 
over the control and RAD52 surfaces at a flow rate of 200 µl min-1, for either a 30s 
(D-I09) or 1-min association phase (D-I03, D-G23), followed by a variable 
dissociation phase at 25 °C using the "one-shot" functionality of the ProteOn 
(Bravman et al., 2006).  
Specific regeneration of the surfaces between injections was not needed 
owing to the nature of the interaction. Data were analyzed using the ProteOn 
Manager Software version 3.0 (Bio-Rad). The responses of a buffer injection and 
responses from the reference flow cell with the anti-HIV mAb 2F5 were subtracted 
to account for nonspecific binding. Experimental data were fitted globally to a 
simple 1:1 binding model. The average kinetic parameters (association [ka] and 
dissociation [kd] rates) generated from three data sets were used to define the 
equilibrium dissociation constant (KD). Data that could not be adequately fitted to 
a binding model were analyzed using equilibrium analysis, plotting the response 
at equilibrium versus concentration and fitting to a steady state model. 
 
Measuring the effect of inhibitors on GFP-RAD52 and RAD51 foci formation.  
GFP-RAD52 foci formation was measured in a BCR-ABL1-positive BRCA1-
deficient 32Dcl3 murine hematopoietic cell line that expresses GFP-RAD52 
(Cramer-Morales et al., 2013). RAD51 foci formation was measured in parental 
32Dcl3. Both cell lines were. The cells were cultured in IMDM plus 10% FBS. The 
cells were plated at 500,000 cells/ml and pretreated for 4 h with either D-G23 or 
D-I03 (2.5 μM) for GFP-RAD52 foci or with D-I03 (2.5 µM) for RAD51 foci (or no 
175 
 
 
 
pretreatment for the control and cisplatin-treated cells). After 4 h of incubation, the 
cells were treated with 3 μg/mL cisplatin for 16 h. Following cisplatin treatment, 
cytospins were prepared using polylysine coated slides (Thermo Scientific). DNA 
was counterstained with DAPI. To detect RAD51 foci, cells were stained with an 
anti-RAD51 antibody (Thermo Scientific), followed by a secondary antibody 
conjugated with AlexaFluor 594. RAD51 and GFP-RAD52 foci were visualized with 
an inverted Olympus IX70 fluorescence microscope equipped with a Cooke 
Sensicam QE camera (The Cooke Co., Auburn Hills, MI, USA). Images from 25-
60 cells/group were processed using SlideBook 3.0 (Intelligent Imaging 
Innovation).  
 
Measuring the effect of D-I03 on single-strand annealing and gene 
conversion in U2OS cells.  
U2OS cells with the chromosomally integrated single-strand annealing 
(U2OS-SSA) or gene conversion HDR (U20S-HDR)-reporter were cultured in 
DMEM (Sigma D-6429) containing 10% FBS (Gibco) supplemented with 
antibiotics (penicillin 100 U/ml, streptomycin 100 μg/ml, and plasmocin 2.5 μg/ml 
(Gunn et al., 2011; Gunn and Stark, 2012).  At 80% confluence, cells were 
trypsinized and plated in triplicate at a density of 2x105 cells/well in 6 well plates. 
After 22 h cells, the wells were washed with 1X PBS and further incubated for 2 h 
in antibiotic-free DMEM-10% FBS.  Cells were transfected with pCBASce (0.8 μg) 
expressing I-SceI endonuclease or, in controls, with pUC19 (0.8 μg) or pMX-GFP 
(0.8 μg) plasmids using Lipofectamine 2000. After 3 h of transfection, cells were 
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washed with antibiotic-free DMEM-10% FBS. Then, cells were incubated in 
DMEM-10% FBS supplemented with antibiotics and containing D-I03 at indicated 
concentrations followed by additional incubation for 48 h. In each well, cells were 
washed with 1X PBS, trypsinized, and fixed with 3.3 % formaldehyde. Fixed cells 
were kept on the ice. The yield of GFP+ positive cells was measured by flow 
cytometry using Guava EasyCyte PRO (EMD Millipore). 
 
A.4 RESULTS 
A.4.1 High-throughput screening for RAD52 inhibitors.  
In order to target hereditary breast cancer and ovarian cancer cells, we 
wanted to develop small molecule inhibitors of RAD52 using high throughput 
screening (HTS) of compound libraries. In vitro, RAD52 carries out annealing of 
complementary ssDNA molecules and an invasion of ssDNA into homologous 
duplex DNA. To screen for inhibitors of RAD52 ssDNA annealing activity, we 
developed a fluorescence-quenching assay (Figure A.2). In this assay, RAD52 
promotes DNA annealing between synthetic ssDNA (Oligo 265-55; 55 nt) and 
tailed dsDNA (tdsDNA) composed of a ssDNA 60-mer (Oligo 337-FLU) carrying 
fluorescein (FLU), a fluorescence donor group, and an ssDNA 39-mer (1337-
BHQ1) carrying black hole quencher 1 (BHQ1), a non-fluorescent acceptor group 
(Figure A.2A). The RAD52-promoted reaction included two steps: 1) annealing 
between Oligo 265-55 and a 15-nt ssDNA region of the tdsDNA and 2) 
displacement of the ssDNA 1337-BHQ1 strand from the tdsDNA resulting in an 
increase in fluorescence due to secession of fluorescence quenching by the BHQ1 
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group (Figure A.2B; an example of the effect of D-I03 inhibitor on RAD52-promoted 
ssDNA annealing is shown in Figure A.2C and Figure A.3). Of these two steps, 
annealing was the limited step of the reaction in our assay, since RAD52 promotes 
DNA strand exchange between ssDNA and blunt end dsDNA poorly (Bi et al., 
2004). In order to decrease RAD52-independent (uncatalyzed) reaction during 
branch migration step, we incorporated a single mismatch in Oligo 265-55 ssDNA 
(Figure A.2A). 
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Figure A.2 Identification and characterization of RAD52 small molecule 
inhibitors. (A) Fluorescence-quenching assay for RAD52 ssDNA annealing (plus 
DNA strand displacement). Experimental scheme. FLU-fluorescein; BHQ 1–black 
hole quencher 1. DNA substrates contain a mismatch (denoted by x) to block 
spontaneous reaction. (B) The kinetics of ssDNA annealing measured on a 
FluoroMax3 fluorimeter. The fluorescence intensity was expressed in arbitrary 
units (AU). Shown is the representative result; the reactions were repeated at least 
three times. (C) RAD52 annealing activity was measured in the presence of D-I03 
in indicated concentrations.  (D) The scheme of the D-loop assay: RAD52 forms a 
complex with ssDNA and promotes its homologous pairing with pUC19 plasmid 
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DNA. Asterisk denotes 32P label on ssDNA. (E) Inhibition of the RAD52 DNA 
pairing activity by tested compounds (30 µM). Error bars indicate standard 
deviation (SD). 
 
 
 
 
 
Figure A.3 The effect of D-I03 concentration on the initial rate of ssDNA 
annealing promoted by RAD52. The rates of RAD52-promoted ssDNA annealing 
were calculated based on the data in Figure A.2C. The data are the mean of 3 
independent measurements; error bars represent the SD. 
 
 
The fluorescence-quenching assay was optimized for 1536 well plates (Z’ 
Avg = 0.64). The primary HTS of the 372,903-compound library yielded 1687 
positive hits that caused more than 30% inhibition of the RAD52-dependent 
fluorescence increase (0.5 % activities), including 628 hits in  a 93672-compound 
Broad’s diversity-oriented synthesis (DOS) library (0.7% activities) and 1115 hits 
in a 279,231-compound Molecular Libraries Probe Center Network (MPLCN) 
library (0.4% Activities). The hits were further analyzed for a concentration 
dependence in inhibiting of RAD52 and by testing their DNA binding affinity using 
the acridine orange assay. As a result, 187 compounds were identified that 
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inhibited RAD52 with the IC50 lower than 10 μM and displayed no DNA binding. 
These remaining compounds were assessed for their potential chemical tractability 
by removing compounds with highly reactive or unstable functional groups and 
focusing on chemotypes that were synthetically accessible and attractive. The 
selected compounds, as well as some closely related new analogs of certain hits, 
were next purchased as dry powders from commercial sources.  After executing 
this selection process, 70 compounds were obtained for further analyses.   
We tested the inhibitory effect of the 70 selected compounds using the D-
loop assay, in which RAD52 promotes pairing between 32P-labeled ssDNA and 
homologous supercoiled plasmid pUC19 DNA (Figure A.2D); the product of the 
reaction, D-loops, were analyzed by electrophoresis in 1% agarose gels. First, by 
testing the effect of the selected compounds at fixed (30 μM) concentration we 
identified 17 compounds that inhibited D-loop formation by more than 90% (Figure 
A.2E). Then, we measured the effect of each of the 17 compounds on RAD52-
dpendent D-loop formation in a concentration dependent manner. The IC50 of 
these compounds varied in a range between 2.7 μM and 17.5 μM (Figure A.4A-C; 
Table A.2). In the D-loop assay, the IC50 values were generally higher than in the 
fluorescence-quenching assay likely due to the higher RAD52 concentration 
employed by the former assay, 450 nM vs 25 nM, and due to the different nature 
of the assays.  
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Figure A.4 The effect of inhibitors on DNA pairing activity of RAD52. (A) The 
products of DNA pairing (D-loops) were analyzed by electrophoresis in 1% 
agarose gels. (B) Graphical representation of the data from A. (C) The IC50 values 
for 17 tested compounds. (D) The effect of the RAD52 inhibitors on DNA pairing 
activity of RAD51. The effect was measured using the D-loop assay at the 
inhibitors concentrations that correspond to their 10 x IC50 values (27 μM - 176 μM) 
for RAD52 pairing activity; concentrations of A05 and B02 were 100 μM. Error bars 
indicate SD. 
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Table A.2 Effect of inhibitors on the ssDNA annealing and DNA pairing 
activities of RAD52 and on the DNA pairing activity of RAD51 
 
Inhibitors  
ssDNA annealing 
(Fluorescence 
quenching),  
IC50, μM  
Inhibition of DNA 
pairing (D-loop 
formation),  
IC50, μM  
Inhibition of 
RAD51 paring 
(D-loop 
formation), %*  
D-A13  5.2  13.6±0.64 102.5±1.1 
D-A19  4.8  7.2±0.28  93.7±2.1 
D-A21  9.8  16.2±0.42 97.5±2.5 
D-C17  6.0  17.6±0.78  92.5±5.0 
D-C19  2.0  4.3±0.35  73.6± 2.2 
D-E05  1.7  11.3±0.35  110.9±4.3 
D-G09  2.0  14.8±2.47  108.2±3.1 
D-G11  6.0  8.9±1.6  110.7±0.2 
D-G23  5.6 7.2±0.96  75.6±7.1 
D-I01  3.6  15.4±0.57  112.5±4.2 
D-I03  5.0  8.0±1.7  95.5±4.3 
D-I05  4.3  8.8±0.42  75.1±4.8 
D-I07  2.0 2.7±0.35  38.4±6.4 
D-I09  6.8  10.6±1.4 58.6±2.9 
D-I11  4.1 6.7±0.78  48.6±2.0 
D-I19  3.5 4.1±0.14 35.3±5.8 
D-K17  2.9 4.8±0.85  89.7±0.4 
 
Note:* The effect of the inhibitors on RAD51 DNA pairing activity was measured 
at the concentrations that correspond their 10 x IC50 for RAD52 pairing activity. 
100% of the D-loop yield correspond to the extent of reaction in the presence of 
4% DMSO; the actual extent of D-loops was 44.7±0.2 % under these conditions. 
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Then, we examined the selectivity of the RAD52 inhibitors using RAD51 as 
a non-specific target. RAD51 is structurally unrelated to RAD52 but shares DNA 
pairing activity with RAD52. Using the D-loop assay, we found that at 
concentrations 10-fold higher than the IC50 for RAD52 DNA pairing activity, none 
of the 17 tested compounds (Figure A.5) showed a significant inhibition of D-loop 
formation (Figure A.4D). However, under suboptimal conditions for the D-loop 
assay at a reduced Ca2+ concentration (1 mM) three tested N-Methyl thieno 
pyrazoles compounds, D-I07, D-I11, and D-I19 (Figure A.5), showed non-specific 
inhibition of RAD51 greater than 2-fold relative to the DMSO control (Figure A.6; 
Table A.2). Overall, as a result of the HTS and several confirmatory and selectivity 
assays, we identified 14 specific inhibitors of ssDNA annealing and ssDNA pairing 
activity of RAD52 in vitro.  
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Figure A.5 Structures of RAD52 inhibitors. 
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Figure A.6 The effect of the RAD52 inhibitors on DNA pairing activity of 
RAD51 in the D-loop assay. To form RAD51 nucleoprotein filament, RAD51 (1 
μM) was incubated with 32P-labeled ssDNA (3 μM, nt) in buffer containing 25 mM 
Tris-Acetate, pH 7.5, 100 μg. ml-1 BSA, 1 mM calcium chloride, 1 mM ATP and 2 
mM DTT for 15 min at 37 °C. Then inhibitors were added at the concentrations that 
correspond to their 10 x IC50 values for RAD52 pairing activity (see Figure 2C; 
Supplementary Table 2) and incubation continued for 15 min at 37 °C. D-loop 
formation was initiated by addition of supercoiled pUC19 DNA (50 μM, nucleotides) 
and was carried out 15 min at 37 °C. The reactions were stopped and the products 
processed as described in Materials and Methods. Error bars indicate SD. 
 
 
A.4.2 Analysis of RAD52 inhibitors in human BRCA1- and BRCA2-deficient 
cells. 
Since it was previously shown that inactivation of RAD52 by siRNA and 
peptide aptamer causes lethality of BRCA1- and BRCA2-deficient cells (Cramer-
Morales et al., 2013; Lok et al., 2013), we suggested that the RAD52 inhibitors can 
also inhibit the growth of BRCA1/2-deficient cells. First, we tested the effect of 14 
RAD52 inhibitors identified in the biochemical assays on the growth of BRCA2-
deficient Capan-1 cells and BRCA2-proficient BxPC3 cells. BxPC3 cells are 
commonly used as a control for Capan-1 cells; these two well-differentiated 
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pancreatic adenocarcinoma cell lines show significant similarity and share the 
mutation status of a number of tumor suppressor genes, including p53, p16, Rb, 
have strong expression of COX-2 and MMP-9 (Abbott et al., 1998; Bogliolo et al., 
2000; Yuan et al., 1999). We found that five of the tested inhibitors preferentially 
suppressed the growth of Capan-1 cells (Figure A.7A).  
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Figure A.7 Effect of the RAD52 inhibitors on cell survival (A) Capan-1 
(BRCA2-) and BxPC3 (BRCA2+) cells and (B) on UWB1.289 (BRCA1-) and 
[UWB1.289 (+BRCA1)] (BRCA1+) cells. Capan-1 and UWB1.289 are denoted by 
the red line; BxPC3 and UWB1.289 (+BRCA1) indicated by a blue line. The 
experiments were repeated at least three times, error bars indicate SD. 
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We then tested the effect of RAD52 inhibitors on the growth of BRCA1-
deficient (UWB1.289 BRCA1-) and BRCA1-proficient (UWB1.289 BRCA+) cells. 
We found that 7 out 14 tested RAD52 inhibitors preferentially suppressed the 
growth of BRCA1-deficient cells; importantly, these 7 compounds included the 5 
compounds that inhibited the growth of BRCA2-deficient cells (Figure A.7B). We 
also tested the effect of the 14 RAD52 inhibitors on the survival of another BRCA1-
deficient cells, MDA-MB-436. Three out 14 compounds, which also inhibited the 
growth of UWB1.289 cells, showed an inhibitory effect on these cells compared 
with the isogenic MDA-MB-436 (BRCA1+) cells (Figure A.8A). Finally, we tested 
the effect of D-I03, the strongest inhibitor on BRCA1- and BRCA2-deficient cells, 
on BCR-ABL1 –positive BRCA1-deficient chronic myeloid leukemia (CML) patient 
cells (Podszywalow-Bartnicka et al., 2014). BRCA1-deficiency in these cells is due 
to constitutive downregulation of this protein. We found that D-I03 selectively 
diminished the growth potential of BRCA1-deficient CML patient cells in 
comparison to BRCA1-proficient normal counterparts (Figure A.8B). 
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Figure A.8 Effect of RAD52 inhibitors on the survival of MDA-MB-436 
(BRCA1-) and MDA-MB-436 (BRCA1+) cells (A) and on the survival of on BCR-
ABL1 –positive BRCA1-deficient CML cells and their BRCA1-proficient normal 
counterparts (B). The experiments were repeated at least three times, error bars 
indicate SD. 
 
 
Overall, two compounds, D-G09 and D-I03, showed an inhibitory effect on 
all three tested BRCA1- and BRCA2-deficient cell lines. Importantly, these 
compounds showed significant structural similarity sharing the quinoline core 
(Figure A.5). Another member of this structural group, D-G11, showed activity on 
two of the tested cell lines (UWB1.289 and Capan-1). Remarkably, three other 
compounds, D-G23, D-I05, and D-K17, that preferentially inhibited at least two 
BRCA1/2-defficient cell lines also share a similarity, but belong to another 
structural type with the quinazoline core. From all tested compounds, D-I03 
showed the strongest and most consistent inhibitory effect on all tested BRCA1-/- 
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and BRCA2-/- cell lines; moreover, it selectively inhibited the growth of BRCA1-
deficient CML cells from patients. 
 
A.4.3 Measurement of inhibitors binding to RAD52 by SPR. 
We then tested whether RAD52 inhibitors that showed activity in the 
biochemical and cell-based assays physically interact with RAD52. Using the 
surface plasmon resonance (SPR) method, we demonstrated that D-I03 (3.12−50 
μM) and D-G23 (3.125−25 μM) bind directly to RAD52 (Figure A.9). The anti-HIV 
mAb 2F5 structurally unrelated to RAD52 was used in control and the non-specific 
binding signal was subtracted from the RAD52 binding signal. The Kd values for 
D-I03 and D-G23 are 26.1±4.5 μM and 34.0 ±8.9 μM, respectively. These values 
are somewhat higher than one might expect from the IC50 values in the biochemical 
and cell-based assays with these inhibitors. Because the active form of RAD52 is 
a hexamer, the apparent differences in the activities of inhibitors may suggest that 
inhibition of RAD52 requires only partial saturation of the RAD52 hexamer with 
inhibitors. Using the acridine orange displacement assay we showed that D-I03 
and D-G23 did not bind DNA. Thus, these compounds inhibit DNA annealing and 
pairing activities of RAD52 through direct binding, not through interaction with DNA 
substrates.  
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Figure A.9 Measurement of D-I03 (A) and D-G23 (B) binding to RAD52. 
Compound D-I03 at concentrations of 3.125, 6.25, 12.5, 25, and 50 µM or 
compound D-G23 at concentrations of 1.56, 3.125, 6.25, 12.5, and 25 were 
injected to the chip with immobilized RAD52. Colored lines indicate experimental 
data, whereas black lines indicate fitting to the simple 1:1 binding model using the 
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ProteOn Manager Software version 3.0 (Bio-Rad). For D-G23 binding to RAD52, 
kinetic values are as follows: ka = 1.15 (±0.44) × 104 M-1s-1; kd = 3.62 (±0.7) × 10-
1 s-1; Kd = 34.0±8.9 µM. (C) For D-I03, the data did not fit to any available binding 
models and the Kd was determined using equilibrium analysis by plotting the 
response at equilibrium (Req) versus concentration of the compound. Experiments 
were repeated at least three times; error bars indicate S.D. 
 
 
A.4.4 Inhibitors disrupt RAD52, but not RAD51, foci formation. 
We wished to test whether D-I03 and D-G23 can inhibit RAD52 activities in 
the cell. In response to DNA damage, RAD52 accumulates in the nucleus forming 
distinct structures known as foci (Essers et al., 2002b; Liu and Maizels, 2000). It is 
thought that the foci represent RAD52 complexes with DNA repair intermediates. 
Inhibitors of RAD52 may decrease RAD52 foci formation by disrupting its 
interaction with DNA substrates. Indeed, we found that both D-I03 and D-G23 
inhibited RAD52 foci formation induced by cisplatin in a BCR-ABL1-positive 
BRCA1-deficient 32Dcl3 murine hematopoietic cell line that expresses GFP-
RAD52 (Cramer-Morales et al., 2013) (Figure A.10A). In the presence of D-I03 (2.5 
μM) and D-G23 (2.5 μM), the fraction of cells with RAD52 foci (≥5 foci) was 
decreased approximately 2.0 - 2.5-fold, from 38.7 ± 10% to 17 ± 1% and 19 ± 
0.4%, respectively; at the same time, the fraction of cisplatin-treated cells without 
foci was increased from 48.4 ± 6.2% to 71.9 ± 4.1 % and 57.6 ± 0.5 % (Figure 
A.10A, bottom right panel). Thus, compounds of two chemotypes, represented by 
D-I03 and G-23, were identified that inhibited the biochemical activities of RAD52 
in vitro, showed preference in suppressing survival of BRCA1- and BRCA2-
deficient cells and inhibited the formation of damage-induced RAD52 foci 
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formation.  We also tested a non-specific effect of D-I03, a strongest of theRAD52 
inhibitors, on RAD51 foci formation. Using parental 32Dcl3 (BRCA1-proficient) 
cells, we found that D-I03 does not have a significant effect on RAD51 foci induced 
by cisplatin (Figure A.10B). Also, D-I03 alone induce neither RAD51 foci nor 
RAD52 foci (in BRCA1-deficient cells; Figure A.10A) indicating low genotoxicity of 
this compound. 
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Figure A.10 Effect of RAD52 inhibitors D-G23 and D-I03 (2.5 µM) on GFP-
RAD52 foci formation in response to cisplatin (10 µM) treatment. (A) GFP-
RAD52 was constitutively expressed in p210BCR-ABL1-positive 32Dcl3 murine 
hematopoietic (BRCA1-deficient) cells. In control, cells were treated with D-I03 (2.5 
µM) alone. On the bottom right, the data are shown as a graph. Cells with a small 
foci number (1-5) were excluded from calculations. Error bars represent SD. (B) 
Effect of D-I03 (2.5 µM) on RAD51 foci formation with and without cisplatin (10 µM) 
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treatment in parental 32Dcl3 (BRCA-proficient) cells. On right, the data are shown 
as a graph. Average numbers of foci per cell on right panel were determined in 
cells with more than 10 foci. Error bars represent SD. 
 
 
A.4.5 D-I03 inhibits single-strand DNA annealing, but not gene conversion in 
U2OS cells. 
In both yeast and mammalian cells, RAD52 promotes single-strand DNA 
annealing (Krogh and Symington, 2004; Stark et al., 2004). Single-strand 
annealing is a type of homologous recombination that is initiated at double-strand 
breaks and mediated by annealing of fortuitous direct repeats flanking double-
strand break ends after their exonucleolytic resection. This mechanism leads to 
end re-joining with concomitant deletion of sequences between direct repeats. 
Here, using the SA-GFP construct integrated into the chromosomal DNA (Gunn et 
al., 2011; Gunn and Stark, 2012), we wished to examine the effect of RAD52 
inhibitor D-I03 on single-strand annealing in U2OS cells. The SA-GFP reporter 
system contains a 5’ fragment of the GFP (5’-GFP) gene, and a 3’ fragment of the 
GFP (3’-GFP) that contains an 18-bp I-SceI site (Figure A.11A). The GFP 
fragments are separated by 2.7 kb region and share a 266 bp region of homology. 
Transfection of cells with I-SceI expressing vector pCBASce induces a double-
strand break in the 3’-GFP. Repair of the double-strand break by single-strand 
annealing leads to the formation of GFP+ cells. Thus, each single-strand annealing 
event can be scored by the appearance of a green fluorescent cell.  
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Figure A.11 D-I03 inhibits single-strand annealing, but not homology 
dependent recombination (gene conversion) in U2OS cells. (A) The scheme 
of the reporter systems. The SSA-GFP reporter contains a 5’ fragment of the GFP 
(5’-GFP) gene, and a 3’ fragment of the GFP (3’-GFP) with an I-SceI site. The 
HDR-GFP reporter system contains the GFP gene interrupted by a Sce-I site and 
a fragment of the GFP with truncated 3’- and 5’-rerminus. Repair of the I-SceI-
induced double-strand break by either single-strand annealing or gene conversion 
leads to the formation of GFP+ cells (21). Effect of D-I03 on the repair of the I-
SceI-induced double-strand breaks in U2OS cells carrying the chromosomally 
located SSA-GFP (B) or HDR-GFP (C) reporter is shown by red line. In a control, 
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the effect of D-I03 on formation GFP+ cells was measured after transfection of 
U2OS cells with a pMX-GFP plasmid expressing GFP protein (green line). 
Formation of GFP+ cells in the absence of D-I03 was expressed as 100%. 
Experiments were repeated at least three times; error bars indicate S.D.  
 
 
We found that D-I03 reduces the formation of GFP+ cells in a concentration 
dependent manner; at 30 μM D-I03 the yield of GFP+ cells was reduced 
approximately 3.4-fold (Figure A.11B, red line; Figure A.12). In control, we 
measured the effect of D-I03 on the formation of GFP+ cells when U2OS cells 
were transfected with pMX-GFP plasmid encoding GFP (Figure A.11B; green line). 
We found that up to 30 μM, D-I03 had no significant effect on the recovery of GFP+ 
cells.  
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Figure A.12 The effect of D-I03 on the repair of the I-SceI-induced double-
strand breaks in U2OS cells carrying the SSA-GFP reporter was determined by 
flow cytometry. Green fluorescence (GRN-Hlog) was plotted against red 
fluorescence (RED-Hlog) for the sample of 10,000 cells. The GFP+ population is 
denoted by the elliptical M1 marker. Cells with I-SceI-induced double-strand 
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breaks were treated with D-I03 at 0, 5, 10, 15, 20, or 30 μM (panels 1−6, 
respectively). In a negative control, U2OS cells were transfected with pUC19, 
instead of pCBASce that expresses I-SceI (panel 7). U2OS cells transfected with 
a pMX-GFP plasmid expressing GFP protein were used as a positive control 
(panel 8). 
 
 
We then tested the effect of D-I03 on double-strand break repair via the 
canonical homology dependent recombination (also known as gene conversion) 
mechanism using the chromosomally integrated DR-GFP construct in U2OS cells 
(Gunn et al., 2011; Gunn and Stark, 2012). Previously, it was shown that RAD52 
has no significant effect on the homology-dependent recombination in mammalian 
cells (Stark et al., 2004). The DR-GFP construct consists of two inactive copies of 
the GFP gene, one that is disabled by insertion of I-SceI recognition site and 
another (iGFP) is truncated at both ends (Figure A.11A). A unique double-strand 
break is generated in this construct after the cells are transfected with the 
pCBASce plasmid. The repair of this double-strand break by gene conversion 
using iGFP as a template gives rise to the functional GFP gene. We found that D-
I03 does not have a significant effect on the formation of GFP-positive cells (Figure 
A.11C, red line; Figure A.13). D-I03 also has no effect on GFP expression or on 
the recovery of GFP-positive cells when U2OS cells were transfected with pMX-
GFP plasmid encoding GFP (Figure A.11C, green line). Taken together, our results 
indicate that consistent with inhibition of RAD52 in human cells D-I03 reduces the 
level of double-strand break-induced single-strand annealing, but not homology-
dependent recombination.    
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Figure A.13 The effect of D-I03 on the repair of the I-SceI-induced double-
strand breaks in U2OS cells carrying the HDR-GFP reporter (to measure 
gene conversion) was determined by flow cytometry. Green fluorescence (GRN-
Hlog) was plotted against red fluorescence (RED-Hlog) for the sample of 10,000 
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cells. The GFP+ population is denoted by the elliptical M1 marker. Cells with I-
SceI-induced double-strand breaks were treated with DI03 at 0, 5, 10, 15, 20, or 
30 μM (panels 1−6, respectively). In a negative control, U2OS cells were 
transfected with pUC19, instead of pCBASce (panel 7). U2OS cells transfected 
with a pMX-GFP plasmid expressing GFP protein were used as a positive control 
(panel 8). 
 
 
A.5 DISCUSSION 
RAD52 is an evolutionarily conserved eukaryotic protein, a member of the 
homologous recombination pathway that is responsible for repair of double-strand 
breaks, recovery of stalled replication forks, and faithful chromosome segregation 
during meiosis(Kowalczykowski, 2000; Moynahan and Jasin, 2010; Symington 
and Gautier, 2011; van Gent et al., 2001). In yeast, Rad52 plays a key role in 
homologous recombination; Rad52 null mutation obliterates nearly all types of 
recombination events and renders cells extremely sensitive to double-strand 
break-inducing agents.  Surprisingly, in mice RAD52 knockouts show virtually no 
DNA repair phenotype. The recent discovery that RAD52 mutations are 
synthetically lethal with mutations in BRCA1/2, PALB2, and RAD51 paralogs 
indicated that in mammalian cells RAD52 constitutes an alternative homologous 
recombination sub-pathway that may play a back-up role during double-strand 
break repair (Feng et al., 2011; Lok et al., 2013). This independent/redundant role 
of RAD52 in mammalian homologous recombination is also supported by 
cytological data. In response to DNA damage both RAD51 and RAD52 form 
nuclear foci, which are thought to play a role of the DNA repair centers. However, 
foci formation by these proteins show only partially overlap(Liu and Maizels, 2000) 
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and their formation is differently affected by mutations in other homologous 
recombination  genes; whereas RAD51 foci formation depends on the functional 
BRCA1, BRCA2, and RAD51 paralogs, RAD52 foci formation is independent of 
these proteins(van Veelen et al., 2005).  
 The mechanistic basis for the RAD52 function in homologous 
recombination in mammalian cells remains to be elucidated. Biochemical studies 
indicate that in S. cerevisiae Rad52 may play a role of a mediator that helps to load 
Rad51 recombinase on ssDNA at the site of double-strand breaks overcoming an 
inhibitory effect of Replicative Protein A (RPA), an abundant protein that has high 
affinity for ssDNA (Sugiyama and Kowalczykowski, 2002; Sung, 1997). The 
RAD51 nucleoprotein filament formed on ssDNA then searches for homologous 
dsDNA and invades it to form joint molecules (D-loops) that provide a template 
and a primer to recover the DNA lost at the site of the double-strand break. 
However, the mediator activity was not demonstrated for human RAD52 in vitro 
(Jensen et al., 2010).  
RAD52 possesses ssDNA annealing activity both in vitro and in vivo which 
can contribute to homologous recombination in several different ways (Mortensen 
et al., 1996; Stark et al., 2004; Sugiyama et al., 1998). This activity was implicated 
in the second DNA end capture during RAD51-dependent double-strand break 
repair resulted in the formation of double D-loops and then of Holliday junctions 
(Bugreev et al., 2007; McIlwraith and West, 2008; Sugiyama et al., 2006).  It was 
also proposed that the ssDNA annealing activity of RAD52 may be responsible for 
a step that follows DNA repair synthesis and D-loop dissociation: re-annealing of 
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the displaced ssDNA with the second DNA end of the double-strand break 
(Bugreev et al., 2007).  In addition, RAD52 ssDNA annealing activity may also 
contribute to homologous recombination in an RAD51-independent manner.  
Genetic data indicate that this activity may be responsible for the error-prone DNA 
single-strand annealing sub-pathway of homologous recombination, which is 
independent of RAD51 (Pâques and Haber, 1999). Furthermore, biochemical data 
show that RAD52, similar to RAD51, is able to promote D-loop formation, albeit 
with lower efficiency (Kagawa et al., 2008), suggesting that RAD52 may potentially 
substitute RAD51 in some homologous recombination events.   
Importantly, the RAD52-dependent mechanism of double-strand break 
repair is essential for viability in mammalian cells that are defective in BRCA1, 
BRCA2, PALB2, or in five RAD51 paralogs (Feng et al., 2011; Lok et al., 2013). 
Synthetic lethality provides a conceptual framework for discovering drugs that 
selectively kill cancer cells while sparing normal tissues (Bryant et al., 2005; 
Farmer et al., 2005; Helleday et al., 2007). In the current paper, we exploited 
synthetic lethality between the RAD52 and BRCA1&2 genes (Feng et al., 2011; 
Lok et al., 2013). We proposed that targeting of RAD52 with small molecule 
inhibitors will disrupt the RAD52-dependent homologous recombination sub-
pathway in BRCA1- and BRCA2-deficient cells causing their lethality. The data 
with peptide aptamer that disrupts RAD52 binding to ssDNA supported this 
hypothesis (Cramer-Morales et al., 2013). RAD52 represents an attractive 
potential therapeutic target also because no RAD52 mutations or inactivation has 
been documented in human tumors (Lok et al., 2013). Using HTS, we identified 
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several small molecule compounds that specifically inhibit RAD52 ssDNA 
annealing and DNA pairing activities. Importantly, the selected inhibitors of two 
different chemotypes showed inhibitory effect on tested BRCA1- and BRCA2-
deficient cells. The compound, D-I03, with the strongest inhibitory effect in human 
cells also selectively inhibited the growth of CML patient cells, in which the 
expression of BRCA1 was constitutively reduced (Podszywalow-Bartnicka et al., 
2014). Finally, RAD52 inhibitors D-I03 and, to a smaller extent, D-G23 also 
disrupted the formation of RAD52 foci induced by cisplatin. At the same time, D-
I03 had no significant effect on the formation of cisplatin-induced RAD51 foci 
indicating specific targeting of RAD52 in cells. In addition, D-I03 seems to have a 
low genotoxicity, as it did not induce RAD52 or RAD51 foci in BRCA1-defecient or 
BRCA1-proficient cells, respectively. In accord with specific targeting RAD52 in 
human cells, D-I03 inhibited the single-strand annealing in USO2 cells, without 
significantly affecting canonical homology-dependent recombination. Previously, 
genetic experiments demonstrated that in mammalian cells RAD52 plays an 
important role in single-strand annealing, but not in homology-dependent 
recombination (Stark et al., 2004).   
Structurally six RAD52 inhibitors that show the biological effect in human 
cells belong to two scaffolds, the quinoline, and quinazoline (Figure A.5). These 
scaffolds represent attractive starting points for medicinal chemistry optimization 
as at least three distinct regions of these chemotypes can be readily modified. 
Another important aspect to evaluate in prospective chemotypes is their calculated 
property profile. Gratifyingly, both chemotypes, represented by D-I03 and D-G23, 
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have calculated properties within ranges generally considered “drug-like” and 
favorable for important parameters such as oral bioavailability (Table A.3).  
 
 
Table A.3. Calculated properties of D-I03 and D-G23 compounds* 
 
  D-I03 D-G23 
molecular weight 429 354 
cLogP 3.65 3.29 
TPSA 47 89 
HBD 2 3 
HBA 5 7 
rotatable bonds 7 7 
* calculated using ADRIANA.code 
 
TPSA = topological polar surface area 
HBD = hydrogen bond donors 
HBA = hydrogen bond acceptors 
  
(https://www.molecular-
networks.com/files/docs/adrianacode/adrianacode_flyer.pdf) 
 
Previously, it was demonstrated that the N’-terminal domain is responsible 
for ssDNA annealing and DNA pairing activities of RAD52 (Kagawa et al., 2002). 
Therefore, we suggest that the selected compounds may specifically target this 
domain. However, more work is needed to investigate the mechanism of action of 
the inhibitors. We propose that RAD52 inhibitors can be used as prototypes for 
development of novel therapies against hereditary breast cancer and ovarian 
206 
 
 
 
cancers with defective BRCA1 or BRCA2 proteins. This therapy can also be 
potentially applied to sporadic cancers in which BRCA1 or BRCA2 are either 
mutated or downregulated, e.g., due to constitutive promoter methylation (Esteller, 
2008; Hansmann et al., 2012). Specific RAD52 inhibitors can also be used as a 
research tool to study the RAD52 biochemical activities and cellular functions. 
 
 
 
 
 
